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ABSTRACT 
Ultrasound Contrast Agents and Their Use in Triggered Drug Delivery 
Nicole R Wallace 
Advisor: Steven P. Wrenn, Ph.D. 
 
 
Over the past few years, ultrasound contrast agents have established their role in contrast 
enhanced medical imaging and bio-nanotechnology. These contrast agents have shown 
their potential for applications in molecular imaging and targeted therapy [7]. Triggered 
drug delivery vehicles in conjunction with ultrasound contrast agents have been recently 
developed to reduce drug dosage, toxicity, and side effects while providing a new 
methodology and technique for treatment of diseases. Different formulations of novel 
contrast agents have made great progress and play an ever increasingly important role in 
molecular imaging.  
 
The first part of this work is the development of the polymeric nested microbubble 
formulation, comprised of lipid coated SF6 microbubbles nested within a spherical 
polymer shell, and optimization of its properties to maximize contrast longevity and 
minimize safety concerns. The second aspect of this research is the design and testing of 
a liposomal nested microbubble containing lipid coated SF6 microbubbles within the 
aqueous core of a liposome which allows for ultrasound triggered release of calcein, a 
fluorescent drug mimic. Various formulations for both the polymeric and liposomal 
nested microbubbles were manufactured, evaluated, and analyzed for feasibility to 
function as a contrast agent and drug delivery vehicle.  
 
xviii 
 
A double passive cavitation detection technique was used to determine the influence of 
the nesting shell on inertial cavitation threshold for various polymeric nested 
microbubble formulations. Nesting shell diameter and microbubble concentration were 
varied from 2 to 20 μm and 2 to 6 x108 microbubbles/mL, respectively, to study their 
effect on inertial cavitation for peak negative pressures ranging from 50 kPa to 2 MPa. 
The nesting shell decreases inertial cavitation events from 97.96 % for an un-nested 
microbubble to 19.09 % for the same microbubble formulation nested within a 2.53 μm 
shell. As shell diameter decreases, the percentage of inertially cavitating microbubbles 
also decreases. For nesting formulations with average outer capsule diameters of 20.52, 
14.95, 9.95, 5.55, 2.53, and 1.95 μm, the percentage of sample destroyed at 1 MPa was 
51.02, 38.94, 33.25, 25.27, 19.09, and 5.37 % respectively. This study proposes that the 
nesting shell changes the resonance frequency of the microbubble, which leads to a 
change in inertial cavitation.  
 
Nesting microbubbles within a polymer shell not only decreases inertial cavitation events, 
but also enhances and prolongs the contrast to tissue ratio (CTR) in a clinically relevant 
imaging assay. The outer shell of the microcapsule is impermeable to gas such that the 
driving force for diffusion is eliminated.  The CTR profiles were measured for a wide 
range of polymeric nested microbubbles formulations in order to develop the theory and 
mathematical model for the gas transport from the gas core of the microbubble to the 
aqueous core of the nesting shell. As compared to un-nested microbubbles, nested 
formulations were longer-lived and gave higher final contrast ratios than a control sample 
comprised of un-nested, but otherwise equivalent, microbubbles. Specifically, the 
xix 
 
contrast ratio of the un-nested microbubbles decreased to a negative value after 4 minutes 
of continuous ultrasound exposure with complete disappearance of the microbubbles after 
15 minutes whereas all nested formulations maintained positive contrast ratio values for 
the duration of the 40 minute trial. A basic model for the diffusion of the microbubble is 
presented which takes into account the saturation level within the aqueous core of the 
polymer shell. 
 
It was found that rupture could not be accomplished for the polymer nesting shell, and 
therefore could not be used as a drug delivery vehicle in its current state. However, when 
the microbubbles are nested within a liposome instead of a polymer, damage to the 
liposome membrane caused by stable and inertial cavitation of the microbubble allows 
for release of the aqueous core of the liposome. Leakage was tested using fluorescence 
assays developed specifically for this drug delivery vehicle and qualitative measurements 
using an optical microscope. These studies were done with a 1 MHz focused ultrasound 
transducer while varying parameters including peak negative ultrasound pressure, 
average liposome diameter, and microbubble concentration. Two regimes exist for 
membrane disruption caused by cavitating microbubbles. A faster release rate, as well as 
permanent membrane damage are seen for samples exposed to high pressure (2.06 to 3.74 
MPa). A slower release rate and dilation/ temporary poration are characteristic of stable 
cavitation for low pressure studies (0.54 to 1.74 MPa). 
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CHAPTER 1: FUNDAMENTALS OF ULTRASOUND CONTRAST AGENTS 
 
1.1 Introduction 
 
Ultrasound imaging techniques are non-invasive and the penetrating nature of ultrasound 
enables direct visualization of the arterial wall itself [8]. To improve the echo generation 
in diagnostic ultrasound imaging, ultrasound contrast agents (UCAs) can be injected into 
the bloodstream [10]. UCAs are used to enhance the ultrasound signal safely and 
effectively by increasing the difference in acoustic impedance between the blood and 
tissue being imaged [11]. Micron-sized coated gas spheres, referred to as microbubbles, 
are currently used as UCAs. The coating monolayer is typically made of proteins, lipids, 
and other surface active materials [12]. This monolayer stabilizes the microbubble against 
surface tension-driven dissolution in aqueous fluids [9]. A stable microbubble with strong 
scattering characteristics is critical for achieving acceptable contrast for an ultrasound 
image.  
 
The development of these contrast agents has gone through several generations leading to 
significant improvements in image quality over the last two decades [12]. The first 
generation of UCAs consists of an air bubble encapsulated by a fatty acid or protein shell 
[13]. Microbubble stabilization techniques improved with the second generation of UCAs 
developed during the 1990s when the gas core of the microbubble transitioned from air to 
low solubility gases for increased longevity [14, 15]. Microbubble coatings also progress 
with the introduction of phospholipid and polymer shells, or a blend of both [16]. The 
encapsulation material preserves the microbubble through added resistance against 
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dissolution in aqueous fluids [9]. The use of these second generation phospholipid-coated 
microbubbles as UCAs is gaining considerable attention in the medical field because of 
the thin (2-3 nm) and highly elastic shell [17]. The third generation consists of 
encapsulated microbubbles whose shells contain special targeting properties [18]. The 
difference in acoustic impedance at the interface is high enough that all of the incident 
sound is reflected (although not all will return to the transducer). The microbubbles 
respond to the ultrasound signal by resonating with a specific frequency depending on the 
microbubble diameter.   
 
Additionally, ultrasound-mediated microbubbles have been proposed as an innovative 
method for noninvasive delivery of drugs and genes in the medical field [19]. The 
presence of microbubbles in the insonified field reduces the peak negative pressure (PNP) 
needed to enhance drug delivery with ultrasound. When acoustic pressure is increased 
beyond a certain threshold, the microbubble will begin to oscillate beyond its critical 
radius. At this point, implosion of the microbubble occurs during the subsequent positive 
pressure wave, known as inertial cavitation [20]. Poration or rupture of a nearby 
membrane as a result of ultrasound-induced cavitation has been proposed as a mechanism 
for facilitating drug delivery [21].  
 
This chapter will introduce the colloidal science of ultrasound contrast agents and address 
the latest innovations and technology involved with microbubble contrast agents and the 
future of this expanding field. The following topics will be discussed: the background of 
contrast agents and their interaction with ultrasound, current research being done in this 
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field, the impact contrast agents have on society, and the direction that research is 
heading in order to improve the efficiency and effectiveness of contrast agents. More 
specifically, the next few sections will outline the physics of the microbubble and how 
this affects their use as a contrast agent and drug delivery vehicle. Research studies will 
be summarized that demonstrate the use of microbubbles in the medical field and what 
the results imply for the future of microbubble contrast agents.  
 
1.2 Ultrasound as a Clinical Imaging Tool 
 
Humans can perceive sound within the frequency range 20 Hz-20 kHz and ultrasound 
encompasses all sound above 20 kHz [11]. In the medical field, ultrasound frequencies 
are in the range 1-40 MHz. These frequencies cannot be transmitted through air, so a 
solid or fluid material must be used in conjunction with the ultrasound transducer. An 
ultrasound transducer acts as both a transmitter and receiver of the ultrasound signal. The 
signal generated by the transducer usually consists of a pulse lasting several 
microseconds with a given center frequency. Some of the signal propagates through the 
tissue, some is reflected by macroscopic structures within the tissue, some is absorbed by 
the tissue, and the rest is scattered by structures smaller than the acoustic wavelength. 
The portion of the signal that is received by the transducer is used to construct an 
ultrasound image. This signal is the superposition of reflections at tissue boundaries and 
echoes from tissue backscattering. Current real time 2-dimensional imaging capabilities 
are in excess of 30 frames per second [22]. 
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An additional benefit of ultrasound is that it can be focused. An acoustic lens is designed 
so that the curvature takes into account the velocity of sound in the liquid and in the lens 
itself. Either a concave array of transducers or a transducer in the shape of a concave 
bowl is used to produce a focus [16]. The individual beams are low enough energy that 
they cannot cause any tissue damage but yet still provide the focus. When ultrasound 
frequencies are higher, closer to 1 MHz, the focus is on the order of a few cubic 
millimeters [23]. The power of the focus can be at a low level suitable for sonodynamic 
therapy or at a high enough power where excessive thermal effects damage tissue within 
the focal region. This is referred to as high intensity focused ultrasound (HIFU) and 
clinical trials are well advanced in its use for the treatment of patients with prostate, liver 
and other soft tissue cancers with the aid of contrast agents [24]. After the targeted region 
is identified, the focus is moved to treat adjoining sections of tissue. The downfall of this 
technique is that the individual beams must come together at the focus after passing 
through different tissue structures which can be difficult. As of now, the focus can only 
be achieved electronically and with accuracy through soft tissues. In one system that 
operates in the UK at the Oxford Churchill hospital, patients lie over a small bath of 
water in contact with their skin [25]. There are two concentric ultrasound transducers 
providing the ultrasonic energy in the base of the bath. A central transducer transmits a 
low-power diagnostic beam, allowing the doctor to visualize the tumor and guide the 
treatment; the other produces the focused beam. 
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1.3 Microbubbles as Ultrasound Contrast Agents 
 
Microbubble Physics 
Blood cells are poor scatterers in the clinical diagnostic frequency because their density 
and compressibility are very similar to that of plasma. The ability to image blood flow 
and measure organ perfusion is desirable in the medical field so markers are added to the 
blood to differentiate between blood and other tissue types [26]. Microbubbles have 
resonance frequency in the medical ultrasonic range and are well suited as an ultrasound 
contrast agent. The pressure inside of the bubble must be higher than the ambient 
pressure; the difference is usually referred to as the surface pressure [27]. To prevent 
rapid dissolution, contrast agent microbubbles contain low solubility gas, such as SF6 
[28]. A bubble in a low-amplitude sound field can be considered a forced damped 
harmonic oscillator. Models describing its behavior based on the Rayleigh-Plesset 
equation are modified to account for the presence of an encapsulating shell when present 
[13, 29, 30]. 
 
A dynamic bubble generates an acoustic signal which depends on the fluid displacement 
by the bubble as a function of time. Detection strategies, such as coded excitation and 
harmonic power Doppler, have been developed that can identify acoustic signal generated 
by ultrasound contrast agent microbubbles from other acoustic signals [22]. These 
strategies are based on the fact that microbubbles are nonlinear oscillators. If a bubble 
with a shell collapses near a free or solid boundary, the effect on the liquid nearby can 
cause bubble asymmetry which leads to differences in acceleration on the bubble surface 
[31]. During further collapse, a funnel shaped jet may protrude through the bubble, 
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shooting liquid to the boundary. These jets have been observed in high speed 
observations of microbubbles [32]. Recently, this phenomenon has been looked into for 
its usefulness in ultrasound guided drug delivery.  
 
Encapsulated Microbubbles 
An unencapsulated gas bubble in liquid lacks stability and would therefore quickly 
dissolve. To stabilize a microbubble, the gas is encapsulated within a solid shell. A 
common way to encapsulate microbubbles is to use a phospholipid monolayer in the gel 
phase [33]. Commonly used lipids are Dilauroyl phosphatidylcholine (DLPC), 
Dimyristoyl phosphatidylcholine (DMPC), Dipalmitoyl phosphatidylcholine (DPPC), 
Distearoyl phosphatidylcholine (DSPC), and Diarachidoyl phosphatidylcholine (DAPC) 
where each phospholipid has a carbon chain length of 12, 14, 16, 18 and 20, respectively. 
The type of lipid has an influence on the dilatational viscosity and surface tension. These 
phospholipids have the ability to self-assemble based on their molecular structure. The 
lipid is amphiphilic so that the tail group is hydrophobic and the head group is 
hydrophilic.  The head group will arrange itself so that it is within the aqueous phase 
(outside of gas microbubble) and the tail group will align itself far from the aqueous 
solution and coat the gas interface, which reduces their free energy [34]. In order to 
further stabilize the lipid and prevent diffusion of the gas core, a polyethylene glycol 
(PEG) hydrophilic polymer can be incorporated into the monolayer. Another benefit of 
the PEG is the prevention of bubble coalescence by creating a steric hindrance between 
bubbles [35]. 
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Brush versus Mushroom Regime 
In 1980 Alexander and De Gennes derived scaling laws that showed that the height of 
grafted polymers is independent of grafting density at low densities (“mushroom” 
regime) and scales with the third root of the grafting density at high densities (“brush” 
regime) [36]. The amount of PEG incorporated into the lipid monolayer determines 
whether the microbubble is in the brush or mushroom regime. At relatively low PEG 
functionalization, the polymer has space sufficient to exhibit a more random structure 
(with one end grafted to the lipid), and is therefore in the mushroom regime. As PEG 
functionalization increases, the polymer strands begin to feel the presence of the others in 
the membrane and begin to straighten and stand upright, normal to the membrane [37]. 
This densely packed formation is known as the brush regime. These two regimes are 
shown in Figure 1.1.  
 
 
1Figure 1.1:   Brush and mushroom regime. 
 
 
 
 
 
 
 
Resting
Expanded
Compressed
Applied 
Pressure
Applied 
Pressure
Fragmented
1. When ultrasound pressure 
is GREATER than the inertial 
cavitation threshold…
2. the bubble expands, 
but the magnitude of
expansion  is small enough....
3. …that the bubble 
survives upon
compression.
B.    INERTIAL 
CAVITATION
1. When ultrasound pressure 
is LESS than the i rtial 
cavitation threshold…
2. the bubble expands
sufficiently large so that 
upon compression…
3.  the bubble 
implodes and
breaks into
fragments.
Expanded
C. MONOLYAER PROPERTIES INFLUENCE 
INERTIAL CAVITATION THRESHOLD
Figure 1 - Inertial Cavitation of Lipid-Coated Microbubbles:  Ultrasound causes
lipid-coated microbubbles to expand and contract.  If the pressure is below a
critical value, called the inertial cavitation threshold,  then the bubble undergoes
sustained oscillations (A). If the pressure is above the threshold, then the bubble
implodes, breaking into small fragments (B).  The inertial cavitation threshold 
pressure depends on the material properties of the lipid coating (e.g., area 
expansion modulus and surface tension), which are set by the monolayer  
composition (lipid chain length, PEG mol. wt. and regime - brush vs. mushroom -,
and on the presence of a PLA microcapsule and distance to the PLA wall (C)). 
A.    SUSTAINED 
OSCILLATIONS
“Brush”
“Mushroom”
1. Lipid chain length
3. Presence of repulsive
encapsulating wall
water
PLA
2. PEG (mole fraction,
mol. wt., and regime)
wall
Resting
Ex anded
Compressed
Applied 
Pressure
Applied 
Pressure
Fragmented
1. When ultrasound pressure 
is GREATER than the inertial 
cavitation threshold…
2. the bubble xpands, 
but the magnitude of
expansion  is small enough....
3. …that the bubble 
survives upon
compression.
B.    INERTIAL 
CAVITATION
1. When ultrasound pressure 
is LESS than the inertial 
cavita ion threshold…
2. the bubble xpa ds
sufficiently large so that 
upon compression…
3.  the bubble 
implodes and
breaks into
fragments.
Expanded
C. MONOLYAER PROPERTIES INFLUENCE 
INERTIAL CAVITATION THRESHOLD
Figure 1 - Inertial Cavi ation of Lipid-Coated Micr bubbl s:  Ultrasound causes
lipid-coat mi robubbles to expand and contract.  If the pr ssure is below a
critical value, called the inerti  cavitation threshold,  then the bubble undergoes
sustained oscillations (A). If the pressu e is above the thresh ld, then the bubble
implodes, breaking into small ragme ts (B).  The inertial cavi ation threshold 
pressure depe ds on t e material properties of the lipid coating (e.g., area 
expansion modulus and surface tensi n), which are set by the monolayer  
composition (lipid chain length, PEG mol. wt. and regime - brush vs. mushroom -,
and on the presence of a PLA microcapsule and distance to the PLA wall (C)). 
A.    SUSTAINED 
OSCILLATIONS
“Brush”
“Mushroom”
1. Lipid chain length
3. Presence of repulsive
encapsulating wall
water
PLA
2. PEG (mole fraction,
mol. wt., and regime)
wall
                                             The cavitation threshold of the microbubble is determined 
by its material properties of the lipid monolayer. These properties are influenced by the 
monolayer compositions, such as (1) the length of the lipid chain, (2)  molecular weight of 
the PEG lipid, the mole fraction of PEG, and the regime (mushroom versus brush), and 
(3) the presence of repulsive forces when the microbubble is encapsulated within a PLA 
microcapsule [1] 
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Interaction between Microbubbles and Ultrasound 
UCAs are used to enhance the ultrasound signal safely and effectively by increasing the 
difference in acoustic impedance between the blood and tissue being imaged. Gas filled 
microbubbles act as echo-enhancers by backscattering the echo intensity which is 
proportional to the change in acoustic impedance between the blood and gas [11]. The 
microbubbles respond to the ultrasound signal by resonating with a specific frequency 
depending on the microbubble formulation. In addition to the main resonance frequency, 
multiple harmonic frequencies are also emitted with decreasing intensity. The second 
frequency, known as the second harmonic, is still strong enough to be used for diagnostic 
imaging with the added benefit that only contrast agent microbubbles resonate with 
harmonic frequencies, while adjacent tissues do not [11]. Microbubbles expand during a 
negative pressure ultrasound wave and contract during a positive pressure ultrasound 
wave, which causes the microbubbles to oscillate or resonate. This process is known as 
cavitation and is discussed in the next section.  
 
1.3.1 Microbubble Cavitation 
 
Microbubbles increase the absorption of sonic energy through a mechanism known as 
cavitation [38]. An ultrasonic wave causes the microbubbles to oscillate with a wall 
velocity on the order of tens to hundreds of meters per second [12]. As ultrasound 
interacts with microbubbles through expansion and contraction during negative and 
positive pressure phases, the microbubbles undergo sustained oscillations, a process  
known as stable cavitation shown in Figure 1.2A [38]. As you increase the peak negative 
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                                                             Ultrasound causes lipid coated microbubbles to expand and contract. 
If the pressure is below the inertial cavitation threshold, then the bubble will continue to contract and 
expand with the positive and negative pressure wave and experience sustained oscillations. If the pressure is 
above the inertial cavitation threshold then upon expansion, the radius is sufficiently large so that during the 
compression phase of that wave, the bubble implodes, known as cavitation [1]. 
pressure, the microbubble will expand so large, typically accepted as twice its resting 
radius [39], that upon subsequent contraction it implodes shown in Figure 1.2B. As the 
bubble contracts from its maximum to minimum radius, the fluid surrounding the bubble 
gains enough momentum that the pressure within the bubble is not able to withstand the 
outside fluid. Therefore, the inertia from the fluid causes the radius of the bubble to 
quickly decrease and collapse. The peak negative pressure at which the microbubble 
implodes and fractures is known as the inertial cavitation threshold, typically around 1.5 
MPa at 2.5 MHz for microbubbles with radii from 0.1 to 10 μm [40, 41]. Acoustic power, 
frequency, and microbubble shell dynamics determine if and when the microbubble will 
be destroyed.  
 
 
2Figure 1.2: Cavitation of microbubble. 
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UCAs are effective nuclei for stable and inertial cavitation and can cause both beneficial 
and deleterious bioeffects when driven into volumetric oscillation upon exposure to 
ultrasound [42]. The local effects of the destruction of the microbubble have been used 
for therapeutic applications [43, 44]. Sustained stable cavitation, which is characterized 
by subharmonic and ultraharmonic acoustic emissions from microbubbles, has been 
shown to facilitate penetration of thrombolytics into clots [45] and delivery of 
therapeutic-loaded ELIP into tissue [46]. Inertial cavitation, which is characterized by 
broadband acoustic emissions from inertially collapsing microbubbles, has been shown to 
facilitate ablation of cancerous tissue [42]. Ultrasound-induced UCA destruction at high 
mechanical indices (MI > 0.4) can also trigger inertial cavitation near cellular membranes 
resulting in microvascular damage, cellular apoptosis and petechial hemorrhage [47]. The 
dynamic state of ultrasound-excited microbubbles (MBs) in the treatment region is 
directly responsible for the therapy outcome and can be controlled by the local acoustic 
field [48]. Therefore, it is essential to control and maintain a desirable type and level of 
MB cavitation in the treatment area inside the body for all patients.  
 
Safety of Ultrasound Contrast Agents 
During inertial cavitation, the velocity at the gas liquid interface on the bubbles surface  
is supersonic in the liquid (~1500 m/s in some cases) [13].  The supersonic movement 
produces shockwaves and an increase in temperature within the surrounding fluid that 
propagates outward. If a biological material is close enough to experience these effects of 
inertial cavitation, the large stresses have been shown to cause damage [49]. This damage 
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to biological materials, including cell death, is linked to reactions with a wide range of  
severity, including human death [50].  
 
In order to prevent damage to cells by inertial cavitation, clinical transducers are designed 
to operate below the predetermined mechanical index (MI) which is used as an estimate 
for the degree of bio-effects a given set of ultrasound parameters will induce. The MI is 
defined as the peak negative pressure of the ultrasound wave in MPa divided by the 
square root of the center frequency of the ultrasound wave in MHz [13]. The current FDA 
stipulation is that the MI cannot exceed 1.9 [13]. This empirical parameter is a single 
value across all transducers and for all microbubble compositions, rather than a value 
based on the inertial cavitation of the microbubble.  
 
The Food and Drug Administration (FDA) dispensed a black box label on commercially 
available ultrasound contrast agents in 2007 due to a death during cardiac imaging [51]. It 
is not clear whether this death was due to the use of contrast agents or other complicating 
factors, but UCAs remain under FDA warning nonetheless. The criticism that has 
surrounded the FDA warning label since 2007 indicates that a concrete general consensus 
surrounding contrast agents is currently lacking [52, 53]. 
 
1.3.2 Microbubble Dissolution 
 
Bubbles suspended in a liquid can coalesce, grow or shrink in response to changes in the 
environment [54]. The surface tension between the gas–liquid interface, the hydrostatic 
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pressure and the acoustic pressure induce diffusion of gas into the surrounding liquid. 
The dissolution process causes free gas microbubble to disappear within seconds after 
having been introduced in the blood circulation. Smaller bubbles are more susceptible to 
these influences, because the excess pressure within the bubble that is generated to 
balance the surface tension inversely scales with the bubble radius, pσ = 2σ/R0 [55]. This 
excess pressure tends to raise the partial pressure of the gas inside the bubble to greater 
than the partial pressure of the gas that is dissolved in the surrounding liquid. The 
Ostwald coefficient (L) is defined as the dimensionless ratio of the solubility of the gas in 
the liquid to the gas density [56]. A gas with a higher value for this parameter dissolves 
faster than a gas with a lower Ostwald coefficient. Commercial UCAs contain a high 
molecular weight gas, such as perfluorocarbons (Definity, Sonazoid, and Optison) or 
sulfur hexafluoride (SonoVue). The diffusion of a gas is inversely proportional to the 
square root of its molecular weight; therefore, gases with a higher molecular weight allow 
for slower diffusion of the gas core [55].  
 
When an encapsulation layer is added to the gas-liquid interface of the microbubble, 
diffusion of the gas core is slowed even further compared to a free gas microbubble 
which is more appealing for clinical use.  Encapsulation materials, such as phospholipids 
and polymers, decrease the surface tension which limits the driving force for dissolution 
of the microbubble. The coating affects the microbubble behavior in the presence of 
ultrasound exposure by dampening the oscillations of the microbubble and altering the 
microbubble’s natural frequency. Although the encapsulation layer alters the 
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characteristics of microbubbles such as viscous damping and microbubble resonance 
frequency, encapsulated bubbles are still highly responsive to ultrasound excitation [57]. 
 
1.3.3 Modelling of Microbubble Behavior 
 
Since the clinical approval and marketing of UCAs in the 1990s, a broad range of UCAs 
and UCA models have been developed. There are several mathematical models available 
in the literature which try to capture the dynamics of the microbubbles dissolution 
mathematically. Recently, Doinikov and Bouakaz have presented an exhaustive study on 
the existing contrast agent models. They compared the principle behind the derivation of 
each model and, specifically, the different formulations introduced for the shell 
parameters of the microbubbles [47]. Although the models have helped in understanding 
the responses of coated bubbles, the influence of the coating has not been fully elucidated 
and UCA models are still being improved. Encapsulated microbubbles were first modeled 
by De Jong et al. [58] and De Jong and Hoff [59] incorporating elasticity and friction 
parameters into the Rayleigh–Plesset model. Church et al. used linear visco-elastic 
constitutive equations to describe the shell [60].  
 
Many models exist to describe the influence of the shell on the behavior of the 
microbubble oscillations, but each model is based on certain assumptions which limit its 
application. Some of these models have not accounted for variation in shell resistance nor 
variation in surface tension due to elastic shell material during the microbubble 
dissolution [61-63]. Also, arbitrary values to many of the microbubble properties such as 
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shell resistance, shell elasticity and the mass transfer resistance have been assumed in 
these reports [30]. Ideally, for ultrasound contrast agents, the model would take into 
account both change in microbubble radius due to dissolution (passive and ultrasound 
induced [64]) in combination with microbubble behavior in the presence of ultrasound. 
At this time there is not a widely accepted dissolution model for a microbubble exposed 
to ultrasound, so we must look at the cavitation behavior of the microbubble separately. 
 
The Rayleigh-Plesset Equation  
The general behavior of the bubble oscillations can be captured by the Rayleigh– Plesset 
equation: a nonlinear ODE derived under the assumption of spherical symmetry from the 
Navier–Stokes equations of the liquid [65]. In 1917, Rayleigh considered the collapse of 
a spherical empty cavity in an incompressible liquid [66]. The link between cavitation 
and bubble dynamics was the introduction of a variable external driving pressure and the 
influence of surface tension by Plesset [67]. Plesset described the dynamics of vapor-
filled bubbles and Noltingk and Neppiras [68] did the same for gas-filled bubbles. The 
effect of viscosity on the equation of motion of a bubble in an incompressible liquid was 
considered by Poritsky. These contributions led to the Rayleigh–Plesset–Noltingk–
Neppiras–Poritsky (RPNNP) equation [69]. Starting from the Navier–Stokes equations 
assuming liquid incompressibility and including viscous effects in the boundary 
conditions, we arrive at this equation, which is now known as the Rayleigh–Plesset 
equation [66]: 
 
15 
 
𝜌𝑙 (𝑅?̈? +
3
2
?̇?2) = (𝑝0 +
2𝜎
𝑅0
− 𝑝𝑣) (
𝑅0
𝑅
)
3𝜅
+ 𝑝𝑣 −
2𝜎
𝑅
−
4𝜇?̇?
𝑅
− 𝑝0 − 𝑃(𝑡) 
(Equation 1.1) 
 
where 𝜌𝑙 is the density of the liquid, R is the dynamic bubble radius, ?̇? is the bubble wall 
velocity, ?̈? is the bubble wall acceleration, 𝑝0 is the ambient pressure, 𝜎 is the interfacial 
tension, R0 is the initial microbubble radius, 𝑝𝑣 is the pressure in the microbubble, μ is 
viscosity of the surrounding water, κ is the polytropic factor, and 𝑃(𝑡) is the driving 
pressure.  
 
Modified Rayleigh-Plesset Equation 
More recent models remove the assumption that the surrounding liquid is incompressible 
which is tantamount to implying that the speed of sound would be infinite. For large 
bubble oscillations (Rmax/R0 > 2, R > 0.01 · c), a modified version of the Rayleigh-Plesset 
equation should be used.  Equations from the Herring–Keller/Keller–Miksis or Gilmore–
Akulichev families [70] incorporate radiation damping, which is applicable for higher 
acoustic pressures and larger bubble vibrations. A modified version of the Rayleigh-
Plesset equation is shown in Equation 1.2:  
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(Equation 1.2) 
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Surfactant Coated Models 
A surfactant coating reduces interfacial tension and provides a barrier to bubble 
dissolution. As the surface concentration of surfactant molecules is increased, the effects 
of the coating become progressively more substantial [71]. Instead of treating the coating 
as a solid elastic layer as in the previous models, more rigorous models have been 
developed to account for the surfactant coating.  
 
Morgan et al. [68] investigated the contrast agent MP1950 (Mallinckrodt, Inc., St. Louis, 
MO) which has a decafluorobutane core coated by a phospholipid monolayer [72]. The 
model used is based on the modified Herring equation, which accounts for the higher 
bubble wall speeds as a result of the higher flexibility of the phospholipid coating. The 
main difference between this equation and the Rayleigh-Plesset equation used by others 
is the treatment of the damping caused by re-radiation. In the Rayleigh-Plesset model, the 
radiative losses are included in a total damping coefficient, but in the modified Herring 
equation the losses are included as a separate term given by  
𝑅
𝑐
?̇?, where ?̇? is the pressure 
in the liquid surrounding the bubble. At driving pressures that result in radial fluctuations 
greater than 100%, the coating elasticity term ensures the model is more accurate than the 
Rayleigh-Plesset equation [10].  
 
Studies have shown that microbubbles react differently to identical ultrasound fields 
based on the properties of the individual bubble [73]. Kooiman et al. investigated the 
distribution of lipids throughout the coating surface in fluorescence confocal microscopy 
studies [74]. For each contrast bubble, different lipid distributions were observed which 
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may be the cause of individual coating properties. Chatterjee and Sarkar suggest that the 
microbubble coating with a thickness of a few molecules should not be considered a solid 
layer [29]. They apply a Newtonian interfacial rheological model to simulate the behavior 
of Optison where only viscous interfacial stresses are considered. This model, however, 
resulted in impractical values for the surface tension of the coating. To circumvent the 
issue, Sarkar et al. added an elasticity term to this model and concluded that a surface 
dilatational elasticity constant that decreases with an increasing fractional area [75] is 
necessary.  
 
More recent models dedicated to large amplitude oscillations of surfactant coated agents 
follow this trend and include coating parameters that vary with the bubble surface area 
[82]. The last model assuming small bubble oscillations described here is the model by 
Doinikov and Dayton [83]. They developed a theoretical description of lipid-coated 
microbubbles in which the linear Maxwell constitutive law was applied instead of the 
Kelvin–Voigt constitutive law. This model replaces the shell elasticity and viscosity used 
in the Kelvin-Voigt equation with six parameters: relaxation time λ, shear viscosity ηs, 
surface tension coefficients σ1 and σ2, density ρs, and thickness of the shell (R2 − R1) to 
describe the coating.  
 
A model accounting for large amplitude, nonlinear microbubble oscillations was first 
proposed by Marmottant et al. [76] describing compression-only behavior. Three 
parameters were used to describe the properties of the shell: a buckling radius, the 
compressibility of the shell, and a break-up shell tension. Using an ad hoc effective 
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surface tension to account for the coating elasticity, the bubble radius is dependent on the 
concentration of phospholipid molecules. During the positive pressure phase, the 
microbubble is compressed, leading to buckling where the bubble coating is in a 
tensionless state with a zero surface tension. In the expansion phase, the coating may be 
ruptured which exposes the gas to the bulk medium. The surface tension in this case is 
equivalent to a gas-liquid interfacial surface tension. More recent studies replace the 
provisional surface tension with a well-defined surface tension for a more accurate 
portrayal of the bubble behavior. In a study done by Tsiglifis and Pelekasis, the Keller-
Miksis equation is used to model the bubble dynamics [77]. In this case, the surfactant 
coating is considered a continuum described by a variable elasticity, G, and viscosity µs. 
Stride proposes a model that considers both the coating elasticity and viscosity as 
instantaneous radius- dependent [78].  
 
The dynamic behavior of UCAs in the presence of an ultrasound wave is applicable to 
endless possibilities for diagnostic and therapeutic use. These uses include sonoporation, 
blood-brain barrier disruption, and enhanced thrombolysis. However, there are many 
challenges in understanding the UCA response. The equations discussed in this chapter 
offer significant improvements to the RPNNP equation, but the microbubble response is 
still incompletely characterized during large amplitude dynamics. As the microbubble 
behavior is clarified, it will have a growing potential for implementation in many 
therapeutic applications.   
 
19 
 
1.4 Therapeutic Application of Microbubbles 
 
Cavitation of microbubbles can be used to dissolve blood clots or deliver drugs [79]. 
Targeting ligands and drugs can be incorporated into microbubbles to make highly 
specific diagnostic and therapeutic agents for activation with ultrasound [43]. In therapy, 
there is clear evidence that microbubbles increase the permeability of the cell membrane 
to large molecules (both drugs and genes) when a suspension of cells is exposed to 
ultrasound in the presence of a UCA [80]. In vivo it has been shown that ultrasound 
enhanced with a UCA may transiently disrupt the blood-brain barrier in animal models 
with minimal damage, providing a technique for non-invasive, localized drug-delivery 
deep within the brain [81].  
 
1.4.1 Microbubbles for Thrombolysis and Coagulation Necrosis 
 
Therapeutic Microbubble Delivery Systems for Thrombolysis 
Thrombolysis is a constant target for therapeutic ultrasound. Birnbaum et al. [21] 
demonstrated the administration of albumin microbubbles for transcutaneous ultrasound 
potentiated arterial thrombolysis without the additional use of tissue plasminogen 
activator (tPA). The controls treated with either ultrasound or microbubbles did not 
induce reperfusion. Culp et al. [21] reported their results using thrombolytic agents 
associated with therapeutic ultrasound where an experimentally induced, autogenous 
venous clot was injected into arteries of swine. The treatment involved intravenous 
injection of eptifibatide, an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class 
[43]. The experimental design included the presence or absence of microbubbles, both 
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using transcutaneous ultrasound. The results indicated that the microbubbles, when 
associated with eptifibatide, resulted in significantly increased thrombus dissolution [21]. 
 
In a later study, these authors reported the use of therapeutic ultrasound for thrombolysis 
using nontargeted microbubbles versus platelet-targeted microbubbles with high MI 
power [21]. This induced thrombolysis within the left anterior descending artery. Both 
targeted and nontargeted microbubbles allowed for an improvement in thrombolysis, 
where the platelet targeted microbubbles were the most successful. The potential that 
targeted therapy has in a clinical setting is extremely intriguing because of the ability to 
limit systolic adverse effects [43]. Researchers in the Netherlands at VU University have 
reported results from a study of the Sonolysis trial where thrombolysis was achieved in 
patients with first acute ST elevation myocardial infarction through the use of 
microbubbles with three dimensional guided therapeutic ultrasound. This demonstrated 
the safety and efficiency of this technique [21]. 
 
Coagulation Necrosis 
Induction of coagulation necrosis using radio frequency has recently been promoted as 
another minimally invasive procedure for tumor ablation. This technique involves an 
electrode probe inserted into the tumor where the probe generates thermal energy via an 
electric current within the tumor, therefore causing necrosis [2]. The use of contrast 
agents for this technique allows for real time imaging guidance of the probe and the 
potential to perform the procedure on an outpatient basis. The increased echogenicity of 
these agents improved detection of parenchymal organ blood flow compared with the 
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echogenicity achieved with routine color Doppler and power Doppler ultrasound [82]. As 
a result, previously undetected differences in vascularity between benign and malignant 
lesions can be detected. The short life (~seconds to minutes) of commercial contrast 
agents makes this process difficult because it requires frequent new doses of contrast 
agent and provides insufficient images of the lesion. These deficiencies lead to a 
recurrence rate of more than 33% [2].  
 
1.4.2 Triggered Drug Delivery 
 
The goal of microbubble use in targeted drug delivery is to improve the efficacy of the 
drug in a localized region of the disease in order to minimize undesired side effects in 
healthy tissue. A popular method combines an externally applied trigger for delivery due 
to its noninvasive nature. This approach controls drug action and deposition in the 
targeted region [83] using non-ionizing radiation, so it does not have the same risks as x-
rays or other types of ionizing radiation. The presence of an ultrasound energy deposition 
tool in the tissues provides an efficient way of perturbing cell membranes and increasing 
their permeability. Aspects of this topic, such as patient safety, drug payload, side effects, 
and effectiveness are currently being researched. 
 
The cellular uptake of drugs and genes is increased when ultrasound is applied to the 
region, and even more so when a contrast agent is present [21]. The increased uptake is 
due to the formation of transient pores in the cell membrane. These pores are large 
enough for the transport of drugs into the cell to take place. This transient 
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permeabilization and resealing of a cell membrane is known as sonoporation. This has 
been accomplished in several studies with pore sizes up to 100 nm diameter, which 
implies that drug size is not a limiting factor [21]. However, the pore opening time should 
be short so that if the drug is internalized, it will be released close to the cell membrane 
when poration occurs. There are two proposed hypotheses for the phenomenon where one 
states that the microbubble oscillations near the cell membrane are able to create the 
pores while the second suggests that microbubble jetting through the cell membrane is 
the cause of the poration. It was concluded that microbubble jetting is not the dominant 
sonoporation mechanism [22]. 
 
Instead of solely facilitating the transient opening of the cell membrane, it has been 
proposed that the microbubble could act as a drug delivery vehicle to carry a drug or gene 
load to a perfused targeted region where the load can be released with the assistance of 
ultrasound. There are 7 microbubble structure classes for drug delivery: (1) attachment to 
the outer shell surface; (2) intercalation between monolayer phospholipids; (3) 
incorporation in a layer of oil; (4) formation of complexes with smaller particles 
(secondary carriers); (5) physical encapsulation in  a polymer layer and coating with 
biocompatible material; (6) surface loading of protein-shelled microbubbles; and (7) 
entire volume loading of protein-shelled microbubbles [22]. The drugs are to be released 
at the site of interest during insonication by disrupting the microbubble shell. 
 
Drugs can be bound to the microbubble shell and attached to site-specific ligands as 
shown in Figure 1.3. The microbubbles act as carriers for these agents until the site is 
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                                     (A) Diagram of a targeted microbubble constructed for drug or 
DNA delivery. Gas-filled microspheres may be designed so that their interior is loaded 
with drug and gas. A stabilizing material, here a lipid, surrounds the perfluorocarbon 
bubble. Drugs may be incorporated by themselves or, if insoluble in water, in an oil layer. 
The microsphere may be targeted to specific tissue by incorporating protein ligands on the 
surface. (B) The schematic diagraph of targeted microbubble to targeted cell surface by 
ligand-receptor. Image used from Liu, et al. [5] 
 
reached, at which point ultrasound is applied and allows for localized release of the drug. 
The benefit of this technique is a lower concentration of systematic drug release only at 
the desired site. This eliminates the hazardous side effects of certain drugs, like cytotoxic 
agents. Albumin-encapsulated microbubbles have demonstrated the ability to adhere to 
the vessel walls in the setting of endothelial dysfunction which could be another method 
of drug delivery without the need for ultrasound [19]. 
 
 
3Figure 1.3:   Targeted microbubble. 
 
 
 
 
 
 
Liposomal Drug Delivery System 
The first description of swollen phospholipid systems was introduced by Bangham et al. 
in 1965 [84]. Over the next few years, early pioneers such as Gregoriadis et al. 
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established the use of liposomes as a drug entrapment vehicle to be used for drug delivery 
systems [85]. Liposomes offer the benefit of a non-toxic, biodegradable, and non-
immunogenic drug delivery vehicle suitable for both hydrophilic and lipophilic drugs. 
They have been shown to retain their contents and remain stable during circulation within 
the body [86]. However, because exposure of all cells in the body to a systematically 
administered chemotherapy drug is the main cause of harmful side effects, a triggered 
release system is desirable. For optimal therapeutic activity, the drug must first be 
delivered to the diseased site and then be released at a sufficient rate. This requires the 
drug-delivery vehicle to change its state from a relatively stable structure with a very 
slow or nonexistent leak rate to an unstable structure which allows for release of its 
contents [87]. Ultrasound can be focused on the targeted site for many different patients 
without the need for a tailored delivery system [88]. An echogenic particle, such as a 
UCA, that reacts to ultrasonic waves is used in conjunction with the liposomal carrier to 
increase membrane permeability and achieve leakage of the membrane [89]. Ultrasound 
interacts directly with circulating echogenic drug delivery vehicles designed to release 
payload in the ultrasound focal region to avoid premature and potentially dangerous 
payload release in an undesired area of the body.  
 
Combination of ultrasound and contrast agent microbubbles is believed to alter liposome 
membrane permeability [80, 90-93] through sonoporation [94, 95]. The microbubble 
must be in close contact with the membrane to cause sonoporation because the cavitation 
shockwave will only disrupt a membrane within a few tens of microns [96]. Considerable 
work has been done evaluating microbubble/liposome constructs as echogenic drug 
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delivery vehicles. One mechanism that has been explored is through attachment of a drug 
loaded liposome to the surface of the microbubble as shown in Figure 1.3 [97]. However, 
shear stress during transport through the microvasculature can destabilize the particle 
[89]. Separate solutions of drug loaded liposomes and microbubbles can be injected and 
activated once they reach the desired tissue, but very close co-localization of both 
particles is required to achieve permeability of the membrane, which is not guaranteed 
with this method. To guarantee a close proximity between microbubble and liposome, gas 
is entrapped within the liposome, termed echogenic liposomes (ELIPs), either in the lipid 
bilayer or in micelles within the aqueous core. Previous attempts at formulating these 
vehicles have very low yields, lack precision with gas and drug encapsulation, stability 
and internal geometry [96].  
 
1.4.3 Summary of Current Research 
 
The research discussed above has started the discussion on the applicability, potential 
benefits, and treatment efficacy improvement by way of ultrasound-microbubble-assisted 
pharmaceutical delivery. The aspects of this topic actively being pursued are the general 
principle of drug delivery, the feasibility of the carrier vehicles, and the safety of the 
treatment. Improvement of therapeutic index, ie, the ratio of the median lethal dose 
(LD50) to the median effective dose (ED50) is taken into consideration for each proposed 
drug delivery system. If a pharmaceutical agent is toxic or expensive, this gives reason as 
to package it into a microbubble carrier. Biodistribution of the free drug, as well as drug-
carrier bubbles, are taken into account. The long-term fate of a toxic drug substance in its 
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bubble carrier form is evaluated in in vitro studies and the beginnings of in vivo studies. 
Drug carrier particles are often captured by liver and spleen; toxic effects of different 
drugs in that setting may vary considerably [12].  
 
A hydrophobic drug can be incorporated into the lipid shell of the bubble but the 
pharmaceutical payload per bubble is limited to a relatively small amount of inherently 
hydrophobic molecules (eg. paclitaxel) [79]. However, plasmid DNA or other 
hydrophilic molecules, such as proteins or antisense oligonucleotides, can be attached to 
the bubble shell electrostatically [83]. Upon ultrasound treatment, during the destruction 
of the microbubble, the shell-associated drug can be released and deposited in the 
insonified tissue area [98].  
 
As a further development to that approach, it was proposed to attach drug carrier 
liposomes to the bubble surface when there is a need to incorporate large amounts of 
water-soluble pharmaceutical material [99]. The potential application of this strategy is 
the ultrasound-triggered release from the drug-containing liposomes. Controlled rupture 
of liposome membrane and drug release in the biologic environment can be achieved 
specifically in the insonified area which is appropriate for targeted tumor therapy or 
therapeutic angiogenesis induction. Rupture of a liposome positioned a short distance 
from an oscillating bubble has been demonstrated in vitro [99]. Placing liposomes in 
direct contact with microbubble membrane improves the efficacy of liposome rupture and 
payload contents release [99]. Loading on the microbubble surface can also be achieved 
using ligand-receptor interactions. For example, Lum et al. reported a study in which 
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nanoparticles were bound to the shell by biotin-avidin linkage [100]. The solid 
polystyrene nanoparticles served as a model system, which could be replaced by 
biodegradable nanoparticles loaded with drugs or genes.  
 
For enhancement of ultrasound-triggered delivery in larger vessels, it may become 
helpful to position drug-carrying microbubbles closer to the vessel wall. If particle 
destruction and drug release occurs in the center of the vessel, far from the vessel wall, 
the probability of extravascular drug delivery is low. The drug would be released mostly 
in the bulk bloodstream toward neighboring red blood cells. In this situation, it is 
obviously beneficial to divert microbubbles toward the vessel wall via additional 
targeting mechanisms [101]. Nondestructive ultrasound with lower intensity can be used 
to push microbubbles toward the vessel wall. Once the bubbles are closer to the target 
vessel wall, a high-intensity pulse could be applied to cause bubble destruction, drug 
release and deposition.  
 
Selective binding with endothelial markers in the region of interest (such as tumor 
angiogenesis-specific molecules) can be also applied to target microbubble-drug 
complexes to the vessel wall [101]. An advantage of this approach would not only be in 
the immediate proximity of the targeted bubble-drug complexes to endothelial layer, but 
also in the selective accumulation of the bubbles in the area of interest. After free 
circulating bubbles clear from the bloodstream, ultrasonic irradiation of targeted drug 
carrier bubbles would accomplish selective therapeutic effect only in the area where 
bubbles have been retained on the target. Preliminary data indicates that the presence of 
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plasmid DNA on the surface of ligand-carrying microbubbles does not obstruct the 
binding of ligand to its receptor and plasmid-carrying bubbles do attach to the receptor-
coated surface [102]. 
 
Overall ED50 improvement, as well as therapeutic index improvement, and general 
benefits to the patient need to be significant to justify a complicated therapeutic strategy. 
A drug that is nontoxic and completely inactive/harmless in the nontarget areas of the 
body until the microbubble-drug complex is activated by ultrasound represents the most 
desirable situation. However, there are many constraints that prevent clinical testing of 
certain systems at this point. 
 
Challenges and Limitations 
Several challenges face the field of targeted drug delivery via microbubble vehicles. The 
most difficult questions include whether the target is present in the particular individual 
legion, could the ligand bind to something other than the target, whether the target is 
abundant enough to bind detectable amounts of the agent, and if the drug payload will 
remain local or enter the circulation system.   
 
Ultrasound contrast microbubbles are relatively large compared with traditional 
pharmaceuticals. Microbubbles are typically 1–10 μm in diameter [16]. Tumor vessels 
are particularly permeable and often have large endothelial gaps; however, contrast 
microbubbles are typically too large to exit the vasculature [12]. This poses a particular 
problem when trying to target receptors that may be present in the tumor tissue rather 
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than on the vascular endothelium. Although ultrasound microbubbles are relatively large 
agents, the amount of drug that can be attached to the bubble surface or incorporated into 
the internal lipid layer is a concern. In a study by Tartis et al., approximately 4 mg/ml 
paclitaxel was incorporated into the internal oil layer of AALs [103]. Currently, the 
recommended systemic paclitaxel dose approaches 175 mg/m2 (Taxol, FDA product 
insert, 1998).  
 
Another concern for this topic is the circulation time of ultrasound contrast agents. For 
example, the elimination half-life of Sonovue is 6 min [104]. Uptake of Albunex occurs 
in the liver, lung, and spleen of rats and pigs, with 70% cleared from the bloodstream in 3 
min [105]. If the agent is taken from circulation by the reticuloendothelial system, the 
circulation time may not be long enough to allow higher amounts of drug to be delivered 
to the target region. Contrast agents are typically administered into a peripheral vein so 
only a small amount of agent will pass through a tumor in a given circulatory cycle [83]. 
Multiple circulations are necessary to allow destruction of enough drug to increase local 
concentration significantly.  
 
The bioeffects associated with ultrasound contrast agents are not fully understood and are 
strongly dependent on concentration and imaging parameters. These effects will need to 
be considered as clinical translation proceeds. Aside from these complications, further 
research on the various new microbubble vehicles present a new era of externally 
triggered, noninvasive drug delivery systems for future application in clinical medicine.  
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1.5 Dissertation Summary  
 
In recent years there have been rapid developments in transducer and contrast agent 
technologies. Not all of the applications have reached a routine level of application yet 
but all of them show great promise.  An improved understanding of encapsulated 
microbubble behavior will lead to more sophisticated detection and delivery techniques 
[22]. This dissertation will discuss studies involving several of the applications for 
ultrasound contrast agents, specifically an SF6 microbubble with a phospholipid 
monolayer. These studies include resonance frequency, inertial cavitation, contrast 
enhancement, triggered drug delivery, and cell death. 
 
The dissertation begins with the presentation of the materials and methods used for 
formulation of the ultrasound contrast agent. The techniques for manufacturing 
encapsulated microbubbles, polymeric nested microbubbles, and liposomal nested 
microbubbles are introduced in Chapter 2. In Chapter 3, the resonance frequency of the 
contrast agent formulation is discussed, which is an important parameter in the 
determination of inertial cavitation. The inertial cavitation detection technique is 
explained in Chapter 4, and the resulting cavitation profiles for each formulation are 
presented. Polymeric nested microbubbles are evaluated for their effectiveness in 
ultrasound image enhancement during in vitro, clinically relevant studies in Chapter 5.  In 
Chapter 6 a means for ultrasound triggered drug delivery is proposed by nesting a 
solution of microbubbles within the aqueous core of a liposome. When exposed to 
ultrasound, the microbubble oscillates which induces microstreaming of the surrounding 
fluid, thus disrupting the membrane. Poration of the membrane facilitates release of the 
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                                                                                a) Encapsulated microbubble; b) 
Microbubble is now nested within a polymer shell; c) Microbubble is now nested within a 
liposome bilayer shell. Microbubble concentration does not vary based on shell material. 
 
drug mimic from the liposome to a nearby structure, which we refer to as reverse 
sonoporation. Chapter 7 is a very brief summary of an experiment designed to determine 
the influence of insonated microbubbles on nearby cells.  
 
To better understand the structures that will be discussed throughout this thesis, an 
illustration is shown in Figure 1.4. This figure introduces three different formulations 
being examined- encapsulated microbubble, polymeric nested microbubble, and 
liposomal nested microbubble. Specific details regarding the formulation and properties 
of each vehicle will be revealed in the next chapter. 
 
 
4Figure 1.4:   Introduction to structures discussed in dissertation.
 
 
 
 
 
 
 
 
 
b) Polymeric nested microbubble a) Encapsulated 
microbubble 
c) Liposomal nested microbubble 
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CHAPTER 2: FORMULATIONS AND CHARACTERIZATION 
 
2.1 Microbubble  
 
Phospholipid-coated microbubbles are effective as contrast agents for diagnostic 
ultrasound imaging and, more recently, as vehicles for targeted drug and gene delivery 
[43, 100]. The microbubble discussed in this dissertation is comprised of a phospholipid 
monolayer encapsulating an SF6 gas core. The manufacture of the coated microbubble 
suspension involves the production of gas bubbles in a solution containing a mixture of 
phospholipids. The surfactant forms a coating on the surface of the bubble, which 
counteracts surface tension thus stabilizing the bubble and preventing rapid dissolution. 
In order to prepare microbubble suspensions, air is replaced by SF6 in the headspace of 
the surfactant mixture using a gas exchange method.  The vial containing the 
microbubble solution is shaken with a VIALMIX® (Lantheus Medical Imaging).  
 
2.1.1 Formulation 
 
Materials 
The lipids, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and 1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-3000] (DSPE-
PEG3000) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). The 1000, 
2000, and 5000 g/mole molecular weight PEG functionalized lipids were also supplied by 
Avanti Polar Lipids.  Sulfur hexafluoride (SF6) and nitrogen gas were purchased from 
Airgas (Allentown PA, USA). DefinityTM microbubbles were purchased from Lantheus 
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Medical Imaging (North Billerica, MA, USA). All other reagents used were of analytical 
grade. 
 
Microbubble formation 
Lipid film solutions of DSPC in chloroform with varying mole fraction between 90 and 
99 % and a PEGylated lipid in chloroform with varying mole fraction between 1 and 10 
% both with a concentration of 25 mg/mL were mixed together and spin dried under a 
constant flow of nitrogen to ensure a uniform film on the bottom of the vial. After 
nitrogen spinning for 15 minutes, the film solution was placed in a vacuum oven to dry 
for 24 hours at 40oC to ensure that all chloroform was removed from the film. After the 
drying stages were completed, the film was rehydrated with aqueous phosphate buffered 
saline (PBS) and sonicated (Hielscher UP200S Ultrasonic Processor, Hielscher, Tetlow, 
Germany) with a 20 kHz transducer at 20% amplitude for 3 minutes. The sonication 
serves a dual purpose of elevating the temperature of solution above the lipid’s gel phase 
transition temperature of 55oC and also ensures that the lipid mixture in solution is fully 
dissolved. After sonication, 1.5 mL aliquots of solution were placed in 2 mL serum vials 
and sealed with a rubber stopper and crimp cap. The air in the headspace of the vial was 
then exchanged with SF6 by method of vacuum exchange. The vials were stored in the 
refrigerator until use. To prepare the vials for use, a Vialmix shaker (Lantheus Medical 
Imaging, North Billerica, MA, USA) was used for 45 seconds to disperse the gas phase 
within the solution. This technique successfully produces stable microbubbles at a 
concentration of 1 x 109 microbubbles/mL with diameters between 1-5 μm. 
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                                                        Microscope images with an optical Carl Zeiss 
Axioskop 2+ microscope (Carl Zeiss AM, Oberkochen, Germany) taken at 20X 
magnification shown for DSPC microbubbles containing 5 mole% DSPE-PEG3000 
2.1.2 Microscopy 
 
Images of the microbubbles were taken with an optical Carl Zeiss Axioskop 2+ 
microscope (Carl Zeiss AM, Oberkochen, Germany). 
 
 
5Figure 2.1:   Phospholipid coated microbubbles.
    
 
  
 
2.1.3 Determination of Size Distribution 
 
As an alternative to using a coulter counter to measure microbubble size distribution, as 
one was not available, image processing techniques can be used instead. Microbubble 
sizes are determined for various lipid shell blends by a homemade image segmentation 
program according to Dicker et al [16].  Each single experiment will consist of one lipid 
with one of the 4 PEGylated lipids (DPSE PEG 1000, 2000, 3000, or 5000) with 7 
concentrations of PEGylated lipid (1, 2.5, 5, 7.5, 10, 12.5, and 15).  Each concentration 
will have 4 samples and each sample will have 4 images taken.  Each experiment will 
therefore generate 122 images. 
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The image segmentation software in MATLAB (Mathworks, Natick, MA) is able to 
identify a size distribution using a technique that involves a binary color scheme. First, 
the software finds the difference between an image which has microbubbles (sample 
image), and a reference image taken with the same objective in the presence of just water 
so that any imperfections in the lens is removed. The program then converts the image 
into a binary color scheme using threshold manipulation. The program traces the edge of 
the white domains and fits them with polygons with a shape fitting algorithm. The 
program then determines the radii by measuring the vertices of the polygons. The 
polygons themselves are nearly circular and are a very close match to the actual radius of 
the microbubbles being images. By identifying the vertices of the polygons, the program 
can calculate the diameters of the imaged microbubbles. Figure 2.2 shows an example of 
the size distribution for a sample of microbubbles and Figure 2.3 details the results for 
varying PEG molecular weight and mole fraction. Both of these figures were taken from 
Dicker et al. [4].  
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                                                                 This histogram describes the size distribution of 
a population of over 200 microbubbles analyzed with a shell composition of 95 mole% 
DPSC and 5 mole% DSPE-PEG 2000.  For this population, the mean radius is 
approximately 1 µm, and the distribution is nearly Gaussian.  Figure from Dicker, et al. 
[4] 
 
 
6Figure 2.2:   Size Distribution of microbubble sample.
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                                                                                                   An image segmentation 
method is used to find the size distribution of DSPE-PEG compositions of 1, 2.5, 5, 7.5, 
10, 12.5, and 15 mole% and PEG molecular weights of 1000 [x], 2000 [○], 3000 [□], and 
5000 [∆] g/mol.  The mean value for the diameter does not significantly change over the 
span of studied shell compositions.  Additionally, the standard deviations of the size 
distributions are very large in comparison to the change in mean diameter. Figure from 
Dicker, et al. [4] 
 
 
7Figure 2.3:  Microbubble mean diameter as a function of shell composition. 
 
 
 
 
 
 
2.2 Polymeric Nested Microbubble 
 
A widely applied approach to encapsulate an aqueous core within a polymer shell is the 
double emulsion method, producing microcapsules such as water-in-oil-in-water 
(W/O/W) emulsion globules. For this system, liquid drops consisting of an aqueous 
microbubble solution are nested within a solid polymeric microcapsule shell. The 
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resulting polymer microcapsules range from 2-20 µm with an aqueous core containing 
either PBS (referred to as empty microcapsules) or a solution of microbubbles (referred 
to as nested microbubbles). 
 
2.2.1 Formulation 
 
Materials 
Polyvinyl alcohol (PVA) supplied by Sigma Aldrich (St. Louis, MO, USA) is reported to 
have a MW of 85,000-124,000 and is 99+% hydrolyzed. Poly (l-lactic acid) (PLA) was 
supplied by Evonik Corporation (Birmingham, AL) and is reported to have a molecular 
weight (MW) of 100,000 and an inherent viscosity of 1.61 dL/g. The lipids, 1,2-
distearoyl-sn-glycero-3-phosphocholine (DSPC) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethyleneglycol)-3000] (DSPE-PEG3000) were 
purchased from Avanti Polar Lipids (Alabaster, AL, USA). The 1000, 2000, and 5000 
g/mole molecular weight PEG functionalized lipids were also supplied by Avanti Polar 
Lipids.  Sulfur hexafluoride (SF6) and nitrogen gas were purchased from Airgas 
(Allentown PA, USA). 
 
Synthesis 
Nested microbubbles were prepared with PLA using the well documented and 
characterized water/oil/water (W1/O/W2) emulsion technique [106, 107]. A solution of 
0.4 mL of the previously described microbubbles (internal aqueous phase W1) was added 
to 4 mL of 10 mg/mL PLA in dichloromethane (DCM), which is the intermediate organic 
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phase (O). The solution of microbubbles and PLA in DCM was homogenized with the 
Polytron PT3100 (Kinematica Inc, Lucerne, Switzerland) for 1 minute. The speed of the 
homogenizer was varied between 5000 rpm and 17500 rpm to control the size of the 
microcapsule shell. After 1 minute, the solution was immediately added to 32 mL of 2% 
PVA in water (outer aqueous phase W2) and further homogenized for 2 minutes at the 
same speed as in the previous step. After homogenization, the contents were added to 64 
mL of the W2 phase. The solution was placed on a magnetic stir plate at 400 rpm for 24 
hours so that the DCM evaporates from the solution, leaving aqueous phase W1 nested 
within the polymer shell. Once the solution had dried, it was centrifuged at 15,000g for 
10 minutes. The supernatant was removed and the remaining pellet, which consisted of 
the nested microbubbles, was rehydrated using a PBS solution.  
 
2.2.2 Determination of Size Distribution 
 
Variation of Homogenizer Speed during Formulation  
The diameter of the polymeric microcapsule shell was varied systematically by adjusting 
the homogenizing speed. Homogenizing speed is a parameter of primary importance in 
the emulsification step because it provides the energy to disperse the oil phase in aqueous 
phase. To determine the statistics on the size distribution for a population of nested 
microbubbles at each homogenizer speed, samples of the selected formulation are 
prepared by the method listed above and then diluted for more accurate reading. The size 
distribution was obtained from a Coulter Multisizer II (Beckmann-Coulter, Brea, CA) for 
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a 50 μL sample of nested microbubbles diluted by a factor of 10. These results are shown 
in Table 2.1.  
 
1Table 2.1:   Size distribution of polymeric nested microbubble populations.  
Homogenizer Speed 
(rpm) 
Shell Diameter 
(μm) 
(Mean ± SD) 
Concentration of 
nested microbubbles 
(Nested MB/mL) 
5000 20.52 ± 1.97 4.53 x 106 
7500 14.95 ± 1.03 1.09 x 107 
10000 9.95 ± 0.86 2.49 x 107 
12500 5.55 ± 0.35 4.93 x 107 
15000 2.53 ± 0.55 7.89 x 107 
17500 1.95 ± 0.29 1.19 x 108 
 
From Table 2.1, we conclude that shell diameter of nested microbubbles is inversely 
proportional to homogenizing speed; consequently an increase in homogenizing speed 
decreases the size of microspheres because the emulsion was broken up into smaller 
droplets at a higher input power in accordance with the study of Yang et al. [108]. A 
Beckmann-Coulter Z1 Particle Counter (Beckmann-Coulter, Brea, CA) was used to 
confirm that when using the same amount of material during synthesis, the number of 
nested microbubbles increases with homogenizer speed. A plot of homogenizing speed 
versus resulting average particle diameter reveals a linear relationship in Figure 2.4, 
which is convenient for predicting particle size by setting the homogenizing speed.   
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                                                                                                           Mean particle size for 
each homogenizing speed shown with a linear best fit line to predict particle size for 
intermediate homogenizing speeds. Sizes were obtained from Coulter Multisizer II 
(Beckmann-Coulter, Brea, CA) for a 50 μL sample of nested microbubbles in this section. 
This data is an average of 5 readings. 
 
8Figure 2.4:   Polymeric nested microbubble diameter versus homogenizing speed.
 
 
 
 
Examples of the size distribution for nested microbubble populations prepared with two 
different homogenizing speeds, 15000 rpm and 17500 rpm, are shown in Figures 2.5 and 
2.6. This distribution is typical for all homogenizing speeds in that it is asymmetric about 
the mean with a tail that extends to the right. 
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                                                                                                                         Size 
distribution obtained from Coulter Multisizer II (Beckmann-Coulter, Brea, CA) for a 50 
μL sample of nested microbubbles prepared with a homogenizing speed of 15000 rpm. 
The mean shell diameter was 2.53 μm with a standard deviation of 0.55 μm, a variance 
of 0.30 μm, 95% confidence limit of 2.50 μm and a median of 2.53 μm. The specific 
surface area is 1.54 μm. The best fitting distribution was the Weibull (3P) distribution 
with α=1.74, β=0.82, and γ=1.75.  
 
9Figure 2.5:   Size distribution for polymeric nested microbubbles formulated at 15000 rpm.
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                                                                                                                          Size 
distribution obtained from Coulter Multisizer II (Beckmann-Coulter, Brea, CA) for a 50 
μL sample of nested microbubbles prepared with a homogenizing speed of 17500 rpm. 
The mean shell diameter was 1.95 μm with a standard deviation of 0.29 μm, a variance of 
0.08 μm, 95% confidence limit of 1.93 μm and a median of 1.93 μm. The specific surface 
area is 1.12 μm.  
 
10Figure 2.6: Size distribution for polymeric nested microbubbles formulated at 17500 rpm. 
 
 
 
 
 
 
 
Before gaining access to the Coulter Multisizer II which reported a size distribution that 
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than 2 µm, and shows a count above an upper and lower set threshold value. From the 
threshold values, the coulter counter also reports the total number of particles measured 
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for each homogenizing speed. 
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                                                                                                Ratio obtained from a 
Beckmann-Coulter Z1 Particle Counter for a sample of nested microbubbles prepared 
with a homogenizing speeds varying between 7500 and 17500 rpm. Particles were 
diluted 100x from original recipe reported in this section. This data is an average of 5 
readings. 
 
11Figure 2.7:   Ratio of particles greater than 5 µm to between 2.5 and 5 µm. 
 
 
 
 
 
The Particle Counter reports a total count for the diluted sample, which can be converted 
into a concentration of particles/mL of solution. The particle count for a sample diluted 
100x the original recipe is shown in Figure 2.8 and the resulting concentration is reported 
in Figure 2.9 for each homogenizing speed.  
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                                                                              Particle count obtained from 
Beckmann-Coulter Z1 Particle Counter for a sample of nested microbubbles prepared 
with a homogenizing speeds varying between 7500 and 17500 rpm. Particles were 
diluted 100x from original recipe reported in this section. This data is an average of 5 
readings. Particle count increases with homogenizing speed because average particle 
diameter decreases with homogenizing speed while the amount of material used during 
formulation remains the same. 
 
12Figure 2.8:   Particle count for polymeric nested microbubbles.  
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                                                                              Particle concentration obtained from 
Beckmann-Coulter Z1 Particle Counter for a sample of nested microbubbles prepared 
with a homogenizing speeds varying between 7500 and 17500 rpm. Particles were diluted 
100x from original recipe reported in this section. This data is an average of 5 readings. 
Particle concentration increases with homogenizing speed because average particle 
diameter decreases with homogenizing speed while the amount of material used during 
formulation remains the same. 
 
13Figure 2.9:   Concentration of polymeric nested microbubbles.
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                                                                                      Microscope images taken at 20X 
magnification shown for A) empty PLA microcapsules, and B) 2.53 µm polymeric nested 
microbubbles comprised of 95 mol % DSPC and 5 mol % DSPE-PEG3000 
microbubbles. 
microcapsules are used to take baseline readings for experimentation. The empty PLA 
microcapsule is compared to the nested microbubble formulation shown in Figure 2.10.  
 
 
14Figure 2.10:   Microscopic images of polymeric nested microbubbles.
 
 
 
 
Another image of the polymeric nested microbubbles taken with a higher magnification 
so that individual microbubbles nested within the polymer shell are shown in Figure 2.11. 
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                                                                                                                     Microscopic 
images taken at 100X magnification shown for 2.53 µm polymeric nested microbubbles 
with 95 mol % DSPC and 5 mol % DSPE-PEG3000 microbubbles. In this image, certain 
aspects of the formulation can be seen, such as the absence of microbubbles in some 
polymer shells, as well as the varying size distributions nested within each shell of the 
same sample. 
 
15Figure 2.11:  Microscopic image of microbubbles within polymeric nested microbubbles.
 
 
 
 
 
The polymeric nested microbubble and empty polymer microcapsule are imaged with a 
Leica Ground State Depletion (GSD) super resolution (SR) system (Leica Microsystems, 
Buffalo Grove, Il) as shown in Figure 2.12. 
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                                                                                                                        Widefield 
images taken with a Leica Ground State Depletion (GSD) super resolution (SR) system 
(Leica Microsystems, Buffalo Grove, Il). The image on the left is an empty PLA 
microcapsule whose shell is illuminated. The image on the right shows a PLA 
microcapsule that contains nested microbubbles. The microbubbles consist of SF6 gas 
core with a lipid monolayer comprising 95% DSPC and 5% DSPE-PEG 3000 and tagged 
with rhodamine-labeled PE. 
 
 
16Figure 2.12:   Widefield images of polymeric nested microbubbles and empty microcapsule. 
 
 
 
 
 
 
 
A lower magnification of the Leica microscope was used to image a distribution of 
polymeric nested microbubbles in Figure 2.13. 
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                                                                                                        Widefield image of a 
2.53 µm polymeric nested microbubble taken with a Leica Ground State Depletion (GSD) 
super resolution (SR) system (Leica Microsystems, Buffalo Grove, Il).  
 
17Figure 2.13:   Widefield image of 2.53 µm polymeric nested microbubble sample.
 
 
 
2.3 Liposomal Nested Microbubble 
 
The double emulsion method described for the polymeric nested microbubble is the 
preferred method for creating the liposomal nested microbubbles discussed in this 
dissertation. A detailed description of the double emulsion method for the liposomal 
nested microbubbles will be given first. Electroformation, SHERPA formulation, and 
pressure extrusion combined with rapid solvent exchange are also introduced and briefly 
discussed as alternative methods to manufacture the liposomal nested microbubbles, but 
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these were not chosen as the primary method for reasons due to instability or insufficient 
size range. 
 
2.3.1 Formulation 
 
Materials  
The lipids, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-3000] (DSPE-
PEG3000), 1,2,3-oleoyl-glycerol (Triolein), and L-α-phosphatidylcholine (Egg-PC) were 
purchased from Avanti Polar Lipids (Alabaster, AL, USA). Sulfur hexafluoride (SF6) and 
nitrogen gas (N2) were purchased from Airgas (Allentown PA, USA). Cholesterol, 
Calcein, Cobalt (II) chloride (CoCl2) and Triton X-100 were purchased from Sigma 
Aldrich (St. Louis, MO) and chloroform was purchased from Fisher Scientific (Fair 
Lawn, NJ). All products were used without further purification. All other reagents used 
were of analytical grade. 
 
Double Emulsion Method 
This process was used to make the liposomal nested microbubbles discussed in the 
experimental sections of this dissertation. Three immiscible phases are mixed in order to 
encapsulate an inner phase within a liposome.  This technique is used to encapsulate 
microbubbles plus calcein, a self-quenching fluorophore, within the liposome shell. 
Liposomal nested microbubbles were prepared with an Egg-PC/ cholesterol/ triolein lipid 
mixture to form the unilamellar vesicle using the water/oil/water (W1/O/W2) emulsion 
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technique [109, 110]. A solution of 0.5 mL of the previously described microbubbles and 
0.5 mL of 0.1 mM calcein solution (internal aqueous phase W1) was added to 1 mL of a 
lipid solution containing 733.5 μL of chloroform, 185 μL of 25 mg/mL Egg-PC in 
chloroform, 50.5 μL of 50 mg/mL cholesterol in chloroform, and 31.0 μL of 100 mg/mL 
triolein in chloroform (intermediate organic phase O). The solution of 
microbubbles/calcein and lipid mixture was homogenized with the Polytron PT3100 
homogenizer (Kinematica Inc, Lucerne, Switzerland) for 1 minute. The speed of the 
homogenizer was varied between 5000 rpm and 15000 rpm to control the size of the 
unilamellar vesicle. After 1 minute, the solution was added to 8 mL of 2% PVA in water 
(outer aqueous phase W2) and further homogenized for 2 minutes at the same speed as in 
the previous step. After homogenization of the solution, the contents were added to 8 mL 
of the W2 phase and placed on a magnetic stir plate at 300 rpm for 24 hours so that the 
chloroform evaporates from the solution, leaving aqueous phase W1 nested within the 
lipid bilayer. External calcein was quenched with 50 μL of 40 mM CoCl2.  
 
Electroformation Method 
Giant unilamellar vesicles (GUVs) are formed by exciting a lipid film with a current in 
order to cause them to bud from the surface and form vesicles in the aqueous media. For 
a 95 mol % Egg PC / 5 mol % [6 - (N - (7 - Nitrobenz - 2 - oxa - 1,3 - diazol - 4 - yl) 
amino) hexanoic acid] (NBD), 0.019 mL of 5x10-4 mg/mL Egg PC and 0.026 mL of 
5x10-4 mg/mL NBD are mixed and then deposited onto the center of the conductive side 
of an indium tin oxide conductive slide.  This serves as the bottom slide which is 
connected to the generator.  The slide is heated to 60 oC on a hot plate and dried in the 
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vacuum oven for 1 hr. Fuchs lithium grease is used to seal the bottom slide to a white 
Teflon spacer, then the chamber is filled with approximately 1 ml of PBS. 
 
After the chamber is filled, another ITO slide is attached with the conductive side 
towards the inside of the chamber to the Teflon space by Fuchs.  Once the chamber is 
alligator clips are attached to each slide, with positive to the coated slide.  The function 
generator is run at 3 V and 10 Hz for 3 hrs. 
 
Other possible film lipid combinations other than the one discussed in this procedure are 
listed in the chart below for reference: 
 
2Table 2.2:   Lipid film preparation parameters. 
Lipid Mol % 
MW 
(g/mol) 
[Stock] 
(mg/ml) 
[Sample] 
(mg/ml) 
Sample 
(mL) 
Vol Needed 
(mL) 
DPPC 0.99 734.04 20 0.367 10 0.181 
DPPE-NBD 0.01 815.99 1 0.041 
 
          
 
Lipid Mol % 
MW 
(g/mol) 
[Stock] 
(mg/ml) 
[Sample] 
(mg/ml) 
Sample 
(mL) 
Vol Needed 
(mL) 
Egg-PC 0.97 768 25 
1.25 3 
0.031 
MS PEG 6000 0.025 6404.07 50 0.012 
DPPE-NBD 0.005 815.99 1 0.034 
 
          
 
Lipid Mol % 
MW 
(g/mol) 
[Stock] 
(mg/ml) 
[Sample] 
(mg/ml) 
Sample 
(mL) 
Vol Needed 
(mL) 
DPPE-NBD 0.005 815.99 1 
3 6 
0.012 
DPPC 0.995 768 25 0.054 
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SHERPA Method 
This method is similar to detergent dialysis but uses organic solvents to dissolve the 
lipids. A slow diffusive introduction of water allows the lipid membranes to seal and 
encapsulate the microbubbles. These malleable nested structures are referred to as 
SHockwavE-Ruptured nanoPayload cArriers (SHERPAs). See [96] for more detail. 
 
The SHERPAs are manufactured in a two-step procedure with the microbubbles being 
formed through a probe sonication process and subsequently encapsulated in the outer 
liposome. Solution 1 refers to the outer lipid solution and Solution 2 refers to the 
externally formulated microbubble solution. 
 
Solution 1 is added drop wise to Solution 2 under vortex at 3200 rpm. This new solution 
is referred to as Solution 3. 1.5 mL Eppendorf tubes are each filled with 200 μL of 
Solution 3. 100 μL of PBS is gently added to the bottom of each tube to initiate the 
closing of the lipid sheets and formation of the SHERPA. After 10 min, the tubes are 
rotated gently at an angle until the bubbles are mixed thoroughly throughout the solution. 
 
Rapid Solvent Exchange / Pressure Extrusion Method 
Rapid solvent exchange is performed according to the method of Buboltz et al [111]. 
Either 10 ml or 50 ml tubes serve as vessels for solvent exchange. A 100 μl gas-tight, 
blunt-tipped syringe (point-style #3, Hamilton, Reno, NV) is used to introduce the lipid 
solution (10–100 μl of 10–100 mM lipid) to the injection tubing. Standard vacuum 
pressure was 23 torr for sample preparation at room temperature (23°C). Samples 
55 
 
containing di16:0-PC were prepared by rapid solvent exchange into the buffer which was 
maintained at 50°C.  
 
Large unilamellar vesicles (LUVs) were prepared by passing a suspension through a 
double stack of polycarbonate membranes using a pressure extruder apparatus. The 
pressurized lipid extruder is set up with 2 membranes stacked and 1 drain disk. The 
extruder apparatus is placed in the hood with the nozzle facing outwards and the top 
component is attached. The collection hose is placed into the desired collection container 
(typically a 20 mL glass vial). 15 mL DI water is run through the system to clean and 
check for leaks. The receptor is loaded with 5-15 mL DI water, the top is fastened 
securely, and the gas hose is attached. Gas is slowly administered to the extruder system 
at 120 psi. Collection is terminated when the last of the air bubbles passes through the 
collection hose. The lipid sample is then loaded in to the system and extrusion is repeated 
for the appropriate number of cycles.   
 
2.3.2 Determination of Size Distribution 
 
Once the liposomal nested microbubbles are formed using the double emulsion method, 
the sample is characterized by first determining the size distribution. 
 
Variation of Homogenizer Speed during Formulation  
The average diameter of the liposome was varied systematically by adjusting the 
homogenizing speed. Homogenizing speed is a parameter of primary importance in the 
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emulsification step because it provides the energy to disperse the oil phase in aqueous 
phase. To determine a size range for a population of liposomal nested microbubbles at 
each homogenizer speed, samples of the selected formulation are prepared by the method 
listed above and then diluted for a more accurate reading. The size distribution was 
obtained from a Coulter Multisizer II (Beckmann-Coulter, Brea, CA) for a 50 μL sample 
of nested microbubbles diluted by a factor of 100. These results are shown below in 
Table 2.3.  
 
3Table 2.3:   Size distribution of liposomal nested microbubble populations. 
Homogenizer Speed 
(rpm) 
Liposome Diameter 
(μm) 
(Mean ± SD) 
Concentration of 
nested MB 
(Particles/mL) 
5000 6.04 ± 1.38 5.42x107 
7500 5.78 ± 1.07 7.87x107 
10000 5.26 ± 1.01 9.04x107 
12500 5.01 ± 0.83 9.32x107 
15000 4.74 ± 0.76 9.60x107 
 
From Table 2.3, we conclude that shell diameter of the liposome is inversely proportional 
to homogenizing speed; consequently an increase in homogenizing speed decreases the 
size of liposomes. The average liposome diameters for each homogenizing speed are the 
same order of magnitude owing to fact that the speed does not have as large of an effect 
on the flexible membrane as it would with a stiffer polymer shell used for imaging 
purposes (see [112]). A Beckmann-Coulter Z1 Particle Counter (Beckmann-Coulter, 
Brea, CA) was used to confirm that when using the same amount of material during 
synthesis, the number of nested microbubbles increases with homogenizer speed. 
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                                                                             Particle count obtained from Beckmann-
Coulter Z1 Particle Counter for a sample of liposomal nested microbubbles prepared with 
a homogenizing speeds varying between 5000 and 15000 rpm. Particles were diluted 
100x from original recipe reported in this section. This data is an average of 5 readings. 
Particle count increases with homogenizing speed because average particle diameter 
decreases with homogenizing speed while the amount of material used during formulation 
remains the same. 
The Particle Counter reports a total count for the diluted sample, which can be converted 
into a concentration of particles/mL of solution. The particle count for a sample diluted 
100x the original recipe is shown in Figure 2.14 and the resulting concentration is 
reported in Figure 2.15 for each homogenizing speed.  
 
 
18Figure 2.14:   Particle count for liposomal nested microbubbles.  
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                                                                             Particle concentration obtained from 
Beckmann-Coulter Z1 Particle Counter for a sample of liposomal nested microbubbles 
prepared with a homogenizing speeds varying between 5000 and 15000 rpm. Particles 
were diluted 100x from original recipe reported in this section. This data is an average of 
5 readings. Particle concentration increases with homogenizing speed because average 
particle diameter decreases with homogenizing speed while the amount of material used 
during formulation remains the same. 
 
19Figure 2.15:   Concentration of liposomal nested microbubbles.   
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stiff so the homogenizer has a more pronounced effect on the size, while the liposomal 
material is flexible and not easily adjusted by homogenizing speed. 
 
 
20Figure 2.16:   Comparing η for liposomal and polymeric nested microbubbles. 
 
2.3.3 Microscopy 
 
Calcein is added to the internal aqueous phase during liposomal nested microbubble 
formulation, and any external calcein is quenched using cobalt chloride. Figure 2.17a 
shows a microscopic image of the liposome shell with microbubbles nested inside, while 
Figure 2.17b is a fluorescent image of the same sample to show that the calcein entrapped 
within the liposome accounts for the fluorescence intensity of the sample and that only 
the external calcein has been quenched.  
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                                                                                    Microscope images taken at 100X 
magnification shown for a) DSPC microbubbles containing 5 mol % DSPE-PEG3000 
nested within a liposomal vesicle, b) image taken with a fluorescent microscope 
(Axioskop 2; Carl Zeiss, Heidenheim, Germany) of the same formulation after external 
calcein has been quenched. 
 
21Figure 2.17:   Microscopic images of liposomal nested microbubble. 
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CHAPTER 3: RESONANCE FREQUENCY OF MICROBUBBLES 
 
3.1 Introduction 
 
Knowledge of resonance frequencies of contrast microbubbles is important for the 
optimization of ultrasound contrast imaging and therapeutic techniques. Matching the 
resonance frequency of a contrast agent to the transmitted frequency provides optimized 
conditions for generating acoustic radiation force, which has shown to be beneficial in the 
enhancement of adhesion of targeted agents and drug delivery [113]. Imaging techniques 
such as subharmonic imaging take advantage of the bubbles subharmonic response which 
can be optimized by utilizing a transmitted frequency of twice the contrast agent’s 
resonance frequency [114]. 
 
The resonant properties of contrast agents are dependent on the parameters of 
encapsulation and the viscosity of the surrounding solution. Therefore, it is important to 
have a method that could predict the value of the transmitted frequency at which the 
contrast agent resonates for a given formulation of contrast agent and acoustic conditions 
[115]. Such measurements also lead to the improvement of theoretical models (modified 
Rayleigh–Plesset equations [116]) by comparing them to experimental recordings.  
 
In the following studies, three different set ups are used to examine the influence of PEG 
composition and molecular weight on microbubble resonance frequency by measuring 
the pressure amplitude loss that occurs when a population of microbubbles are insonated. 
Previous studies [58] have examined the dynamics of commercially available contrast 
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agents, for which the chemistry is fixed, but in these studies the resonance frequency is 
measured systematically as a function of PEG composition and molecular weight. 
 
To describe a dynamic microbubble system as a function of shell properties, a 
modification to the Rayleigh-Plesset equation is used.  In previous works, authors such as 
Church and de Jong proposed models taking into account the effects of a shell on bubble 
dynamics [41, 58].  Hoff et al. used a modification of Church’s equation [58] to 
characterize the shell using bulk material properties in conjunction with shell thickness.  
A model derived by Sarkar [33] incorporates surface tension  and characterizes the shell 
using defined membrane material properties, including dilatational viscosity and area 
expansion modulus (ES). 
 
The Sarkar model describing microbubble radius is linearized in Equation 3.1 as shown 
by Dicker et al. [6] which allows the equation to take the form of a forced, damped 
oscillator. The natural frequency, ω0, arises as  
 
𝜔0 =
1
𝑎𝑒
√
1
𝜌𝐿
(3𝜅𝑝0 + 12𝐺𝑆
𝑑𝑆𝑒
𝑎𝑒
)               (Equation 3.1) 
 
where κ is the polytropic coefficient, 𝑝0 is the hydrostatic pressure, and 𝐺𝑆 is the shear  
modulus. This equation allows us to express natural frequency in terms of material 
properties and will serve as the mathematical model of resonance frequency to compare 
with experimental results. Attenuation, which is the loss in pressure amplitude, is 
measured as oppose to measuring the actual resonance frequency. 
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The damping coefficient, after dividing by natural frequency, can be separated into two 
components, one arising from the viscosity of the liquid surrounding the microbubble and 
the other arising from the dilatational viscosity of the microbubble shell giving the two 
damping terms 
 
               (Equation 3.2) 
 
A term to account for losses due to acoustic radiation must be included in the bubble 
dynamics model. This is an important consideration for attenuation experiments because 
attenuation can arise from both absorption and scattering.  A radiative damping term, δrad, 
is included in the equation to arrive at the total damping, δtot, necessary to describe the 
loss in pressure amplitude that occurs as an ultrasound wave passes through a suspension 
of microbubbles. 
 
         (Equation 3.3) 
 
where ω is the driving frequency and c is the speed of sound. 
 
The way in which ES varies with PEG molecular weight and mole fraction is well 
described [117]. The amount of PEG determines the concentration regime, either brush or 
mushroom, which both have different physical characteristics [118] and exhibit different 
PEG chain density dependencies, and therefore different values of area expansion 
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modulus, on PEG molecular weight and mole fraction.  A crucial insight is that the 
composition of a mixed phospholipid/polymer monolayer is not equal to the composition 
of the solution from which it is formed. Species with a stronger partiality to the surface, 
or with a smaller energetic penalty due to localization, will exist in the monolayer at a 
higher fraction than in the initial mixture [119].  
 
Measured Attenuation 
When an ultrasound beam travels a distance, d, the microbubbles attenuate the ultrasound 
intensity from an initial value I0 to a value I. This is done via a combination of absorption 
and scattering according to Equation 3.4. 
 
𝐼 = 𝐼0𝑒
−∝𝑑           (Equation 3.4) 
 
where α is the attenuation (distance-1).  By measuring two values of I, one for a reference 
sample containing no microbubbles and one for a sample containing microbubbles, the 
attenuation coefficient is found. Intensity is calculated from voltage, so by measuring two 
voltages and recognizing that ultrasound intensity is proportional to the square of 
ultrasound pressure which is proportional to voltage, attenuation can be found. 
 
 
         (Equation 3.5) 
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Calculated Attenuation 
From a theoretical viewpoint, Equation 3.4 can be rewritten as 
 
𝐼 = 𝐼0𝑒
−𝜎𝑒𝑁𝑑                 (Equation 3.6) 
 
where N = microbubble number concentration and σe = microbubble extinction cross 
section, given by 
 
𝜎𝑒 =
4𝜋𝑅0𝑐𝛿𝑡𝑜𝑡
𝜔0
Ω2
[(1−Ω2)2+Ω2𝛿𝑡𝑜𝑡
2 ]
                     (Equation 3.7) 
 
where Ω = ω/ωo. Now we find that α = σe N and attenuation can be calculated in terms of 
shell properties using Equations 3.4 through 3.7. Using a factor of 10/2.303 to convert 
experimental values to units of dB/cm and accounting for the fact that the microbubbles 
are not monodisperse, it is necessary to integrate over the size distribution. The final 
result is 
 
𝛼𝐶𝐴𝐿𝐶 = (
10
2.303
∫ 𝜎𝑒(𝑅0, 𝜔)𝑛(𝑅0)𝑑𝑅0
𝑅0,𝑚𝑎𝑥
𝑅0,𝑚𝑖𝑛
)   (Equation 3.8) 
 
where n ( Ro ) = number of microbubbles of a given resting radius, Ro. 
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3.2 Attenuation Measurements Using Cylindrical Chamber 
 
The resonance frequency detection setup, as well as the details of this measurement, can 
be found in Dicker et al. [6] and is shown in Figure 3.1. The technique described in this 
paper will be briefly summarized. 
 
3.2.1 Resonance Frequency Measurement 
 
The set up consists of two 7.5 MHz center frequency, 5 cm spherical focus ultrasound 
transducers (Olympus NDT, Waltham, MA, US) positioned axially 10 cm apart with their 
overlapping foci inside a cylindrical steel sample chamber, filled with PBS, and sealed 
with rubber gaskets.  During the experiments, microbubbles are added to the cylinder so 
that the microbubbles fill the entire volume.  The transmitter is driven by an Inoson 
model MT 06013 pulser/receiver (Inoson, St. Ingbert, Germany), and the received signal 
is filtered between 1 kHz and 36 MHz and amplified by +26 dB by a Panametrics model 
5900RR (Olympus NDT, Waltham, MA, US), and digitized by an oscilloscope (GaGe 
Compuscope, Lockport, IL, PA).  The transmitted signal is defined by a chirp function, 
increasing in frequency from 750 kHz to 13 MHz over a period of 25 µs with a pulse 
repetition time of 1 ms for a total of 100 pulses.  This pulse train undergoes 40 repetitions 
with one second pauses to analyze the change in frequency response over time.  The peak 
negative pressure of the ultrasound was kept below 10 kPa to ensure that the 
microbubbles were not being destroyed during sonication and to ensure oscillations were 
linear. The signal travels axially through the sample chamber and interacts with the 
population of microbubbles floating freely within.   
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                                                           The resonance frequency of lipid-shelled 
microbubbles was determined in a system consisting of two 7.5-MHz center frequency 
spherically focused (5-cm) ultrasound transducers positioned axially 10 cm apart inside a 
steel cylinder, such that their foci overlap. The transmitter was driven by a pulser/receiver 
(Inoson, St. Ingbert, Germany), which emits a chirp that is attenuated inside the sample 
chamber. Figure from Dicker et al. [6]. 
 
The microbubbles consist of a set of compositions with PEG molecular weights of 1000, 
2000, 3000, and 5000 g/mol and PEGylated lipid with an overall mole fractions of either 
0.010 (mushroom regime) or 0.075 (brush regime). The received signal is attenuated by 
the microbubbles depending on their concentration and resonance frequency at each 
frequency of the chirp.  The received signal is then processed by MATLAB to determine 
the pressure amplitude loss in the frequency domain which allows the identification of 
the frequency that yields the highest loss for a given sample.  The frequency spectra are 
normalized by a reference spectrum generated with signals traveling through only PBS.   
 
 
22Figure 3.1:   Resonance frequency detection setup. 
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3.2.2 Results 
 
A reference is compared to the signal received from the microbubble sample and the 
results are plotted as attenuation (dB/cm) versus frequency. When the attenuation is at a 
maximum, the natural frequency of the sample can be identified. The maximum should 
not vary in frequency space with a change in concentration because the concentration 
only changes the magnitude of the attenuation profile. This approach is repeated for a 
range of microbubble shell compositions as shown in Figure 3.2a which gives the 
measured attenuation profiles for the four samples corresponding to the mushroom 
regime (1 mole% PEG having molecular weights of 1000, 2000, 3000 and 5000 g/mol). 
Figure 3.2b shows the measured attenuation profiles corresponding to the brush regime 
(7.5 mole% PEG with molecular weights of 1000, 2000, 3000 and 5000 g/mol). The 
experiment was repeated four times so that the attenuation profile is displayed as an 
average of the measurements. This average is scaled to account for the fact that the 
microbubble concentration varied slightly between samples, so the magnitude of the 
profile was affected.  
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                                                                                                Attenuation values calculated 
from raw voltage (pressure) data are shown for samples in the mushroom (A) and brush 
(B) regimes.  Each profile is the average of four measurements for a given PEG 
formulation for a microbubble sample with a concentration of approximately 15000 
microbubbles/mL.  PEG mole fractions were 0.010 and 0.075 in the mushroom and brush 
regimes, respectively.  PEG molecular weight exerts relatively little influence on 
resonance frequency in the mushroom regime, whereas resonance frequency decreases 
significantly with increasing PEG molecular weight in the brush regime. Figure taken 
from Dicker et al.  [6] 
 
23Figure 3.2:   Measured attenuation profiles for varying shell formulations.
 
 
 
 
 
 
 
 
The samples in the mushroom regime show little, if any, dependence of resonance 
frequency on PEG molecular weight (Figure 3.2A), whereas samples in the brush regime 
exhibit a noticeable decrease in resonance frequency, along with an increase in 
attenuation, with increasing PEG molecular weight (Figure 3.2B). A similar decrease in 
resonance frequency with PEG molecular weight was observed at brush regime PEG 
mole fractions 0.050 and 0.100; the trend seems to be a general feature of the brush 
regime. 
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3.3 Attenuation Measurements Using Time-Delay Spectrometry 
 
The use of a frequency-modulated excitation in resonance spectroscopy is commonly 
used for solid structures [116]. For a correct measurement of the resonance curve, the 
sweeping rate must be slow enough to minimize transient resonant behaviors.  
 
3.3.1 Resonance Frequency Measurement 
 
A novel calibration method suitable for performance evaluation of hydrophones for 
ultrasonic dosimetry in the frequency range between 1 and 10 MHz is used to record 
microbubble acoustic response [120]. The principal advantage of this method is that it is 
able to detect rapid and significant variations in frequency response of the ultrasonic 
hydrophones due to e.g. spurious mechanical resonances [121]. The method employs 
Time Delay Spectrometry (TDS) technique which allows both frequency response and 
directivity patterns of the ultrasonic hydrophone probes to be determined as a continuous 
function of frequency. The advantages and limitations of the TDS technique are pointed 
out. 
 
This technique converts a given propagation time from transmitter to receiver into a 
given frequency shift by keeping a constant sweep rate so the time and frequency are 
linked together. Consequently, selectivity in time is proportional to selectivity in 
frequency with the sweep rate as conversion factor (e.g. 0-20 MHz sweep in one second 
corresponds to 20 Hz per microsecond) and if a band pass filter receiving the electrical 
signal from the ultrasonic hydrophone is swept with a suitable delay in relation to 
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transmitter driving signal and has an appropriate (narrow) bandwidth, only one direct 
signal will be picked up. Hence the TDS technique virtually eliminates the effects of 
multiple transmission paths, standing waves and other interferences due to reflected 
signals. A much more comprehensive description of the TDS technique is given in [122]. 
 
The experimental set up employed in this work utilizes sweeping heterodyne spectrum 
analyzer (Hewlett-Packard 3585A) with a built-in frequency offset unit. The sine swept 
signal from the tracking generator drives specially designed, broadband radiating 
transducer (transmitter) via a power amplifier (EN1 240L RF). The transmitter is made of 
a 10 mm diameter, 22 MHz, plane piezoelectric ceramic disc. The ceramic material is of 
PZ-24 type (trademark of Ferroperm A/S, Vedbaek, Denmark) and is polarized in the 
thickness direction. The signal detected by the receiving transducer (hydrophone) is fed 
into the spectrum analyzer input and then displayed on its screen. This displayed signal 
represents relative, continuous, free field, combined frequency response of the measured 
hydrophone and the transmitter including associated electronics. As the TDS calibration 
method yields a relative frequency response, it requires a reference hydrophone. The 
reference hydrophone used in this work was a needle-like, 1 mm diameter polymer probe, 
which was calibrated by the reciprocity method.  
 
The calibration was carried out at 20 kHz steps up to 10 MHz and was independently 
checked. The difference between these calibrations was less than 0.5 dB (5%) up to 7.6 
MHz and less than 1 dB (11%) from 7.6 MHz to 10 MHz.  
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                                                                                                                                                           The 
received ultrasonic signal was then converted to an electrical signal by the 
pulser/receiver, amplified, and transferred to an oscilloscope to observe and measure the 
corresponding signal. 
The attenuation coefficient measurement was performed using a set-up similar to the one 
used in Umchid et al. [121] as shown in Figure 3.3. The transducer and hydrophone were 
placed in the deionized water inside the water tank. All measurements were made at room 
temperature (24°C). The received ultrasonic signal was then converted to an electrical 
signal by the pulser/receiver, amplified, and transferred to an oscilloscope to observe and 
measure the corresponding signal. Another program was used for displaying and 
recording the waveforms on the computer from the oscilloscope for further analysis. The 
transmitter and the hydrophone were separated by the minimum acceptable distance, 
called far-field distance, to minimize interference from reflections.  
 
 
24Figure 3.3:   Experimental set up for TDS system to measure microbubble attenuation [121]. 
 
 
Sample chamber 
(opticell) 
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3.3.2 Results 
 
Microbubbles with a DSPC monolayer are analyzed for their resonance frequency 
(maximum attenuation) for varying PEG mole% (1-10 %) and PEG molecular weight 
(2,000 g/mol-5,000 g/mol). The same trends are expected with this setup as those found 
in Section 3.2, although it was found that the TDS system is not sensitive enough to 
detect the resonance frequency of the microbubble sample. Concentrations were also 
varied and are labeled as L (low- 10,000 bubbles/mL), M (medium- 30,000 bubbles/mL, 
and H (high- 45,000 bubbles/mL). There should be no effect on the resonance frequency 
by changing concentration, although the magnitude of attenuation should increase with 
concentration. 
 
In Figures 3.4-3.6, the concentration of microbubbles remains constant at 30,000 
bubbles/mL. Figure 3.4 shows the results for a microbubble in the mushroom regime, 
where we expect no change in the resonance frequency as PEG molecular weight is 
increased.  
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                                                                                      Attenuation of microbubbles in the 
mushroom regime comprised of 99% DSPC/ 1 % PEG microbubbles. PEG molecular 
weight is varied between 2000 and 5000 (given by PEG2k, PEG3k, and PEG5k, 
respectively). The concentration of microbubbles remains constant at 30,000 
bubbles/mL. 
 
 
25Figure 3.4:   Attenuation of microbubbles in the mushroom regime.
 
 
 
 
A microbubble with a 99 % DSPC/ 1 % PEG monolayer falls in the mushroom regime, 
and as predicted, there seems to be no change in resonance frequency since the maximum 
attenuation occurs at the same frequency for both PEG-3000 and PEG-5000, although the 
trend for PEG-2000 is not clear. There is a noticeable increase in attenuation as PEG 
molecular weight is increased, which agrees with the data shown in Figure 3.2.  
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                                                                              Attenuation of microbubbles in the 
brush regime comprised of 95% DSPC/ 5% PEG microbubbles. PEG molecular weight is 
varied between 2000 and 5000 (given by PEG2k, PEG3k, and PEG5k, respectively). The 
concentration of microbubbles remains constant at 30,000 bubbles/mL. 
 
 
26Figure 3.5:   Attenuation of microbubbles in the brush regime. 
 
 
 
 
Figure 3.5 displays results for a microbubble in the brush regime. The attenuation does 
not increase with PEG molecular weight for a 95% DSPC/ 5% PEG microbubble 
monolayer as we would expect from previous attenuation measurements in Section 3.2. 
We do, however, see evidence that the resonance frequency is decreased as PEG 
molecular weight is increased.  
 
Figure 3.6 displays results for a 90 % DSPC/ 10 % PEG microbubble in the brush regime. 
The attenuation should increase with PEG MW although we see no trend here. We also 
are not able to conclude whether the resonance frequency is increased or decreased as 
PEG MW changes.  
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                                                                                                      Attenuation of 
microbubbles in the brush regime comprised of 90% DSPC/ 10% PEG microbubbles. 
PEG molecular weight is varied between 2000 and 5000 (given by PEG2k, PEG3k, and 
PEG5k, respectively). The concentration of microbubbles remains constant at 30,000 
bubbles/mL. 
 
 
 
27Figure 3.6:   Attenuation of microbubbles in the brush regime with 10% PEG. 
 
 
 
 
Figures 3.7 through 3.8 demonstrate the effect of varying microbubble concentration in 
the sample chamber for each combination of PEG molecular weight (2000, 3000, and 
5000 g/mol) and PEG concentration (1, 5, and 10 %). We would expect that resonance 
frequency does not change with concentration, only attenuation increases with increasing 
microbubble concentration.  
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                                                                                                                          Attenuation 
versus frequency results for a) DSPC 10% PEG-5000 and b) DSPC 5% PEG-5000 where 
we find the data matches the expectation that there should be no change in resonance 
frequency while changing concentration and only an increase in attenuation with increasing 
concentration. For c) DSPC 10% PEG-3000 and d) DSPC 5% PEG-3000, the same trend 
follows but is not as pronounced. Concentrations were also varied and are labeled as L 
(low- 10,000 bubbles/mL), M (medium- 30,000 bubbles/mL, and H (high- 45,000 
bubbles/mL). 
 
28Figure 3.7:   Attenuation of ultrasound signal for microbubbles with varying concentration.
 
 
 
 
 
 
 
 
 
 
 
 
The results for PEG-2000 are shown below in Figure 3.8. There is no evident relationship 
between concentration and attenuation, but the results are displayed for further 
examination. 
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                                                                                                                       Attenuation 
versus frequency results for a) DSPC 10% PEG-2000, b) DSPC 5% PEG-2000, and c) 
DSPC 1% PEG-2000 where we find no significant trend relating microbubble 
concentration to attenuation, although we do see that resonance frequency doesn’t change 
with concentration as one would expect.  Concentrations were also varied and are labeled 
as L (low- 10,000 bubbles/mL), M (medium- 30,000 bubbles/mL, and H (high- 45,000 
bubbles/mL). 
 
 
29Figure 3.8:   Attenuation for DSPC PEG-2000 microbubbles with varying concentration. 
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3.4 Attenuation Measurements Using Pulse-Echo System 
 
In an attempt to measure the resonance frequency of microbubbles with yet another set 
up, the Sarkar group at George Washington University employed their attenuation 
measurement technique in an attempt to identify resonance frequency.  
 
3.4.1 Resonance Frequency Measurement 
 
The experimental setup for attenuation measurement used a pulse-echo system at room 
temperature as described by Paul et al. [123] and is shown in Figure 3.9. Attenuation 
from a suspension of contrast agent (constantly stirred) was measured using unfocused 
broadband transducers (Olympus NDT, Waltham, MA, USA) with central frequencies 
2.25 MHz (V306–SU), 3.5 MHz (V382–SU) and 5 MHz (V309–SU) operating in 
transmit/receive mode. The -6 dB bandwidth ranges of the transducers were 1.178–3.32, 
2.5–4.99 and 3.13–6.19 MHz, respectively. A pulser/receiver (Model 5800; Panametrics-
NDT, Waltham, MA, USA) was used to excite the transducers at a pulse repetition 
frequency of 100 Hz; it generated a broadband pulse of duration of 440 ns. The pulse 
generated at the face of the transducer traveled a total distance of 12 cm through the 
contrast agent suspension (from the transducer face to the container wall and back; 
container is made of 1.17-cm-thick polycarbonate sheet) before being received and fed to 
the digital oscilloscope (Model TDS 2012; Tektronix, Beaverton, OR, USA) to observe 
the signal in real time. Twenty voltage–time radio frequency traces were acquired in an 
averaging mode (64 sequences are used for averaging) and saved. The excitation 
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                                                                                                 a) A 3-D view of the setup for 
measuring scattering using a larger volume. b) Schematic representation of the 
experimental setup to measure acoustic scattering in vitro using a large sample volume.  
amplitude, 200 kPa peak negative pressure, is low enough so that the frequency-
dependent broadband attenuation does not depend on the acoustic pressure. 
 
 
30Figure 3.9:   Schematic of the attenuation measurement pulse-echo system.
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                                                                                                   The fundamental response 
versus excitation pressure for microbubbles with a monolayer composition of 99 % DSPC/ 
1 % PEG-2000 (referred to as PEG2K in legend), 95 % DSPC/ 5 % PEG-3000 (referred to 
as PEG3K in legend), and 90 % DSPC/ 10 % PEG-5000 (referred to as PEG5K in legend) 
at a concentration of 10 µL MB solution/mL.  The excitation frequency is 3.5 MHz (32 
cycles), and the excitation pressure is 100, 250, 400, 500, 700, 800, and 1000 kPa.  
 
3.4.2 Results 
 
Figures 3.10 through 3.12 display the fundamental, subharmonic, and second harmonic 
response versus excitation pressure for microbubbles with a monolayer composition of 99 
% DSPC/ 1 % PEG-2000,    95 % DSPC/ 5 % PEG-3000, and 90 % DSPC/ 10 % PEG-
5000 at a concentration of 10 µL MB solution/mL.  The excitation frequency is 3.5 MHz 
(32 cycles), and the excitation pressure is 100, 250, 400, 500, 700, 800, and 1000 kPa.  
 
 
31Figure 3.10:   Fundamental response vs excitation pressure for microbubbles.
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                                                                                                    The subharmonic response 
versus excitation pressure for microbubbles with a monolayer composition of 99 % 
DSPC/ 1 % PEG-2000 (referred to as PEG2K in legend), 95 % DSPC/ 5 % PEG-3000 
(referred to as PEG3K in legend), and 90 % DSPC/ 10 % PEG-5000 (referred to as 
PEG5K in legend) at a concentration of 10 µL MB solution/mL.  The excitation 
frequency is 3.5 MHz (32 cycles), and the excitation pressure is 100, 250, 400, 500, 700, 
800, and 1000 kPa.  
 
 
32Figure 3.11:  Subharmonic response vs excitation pressure for microbubbles.   
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                                                                                                         The second harmonic 
response versus excitation pressure for microbubbles with a monolayer composition of 99 
% DSPC/ 1 % PEG-2000 (referred to as PEG2K in legend), 95 % DSPC/ 5 % PEG-3000 
(referred to as PEG3K in legend), and 90 % DSPC/ 10 % PEG-5000 (referred to as 
PEG5K in legend) at a concentration of 10 µL MB solution/mL.  The excitation 
frequency is 3.5 MHz (32 cycles), and the excitation pressure is 100, 250, 400, 500, 700, 
800, and 1000 kPa.  
 
 
33Figure 3.12:   Second harmonic response vs excitation pressure for microbubbles. 
 
 
 
 
 
 
From Figures 3.10 through 3.12 we conclude that PEG-5000 and PEG-2000 gave the 
strongest signal for fundamental response. PEG-2000 gave the most intensive 
subharmonic response and PEG-3000 degenerated fast after ultrasound impinged on it. 
The signal lasted for less than 5 minutes when excitation pressures were above 250 kPa. 
 
The second set of experiments done with this set up utilize microbubbles with a 
monolayer composition of 99 % DSPC/ 1 % PEG-3000,    95 % DSPC/ 5 % PEG-3000, 
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                                                                                                                      99 % DSPC/ 1 
% PEG-3000 a) Attenuation vs Pressure at a concentration of 30 µL/100mL and b) 
Attenuation vs Concentration at 15 kPa excitation pressure. An unfocused transducer with 
a center frequency of 5 MHz was employed. The excitation pressures were no higher than 
70 kPa. 
 
 
and 90 % DSPC/ 10 % PEG-3000 at a concentration of 10 µL MB solution/mL.  An 
unfocused transducer with a center frequency of 5 MHz was employed. The excitation 
pressures were no higher than 70 kPa. 
 
 
34Figure 3.13:   Attenuation of microbubble with a 99 % DSPC/ 1 % PEG-3000 monolayer. 
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                                                                                                                      95 % DSPC/ 5 
% PEG-3000 a) Attenuation vs Pressure at a concentration of 30 µL/100mL and b) 
Attenuation vs Concentration at 15 kPa excitation pressure. An unfocused transducer 
with a center frequency of 5 MHz was employed. The excitation pressures were no 
higher than 70 kPa. 
 
 
                                                                                                                       90 % DSPC/ 
10 % PEG-3000 a) Attenuation vs Pressure at a concentration of 30 µL/100mL and b) 
Attenuation vs Concentration at 15 kPa excitation pressure. An unfocused transducer 
with a center frequency of 5 MHz was employed. The excitation pressures were no 
higher than 70 kPa. 
 
 
 
35Figure 3.14:   Attenuation of microbubble with a 95 % DSPC/ 5 % PEG-3000 monolayer.  
 
 
 
 
 
 
36Figure 3.15:   Attenuation of microbubble with a 90 % DSPC/ 10 % PEG-3000 monolayer.
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                                                                                                  Comparison of three samples 
(99 % DSPC/ 1 % PEG-3000, 95 % DSPC/ 5 % PEG-3000, and 90 % DSPC/ 10 % PEG-
3000) for a) Attenuation vs Pressure at a concentration of 30 µL/100mL and b) 
Attenuation vs Concentration at 15 kPa excitation pressure. 
 
                                                                                                                               
Attenuation coefficient for 99 % DSPC/ 1 % PEG-3000 (referred to as PEG3K-1%), 95 
% DSPC/ 5 % PEG-3000 (referred to as PEG3K-5%), and 90 % DSPC/ 10 % PEG-3000 
(referred to as PEG3K-10%)  
 
37Figure 3.16:   Comparison of attenuation versus concentration and pressure. 
  
 
 
 
 
38Figure 3.17:   Comparison of samples at 30 µL/100 mL concentration and 15 kPa excitation pressure. 
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3.5 Conclusion 
 
Three different experimental setups attempting to measure the attenuation of 
microbubbles were presented and explored. Based on the results of these studies, the first 
method using a cylindrical chamber was the most reliable (results presented in [6]). It 
was found that microbubble resonance frequency is sensitive to changes in the PEG 
molecular weight and concentration within the microbubble monolayer. Studies have 
been done measuring the attenuation of commercially available contrast agents, but that 
did not allow for a variation of parameters in the microbubble characteristics. A 
linearized equation describing microbubble dynamics was used to uncover the 
mathematical equation for natural frequency of the microbubble. This equation defines 
the resonance frequency in terms of rigorously defined membrane material properties, 
including surface tension, area expansion modulus, and dilatational viscosity.   
 
The shell composition of the microbubble can be used to predict the desired resonance 
frequency for tailored applications in the range of 1 – 10 MHz. From these experiments, 
we find that when the microbubble is in the brush regime, the amount of PEG does not 
affect the resonance frequency of the microbubble. When the microbubble exists within 
the mushroom regime, resonance frequency decreases as PEG molecular weight 
increases. This trend was not transparent in all setups, but it was reproduced for reliable 
data in the first experimental setup. This suggests errors with the TDS system and the 
pulse echo system, which were implemented in an attempt to avoid the formation of a 
standing wave.  
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The transmitted frequency at which the resonant excitation of microbubble oscillation 
occurs is taken to be equal to the undamped natural frequency. Every harmonic of the 
backscattered signal has its own resonance frequency. In particular, a monodisperse 
suspension of microbubbles cannot produce the resonant backscatter at both the 
transmitted frequency and twice the transmitted frequency. Because a microbubble 
suspension is polydisperse, there exist bubbles of one size that produce the resonant 
backscatter at the transmitted frequency and bubbles of another size that produce the 
resonant backscatter at twice the transmitted frequency. The ability to adjust the 
microbubble resonance frequency is significant in the field of harmonic imaging or phase 
inversion ultrasound. If the resonance frequency of the microbubble is near the 
transmitted ultrasound frequency, the signal quality of the ultrasound contrast agent 
formulation can be improved through frequency matching. Tuning the microbubble 
resonance frequency also provides a way to improve efficacy in triggered drug delivery 
vehicles employing microbubbles [16].  
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CHAPTER 4: INERTIAL CAVITATION DETECTION 
 
4.1 Introduction 
 
Although controlled inertial cavitation can be used for therapeutics, the local increase in 
temperature and pressure of up to 5000 K and 100 MPa respectively have been shown to 
cause damage to nearby microstructures, including cells [49, 58, 124]. For this reason the 
safety of microbubble contrast agents has been questioned [125]. Unique UCA 
formulations are desirable to increase the inertial cavitation threshold and therefore 
decrease the negative effects of inertial cavitation within the body.  
 
In this chapter, a fourth generation of UCAs termed polymeric nested microbubbles is 
discussed. The novel UCA is constructed by nesting a second generation UCA- an SF6 
microbubble encapsulated by a phospholipid monolayer- within the aqueous core of a 
polymer shell. The nested formulation provides similar contrast, in both acoustic 
response and image intensity, to the un-nested contrast agent, with the improvement of 
increased longevity [2, 112, 126]. Data generated by the nested microbubbles is displays 
a clear potential for enhanced imaging, but a theoretical model involving the intricate 
details of this system is still under development. This chapter investigates the proposed 
fourth generation of UCAs and elucidates the new phenomena brought on by the nesting 
shell, specifically relating to the cavitation behavior.  
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4.2 Cavitation Detection Technique  
 
A 2.25 MHz, 7.5 cm focused ultrasound transducer (Olympus NDT, Waltham, MA, 
USA) is driven by a home built high voltage pulser described in previous works [20, 49, 
126, 127] so that a double passive cavitation detection technique can be employed [128]. 
An identical transducer is placed at a 90° angle from the transmitting transducer. The 
overlap of the foci is a 1 mm3 volume located within the sample chamber of the setup 
shown in Figure 4.1. The transducer can generate a peak negative pressure (PNP) of up to 
3 MPa, which was calibrated using a needle hydrophone. The signal is filtered using a 5 
MHz lowpass filter (Minicircuits, Brooklyn, NY), amplified by +26 dB (Panametrics 
NDT, Waltham MA) and then digitized with an oscilloscope (Cleverscope Ltd, 
Auckland, NZ). The setup is contained within a 15 L tank filled with deionized water, as 
shown in Figure 2. The pulser signal consists of 600 pulse trains per experiment at a 
pulse repetition frequency of 5 Hz, where each train has four pulses of four cycles with 
an 80 ms pause between pulses. Consecutive pulses are inverted to allow for phase 
inversion signal processing. An experiment consists of one amplitude, where each 
amplitude corresponds to a peak negative pressure between 50 kPa and 2 MPa.  
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                                             The Cavitation Detection System consists of two spherically 
focused ultrasound transducers, one for transmission (T) and a second at 90° relative to 
the first used to receive (R) acoustic waves within the region of focal overlap. A 
computer is used to program a signal generator and, with the assistance of an amplifier, 
drive the transmitting transducer. A microbubble in the confocally aligned region scatters 
sound which is picked up by the receiving transducer, amplified, digitized, and analyzed 
by a computer program to determine whether cavitation has occurred.  
  
 
39Figure 4.1:   Cavitation detection system. 
 
 
 
 
 
 
 
In order to minimize sound reflection from the walls of the sample chamber, a latex cot 
(Duro-Med Industries, Valencia, CA) is used to contain the sample within the acoustic 
focus region. The sample is inserted into the latex cot at the beginning of each experiment 
then diluted to a concentration such that one particle will be sampled in the focus for 
every six pulse trains. This dilution is based on the assumption that one billion 
microbubbles per milliliter exist in the initial microbubble solution, and if well mixed one 
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bubble will pass through the acoustic overlap region every six pulses. While in practice 
this is not exactly true, adjacent pulse trains in which a bubble is detected are discarded to 
avoid the possibility of recording the response from the same microbubble. The mixing 
speed is set at 600 rpm so that the maximum distance a microbubble can travel within the 
time of a single pulse train does not exceed 50 μm, and therefore cannot travel out of the 
foci distance of 1 mm3 in the time span of one pulse train. For statistical significance, at 
least 100 particles are analyzed per amplitude, and any adjacent pulse trains that detected 
the presence of a microbubble are dismissed to eliminate the possibility of analyzing the 
same particle twice. 
 
The received signal is processed with a MATLAB program that determines whether a 
microbubble is found and if so, whether that same microbubble is destroyed after 
ultrasound exposure. The excitation signal consists of four pulses, with two positive and 
two negative pulses with programmable center frequency and burst length. Since these 
pulses are inversions of each other, any nonlinear signal from an oscillating microbubble 
will result in a non-zero summation. These waveforms are evaluated for the presence of a 
microbubble. In summary, the first two pulses determine whether a bubble is found. The 
third and fourth pulses determine whether the microbubble that was found in the first two 
pulses has been destroyed. The summation of the third and fourth pulses is subtracted 
from the summation of the first two pulses and this resulting number is compared to the 
empirically determined destruction threshold of the max signal divided by the mean 
signal of the waveform. Details of this technique are described in previous work [127]. If 
the result is greater than that threshold, it can be concluded that the bubble was destroyed. 
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When the max/mean value of the phase inverted signals is greater than 10, a bubble is 
considered to be found. When the difference of the inversions has a max/mean value 
greater than 7, the found microbubble is considered to be destroyed. While these values 
may seem arbitrary, it is clear from acoustic spectrograms (which can be found in Dicker 
et al. [16])  that these thresholds coincide with cases of microbubble detection or the lack 
thereof. This method can generally be referred to as the double passive cavitation 
identification technique. Using this technique, the program can determine the percent of 
microbubbles destroyed at a given amplitude.  
 
It should be noted that the mechanisms of microbubble destruction involve both inertial 
cavitation (fragmentation) and/or acoustic dissolution of the encapsulated gas core [34, 
129]. We conclude that inertial cavitation is the dominating mechanism of destruction in 
our studies by analyzing the time scale of events leading to the disappearance of a gas 
bubble in a liquid medium [129, 130]. The time scale necessary for the destruction of a 
microbubble varies significantly with each mechanism. Fragmentation is hypothesized to 
occur on a time scale of microseconds while acoustically driven diffusion occurs within 
microseconds but requires tens of milliseconds to destroy a bubble (because multiple 
pulses are needed) [129]. Other studies suggest that acoustic dissolution causes bubble 
shrinkage until the microbubble reaches a metastable diameter [34, 64], usually occurring 
after 50-150 pulses at 2 MHz (up to 2 min) [130]. Up to 1000 additional pulses are 
needed to induce further bubble shrinkage [130]. These studies suggest that the 
acoustically induced dissolution would not result in complete destruction of the 
microbubble. The time scale in our experiments, which involved examination of the 
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presence (or lack thereof) of a microbubble in the acoustic focal region after exposure to 
two pulses, was approximately 200 μs and points toward fragmentation as the mechanism 
of destruction. Although we have no optical evidence from direct observations of 
microbubble dynamics to determine whether acoustic dissolution or fragmentation is 
occurring, we believe that in comparison to the time scales of other studies we can 
conclude destruction is a result of inertial cavitation.  
 
4.2.1  Empirical Threshold Determination 
 
In order to determine whether a microbubble exists in the focal region and whether it has 
been destroyed after the microbubble pulse, an empirical threshold is used. Because the 
threshold is determined empirically rather than theoretically, a section dedicated to the 
threshold determination is needed. Here, a more detailed explanation taken from Mleczko 
et al. [127] is provided on the set up which leads into the empirical threshold 
determination discussion. 
 
This work was based off of a double passive cavitation detection system as published in 
King et al. [128]. The received signal is processed with a MATLAB program that 
determines whether a microbubble is found and if so, whether that same microbubble is 
destroyed after ultrasound exposure using a technique described in previous work [127]. 
The excitation signal consists of four pulses, with two positive and two negative pulses 
with programmable center frequency and burst length. Since these pulses are inversions 
of each other, any nonlinear signal from an oscillating microbubble will result in a non-
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zero summation. To determine if a bubble is found within the foci overlap, the waveform 
is initially decomposed into 4 elements x1,…, x4 that correspond to the excitation signals. 
The Phase Inversion waveforms xpi,1 and xpi,2 are calculated from x1,…, x4: 
 
xpi,1 (t ) = x1 (t ) + x2 (t )                           (Equation 4.1) 
 
xpi,2 (t ) = x3 (t ) + x4 (t )               (Equation 4.2) 
 
These waveforms are then evaluated for the presence of a microbubble. There are three 
distinct cases that can occur. One possibility is that no bubble was detected. The other 
two cases are when a bubble is detected it either survives or is destroyed. Bubble 
detection is conducted by evaluation of signal power in the passband of the transducer in 
relation to noise power in the signal xpi,1 . A detection event is counted if the condition 
 
𝑑𝑑𝑒𝑡 =
𝑚𝑎𝑥𝜔𝑒Ω𝑝𝑏(|𝑥𝑝𝑖,1
(𝜔)|)
𝑚𝑒𝑑𝑖𝑎𝑛𝜔𝑒Ω𝑠𝑏(|𝑥𝑝𝑖,1
(𝜔)|)
> 10            (Equation 4.3) 
 
is met, with 𝑥𝑝𝑖,1(𝜔)|𝜔𝑒Ω𝑝𝑏
 denoting the frequency components in the passband of the 
ultrasound transducer of the signal xpi,1. 𝑋𝑝𝑖,1(𝜔𝑠𝑏)|𝜔𝑒Ω𝑠𝑏
 denotes frequency components 
in the stopband of the transducer where measurement noise dominates. For the detection 
of bubble destruction, a similar approach is taken. To determine whether a bubble was 
destroyed, the difference xpi,2 - xpi,1 is considered. The criterion for a bubble destruction 
event is given by 
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                                                                                          Acoustic spectrograms on the left 
and phase inverted waveforms displayed on the right for the 3 conditions met if a 
microbubble is detected but not destroyed. Phase inversion of the first two pulses (top) 
shows that a microbubble is found. Phase inversion of the second two pulses (middle) 
shows that the microbubble still remains after ultrasound exposure. The difference 
between the 2 pulse sets (bottom) identify that the found microbubble has not been 
destroyed.  
𝑑𝑑𝑒𝑠 =
𝑚𝑎𝑥𝜔𝑒Ω𝑝𝑏(|𝑋𝑝𝑖,2
(𝜔)−𝑋𝑝𝑖,1(𝜔)|)
𝑚𝑒𝑑𝑖𝑎𝑛𝜔𝑒Ω𝑠𝑏(|𝑋𝑝𝑖,2
(𝜔)−𝑋𝑝𝑖,1(𝜔)|)
> 7                           (Equation 4.4) 
 
ddet and ddes are compared to empirically determined thresholds to determine if a bubble is 
found and whether the identified bubble is then destroyed.  
 
The empirically determined thresholds are identified by examining sample pulse trains 
which specify a bubble surviving the ultrasound exposure in Figure 4.2 and a bubble 
destroyed from ultrasound in Figure 4.3 [16].  
 
 
40Figure 4.2:   Conditions for a microbubble detected but not destroyed.  
ddet =14.31 
ddes =3.33 
ddet =12.42 
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                                                                                                         Acoustic spectrograms 
are on the left, while phase inverted waveforms are displayed on the right for the 3 
conditions met if a microbubble is detected and destroyed from ultrasound exposure. 
Phase inversion of the first two pulses (top) shows that a microbubble is found. Phase 
inversion of the second two pulses (middle) shows only noise present. Therefore, the 
difference between the 2 pulse sets (bottom) determines that the found microbubble has 
been destroyed. Acoustic spectrograms are displayed as a frequency index versus a time 
index, and the waveforms are a voltage versus time index. 
 
41Figure 4.3:   Conditions for a microbubble detected and subsequently destroyed. 
 
 
 
 
 
 
 
 
 
If the ddet value of the phase inverted signals (top or middle row) is greater than 10, than a 
bubble is considered to be found. Additionally, if the difference of the inversions (bottom 
row) has a ddes value greater than 7, the found microbubble is considered to be destroyed. 
While these values may seem arbitrary, it is clear from the above figures that there exist 
clear cases of microbubble detection or lack thereof. Depending on the acoustic pressure, 
the ddet values when a microbubble is detected can drop as low at 7.5; however, even at 
ddet =16.83 
ddet =3.17 
ddes=10.78 
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the highest acoustic pressures studied here, the ddet value for noise (or no microbubble 
found) never reaches higher than 3.5. Taken together, these results coincide with the 
selection of the max/min threshold values for detection and destruction. 
 
Vary Threshold to Find Microbubble 
To confirm that the destruction data is statistically significant, the program must find at 
least 100 microbubbles for each pressure. Depending on the size of the particle (nested 
microbubble versus un-nested microbubble) and the experimental conditions, the 
threshold for the presence of a microbubble may need to be altered in the MATLAB 
analysis. An example of the effect of varying the threshold is shown in Figure 4.4 where 
the “find_thresh” value is varied and the number of bubbles found at each pressure is 
recorded. The best possible value depends on the formulation used, so these parameters 
would not necessarily hold true for polymeric or liposomal nested microbubbles.  
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                                                                                 The MATLAB analysis program was 
run with different values for the find_thresh (empirical value for determination of 
microbubble presence) ranging from 3.7 to 4.5. The highest threshold value of 4.5 results 
in the largest number of bubbles found for each pressure. The threshold can be changed 
for each sample because if the concentration within the sample chamber is too low, the 
program will not find an adequate number of bubbles for analysis. On the other hand, if 
the concentration is too high, the program can not find a significant amount of trials where 
only one microbubble is present in the chamber. This confirms that our threshold value is 
acceptable for microbubbles, and also identifies the best value where the maximum 
number of bubbles are found.  
 
 
42Figure 4.4:   Varying threshold for cavitation detection program.
 
 
 
 
 
 
 
 
 
4.2.2 Calibration of Transducers  
 
The function generator used 50 cycle burst, 10 ms period, 16 cycle average. It was 
calibrated with a Marconi (wrinkled) hydrophone with sensitivity at 5 MHz of 0.0172 
μV/Pa. The function generator produced a voltage which was amplified by +55dB using a 
power amp. The output pressure was measured for each voltage. The intensity, Isptp, was 
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                                                                                             5 MHz 75 mm focused transducers a) 
serial number 866395 and b) serial number 866394 were calibrated and displayed with a line of 
best fit.  
 
then calculated in W/cm2. The error in reading was ±10% so the pressure readings were 
adjusted by 10% to get an intensity that closer matched literature. Also, the set voltage 
(the “amp” parameter in the MATLAB program) was measured for its output voltage.  A 
best fit line was created for this to match any set voltage to output voltage based on the 
linear relationship. 
 
 
43Figure 4.5:   Pressure vs voltage for 5 MHz transducer calibration. 
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                                                                                  5 MHz 75 mm focused transducers output 
voltage for each amplitude, a parameter set by the user in MATLAB. 
 
During experimentation, the amplitude is set by the user in a MATLAB program. The 
output voltage is measured for each set amplitude during calibration to more accurately 
identify the energy exposure within the sample chamber.  
 
4Table 4.1:   Set amplitude vs output voltage for inertial cavitation detection program.  
 
 
This data was used to plot output voltage versus set amplitude. 
 
 
44Figure 4.6:   Voltage vs set amplitude for 5 MHz transducer  
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                                                                                                                    Graph of adjusted 
pressure (MPa) versus input amplitude in MATLAB that includes the 10% adjustment to better 
match literature values. The adjustment value was found during calibration. 
 
Combining the best fit line equation for pressure vs voltage, as well as the best fit line equation 
for output voltage data for each set voltage, we create a graph of adjusted pressure (MPa) versus 
input amplitude in MATLAB that includes the 10% adjustment to better match literature values in 
Figure 4.6 and then calculate intensity (Isptp) at each amplitude from the pressure value shown in 
Figure 4.7. 
 
 
45Figure 4.7:   Adjusted pressure versus input amplitude for MATLAB program.
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                                                                                                                       The output pressure was 
measured for each voltage. The intensity, Isptp, was then calculated in W/cm2. 
 
 
46Figure 4.8:   Calculated intensity for each input amplitude in MATLAB program. 
 
 
4.3 Inertial Cavitation of Microbubbles  
 
As a reference point for the inertial cavitation detection experiment, a combination of 
microbubble/PBS concentrations are tested. The number of microbubbles found for each 
amplitude is summed up in Table 4.1. First PBS was added to a separate vial (always 2 
mL in this table and referred to as PBS). Microbubbles were then extracted from the vial 
with a syringe with a volume varying between 2 and 30 µL and reported as “_uBub”. The 
third value reported in each recipe was the amount of the diluted microbubble solution 
(PBS plus microbubbles) which was either 2 or 3 µL in each case and reported as 
“_uSoln”. This was done for several microbubble compositions, with the best 
concentration (most microbubbles found) highlighted in each section. For the last sample, 
there were two sets of concentrations that were both acceptable for the program.  
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5Table 4.2:   Determination of ideal concentration for cavitation detection technique. 
90 % DSPC / 10 % PEG-3000 0 2 8 18 37 Amplitudes 
2mPBS,2uBub,2uSoln 29 85 94 92 36 Bub Found 
2mPBS,5uBub,2uSoln 94 85 86 80 13 Bub Found 
2mPBS,8uBub,3uSoln 131 95 79 84 57 Bub Found 
2mPBS,30uBub,3uSoln 41 5 2 4 9 Bub Found 
99 % DSPC / 1 % PEG-3000 0 2 8 18 37 Amplitudes 
2mPBS,5uBub,3uSoln 36 33 27 65 2 Bub Found 
2mPBS,2uBub,3uSoln 27 134 63 91 1 Bub Found 
2mPBS,2uBub,2uSoln 62 129 90 107 1 Bub Found 
2mPBS,20uBub,2uSoln 138 5 1 3 12 Bub Found 
90 % DSPC / 10 % PEG-5000 0 2 8 18 37 Amplitudes 
2mPBS,2uBub,2uSoln 63 113 83 78 10 Bub Found 
2mPBS,4uBub,3uSoln 146 54 83 76 84 Bub Found 
2mPBS,6uBub,3uSoln 123 22 87 69 66 Bub Found 
2mPBS,9uBub,3uSoln 102 9 74 74 88 Bub Found 
95 % DSPC / 5 % PEG-5000 0 2 8 18 37 Amplitudes 
2mPBS,2uBub,2uSoln 137 36 81 75 80 Bub Found 
2mPBS,1uBub,2uSoln 65 94 90 94 86 Bub Found 
2mPBS,3uBub,3uSoln 139 5 65 81 93 Bub Found 
2mPBS,5uBub,3uSoln 23 2 58 73 83 Bub Found 
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4.3.1 Effect of PEG on Inertial Cavitation  
 
It has been found that the area expansion modulus does not vary greatly with lipid chain 
length, PEG mole fraction or PEG molecular weight in the mushroom regime, but it does 
depend on these factors in the brush regime [16]. By varying the mole fraction and 
molecular weight of PEG in the brush regime, experimental data linking these parameters 
to the cavitation threshold can be found. 
 
To study the effect of the PEG mole percent, two microbubble populations were 
formulated so that one sample fell in the mushroom regime and the other was outside of 
this regime. The sample in the brush regime consisted of 90 mol % DSPC and 10 mol % 
DSPE-PEG3000 while the second sample was composed of 95 mol % DSPC and 5 mol 
% DSPE-PEG3000. Using the cavitation detection system, the cavitation profile for the 
sample was produced. It is shown in Figure 4.8 that increasing the mole fraction increases 
the cavitation threshold. As the mole fraction is increased, the monolayer becomes stiffer, 
and therefore increases the cavitation threshold. 
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                                                                                                               Within the brush regime, 
increasing the PEG mole fraction (from 5 to 10 mole % PEG at a fixed mol. wt. of 3000 g/mol) 
increases the cavitation threshold. Both samples comprised sulfur hexafluoride (SF6) as the gas core 
and DSPC as the coating phospholipid. 
 
47Figure 4.9:   Inertial cavitation profile for microbubbles in the brush regime. 
 
 
 
To study the effect of PEG molecular weight, one sample was prepared using PEG with a 
molecular weight of 3000 g/mol and another with 5000 g/mol. It can be seen in Figure 
4.9 that cavitation threshold decreases with increasing molecular weight. An increase in 
molecular weight within the monolayer makes the monolayer stiffer but with an increase 
in molecular weight of PEG, there is a decrease in the amount of PEG which can be 
integrated into the monolayer. This is due to the steric hindrance preventing PEG 
incorporation resulting from the impenetrability of the crowded monolayer. The overall 
effect is that there is a decrease in area expansion modulus when the overall mole fraction 
of PEG within the system is increased.  
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                                                                                                               Within the brush regime, 
increasing the PEG MW (from 3000 to 5000 g/mol PEG at a fixed mole fraction of 10%) decreases 
the cavitation threshold. Both samples comprised sulfur hexafluoride (SF6) as the gas core and 
DSPC as the coating phospholipid. 
 
48Figure 4.10:  Inertial cavitation profile for increasing PEG molecular weight.  
 
 
 
 
4.3.2 Effect of Transducer Frequency on Inertial Cavitation  
 
Chapter 3 discussed the resonance frequency of the microbubble where the microbubble 
oscillations grow larger in magnitude as the transducer frequency approaches the 
resonance frequency. By changing the operating frequency of the transducer from 2.25 
MHz as was done in the previous study to 1 MHz, we observe the effects on inertial 
cavitation for microbubble samples with varying PEG molecular weight and mole 
percent.  
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                                                                                             Using a 75 mm 1 MHz focused 
transducer, inertial cavitation profiles are plotted for DSPC microbubbles for PEG MW 
(a) 2000, (b) 3000, and (c) 5000 g/mol PEG at mole fractions of 1, 5, and 10%. As PEG 
mole fraction increases, inertial cavitation decreases in each case. As PEG molecular 
weight increases, the difference in cavitation for each PEG mole fraction decreases.  
 
 
49Figure 4.11:   Inertial cavitation profile at 1 MHz for varying PEG mol wt. 
 
 
 
 
Microbubble destruction varies between 9% and 25% for the DSPC PEG-2000 sample at 
the highest peak negative pressure, while cavitation varies between 22% and 32% for the 
DSPC PEG-5000 sample. 
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                                                                                                 Using a 75 mm 1 MHz 
focused transducer, inertial cavitation profiles are plotted for DSPC microbubbles for 
PEG mole fraction (a) 1% and (b) 10% for varying PEG molecular weight between 2000 
and 5000 g/mol. As PEG mole fraction increases, the difference in cavitation for each 
PEG mole fraction also increases.  
 
50Figure 4.12:   Inertial cavitation profile at 1 MHz for varying PEG mol frac. 
 
 
 
 
An interesting aspect of these graphs is that the fraction of microbubble destruction never 
reaches 100%, even at 2 MPa applied pressure. One reason could be that the machine was 
not calibrated properly, which skews the percentage of bubbles detected. Another 
possible explanation is that 1 MHz is further from the microbubble’s resonance 
frequency, which decreases oscillations, and prevents the microbubble from ever 
reaching its critical radius where inertial cavitation would take place.  
 
4.4 Inertial Cavitation of Polymeric Nested Microbubbles  
 
When phospholipid-coated microbubbles are nested within the aqueous core of a poly-
lactic acid (PLA) microsphere, the inertial cavitation threshold increases significantly 
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of 1 MPa caused cavitation of approximately 70% of an un-nested microbubble sample 
encapsulated by a monolayer comprised of 95% gel phase lipid, 1,2-Distearoyl-sn-
Glycero-3-Phosphocholine (DSPC) and 5% Polyethylene Glycol (PEG) functionalized 
lipid, 1,2-Disteroyl-sn-Glycero-3-Phosphoethanolamine-N-[Methoxy 
(Polyethyleneglycol) - 5000] (DSPE-PEG5k). Destruction decreased to 20% at the same 
PNP of 1 MPa when the sample was nested within a polymer shell [126]. PLA allows for 
greater stability of the contrast agent [112] and is already approved by the FDA for 
several in vivo applications, such as medical implants [2, 53]. We contend that the 
decrease in inertial cavitation due to the nesting shell is caused by a combination of a 
change in stiffness of the system and an added resistance to microbubble expansion as 
water must be passed through the shell to accommodate for its incompressibility [11, 
131]. Experimental results presented in this section explore the dependence of 
microbubble concentration used during formulation, ranging from 3x108 to 6x108 
microbubbles/mL, and the nesting shell diameter, ranging from 1.95 to 20.52 μm, on 
inertial cavitation threshold.  
 
In order to ensure that the polymer shell encapsulating the lipid microbubbles does 
indeed increase the cavitation threshold of a microbubble population, the cavitation 
detection system was used to determine the cavitation profiles for two samples of 
microbubbles. One sample is purely microbubbles while the other sample consists of an 
identical formulation of microbubbles nested within a polymer shell using the 
water/oil/water double emulsion. For a population of sulfur hexafluoride (SF6) gas filled 
microbubbles with a lipid monolayer composed of 95 mol % DSPC and 5 mol % DSPE-
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                                                                                                  Cavitation destruction 
profiles for two samples of microbubbles, both having identical coatings of 95 mol % 
DSPC and 5 mol % DSPE-PEG3000. Freely floating microbubbles and microbubbles 
nested within the aqueous core of a PLA microcapsule are compared to determine the 
effect that nesting has on the cavitation threshold. Nesting microbubbles within PLA 
microcapsules significantly reduces inertial-cavitation induced destruction of 
microbubbles. For example, whereas complete destruction is achieved at a pressure of 1.0 
MPa when the microbubbles are freely floating, about half of the microbubbles are 
destroyed when the microbubbles are nested inside the microcapsule. 
 
PEG3000, at a pressure of 1 MPa approximately 100% of the microbubbles were 
destroyed, while only 50% of the nested microbubbles were destroyed. 
 
 
51Figure 4.13:   Inertial cavitation profile of un-nested vs nested microbubbles.
 
 
 
 
 
 
 
 
This is shown pictorially in Figure 4.14, which was imaged using a Leica Ground State 
Depletion (GSD) super resolution (SR) system (Leica Microsystems, Buffalo Grove, Il) 
in a) wide-field and b) super resolution mode. Microbubbles were made according to the 
method in Chapter 2, except a fluorescent lipid (NBD) is added to the monolayer of the 
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microbubble. The fluorescent lipid is soluble in the organic phase, as well as the polymer 
shell of the nested microbubble, which explains why the shell of the particle is also 
fluorescing. Individual microbubbles at varying depths within the polymer shell can be 
seen in the bottom row of Figure 4.14. The first particle received four sets of “high” 
applied pressure, where each pressure was applied for 600 pulse trains at a pulse 
repetition frequency (prf) of 5 Hz. The applied pressures for the first particle were 1.26, 
1.50, 1.75, and 2.01 MPa. The second particle received three sets of “medium” applied 
pressure, where each pressure was applied for 600 pulse trains. The applied pressures for 
the second particle are 0.34, 0.50, and 0.60 MPa. The third particle received one set of 
“low” applied pressure applied for 600 pulse trains at 0.05 MPa. The top images are wide 
field images. The bottom set of images are super resolution images.  
 
The particles receiving “high” applied pressure, the first image in (a) and (b), express the 
least amount of fluorescence because most microbubbles have been destroyed, and 
therefore no longer fluoresce. The particles receiving “low” applied pressure, last image 
in (a) and (b), display the most fluorescent activity because the fluorescent monolayer of 
the microbubbles are still intact.  
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                                                                                           20.52 µm polymeric nested 
microbubbles receiving varying pressures of ultrasound. The particle on the left side 
received four sets of “high” applied pressure, where each pressure was applied for 600 
pulse trains at a pulse repetition frequency (prf) of 5 Hz. The applied pressures for the first 
particle were 1.26, 1.50, 1.75, and 2.01 MPa. The particle shown in the middle of the three 
images received three sets of “medium” applied pressure, where each pressure was 
applied for 600 pulse trains. The applied pressures for the second particle are 0.34, 0.50, 
and 0.60 MPa. The particle on the right received one set of “low” applied pressure applied 
for 600 pulse trains at 0.05 MPa. The top images (a) are wide field images. The bottom set 
of images (b) are super resolution images where the depth of the fluorescent microbubbles 
is shown using the key all the way to the right of Figure 4.14 b. 
 
 
 
52Figure 4.14:   Polymeric nested microbubbles after ultrasound exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
b) 
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4.4.1 Varying Polymer Shell Diameter 
 
The percentage of nested microbubbles destroyed is measured for each shell diameter 
ranging from 2-20 μm using the cavitation detection technique described above. Each 
sample is sonicated at PNPs of 50, 100, 225, 350, 500, 600, 800, 1000, 1250, 1750, and 
2000 kPa. The percentage of microbubbles destroyed was determined with a 95% 
confidence interval. These results are then plotted in the form of fraction of microbubbles 
destroyed versus PNP to give the destruction profile for each sample. 
 
In Figure 4.15 the concentration of microbubbles used during formulation remained 
constant at 4 x 108 microbubbles/mL aqueous solution. Note that the exact number of 
microbubbles within the shell remains unknown until a reliable way to measure nesting 
efficiency is developed. The cavitation profile of polymeric nested microbubbles of 
varying size comprised of microbubbles with a monolayer of 95 mol % DSPC/ 5 mol % 
DSPE-PEG3000 is compared to a control of un-nested microbubbles of identical 
composition.  
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                                                                                                                              Fraction of 
microbubbles destroyed versus the peak negative pressure (MPa). A 2.25 MHz focused 
transducer was used to sonicate each sample. The control is a sample of un-nested 
microbubbles formulated with a 95 mol % DSPC/ 5 mol % DSPE PEG3k monolayer which 
shows a sigmoidal cavitation profile. The nested microbubbles are formulated with the 
same monolayer composition as the control. Each nested microbubble sample is identified 
by the average diameter of the nesting shell. As the size of the nesting shell decreases, the 
cavitation profile loses its sigmoidal shape, and the threshold for destruction at a given 
pressure decreases. Note that the difference in concentrations resulting from homogenizer 
speed have no effect on these results as the sample is diluted so that only one microbubble 
is being analyzed. 
 
 
53Figure 4.15:   Inertial cavitation profile of polymeric nested microbubbles of varying diameter. 
 
   
  
  
  
 
 
 
 
 
The un-nested microbubbles show a sigmoidal inertial cavitation profile as discussed in 
previous works [126]. The samples with the two largest shell diameters exhibit behavior 
similar to the un-nested sample, but reveal a less prominent sigmoidal shape. As shell 
diameter is decreased the inertial cavitation threshold, the peak negative pressure at 
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                                                                                                       Percentage of 
microbubble destruction for each sample as compared to the control of un-nested 
microbubbles. The average diameter of the shell corresponding to each homogenizer 
speed is shown as davg, shell. As the shell diameter is increased, the percent destruction is 
increased until it reaches that of an un-nested microbubble. 
 
which the microbubble implodes, increases and the shape of the profile transitions from 
sigmoidal to exponential. At 1 MPa, the percent destruction of un-nested microbubbles is 
97.96%, while that of nested microbubbles is 51.02, 38.94, 33.25, 25.27, 19.09, and 5.37 
% respectively for decreasing shell diameters of 20.52 to 1.95 μm. These results are 
summarized below in Table 4.2. Note that the concentration of nested microbubbles for 
each homogenizing speed has no effect on experimental results presented in this 
manuscript because only one microbubble is analyzed at a time for data collection. 
     
6Table 4.3:   Summary of microbubble destruction of polymeric nested microbubbles.    
 
 
 
 
Homogenizer 
Speed 
(rpm) 
davg,shell 
(μm) 
% 
Destroyed 
at 1 MPa 
Un-nested - 97.96 
5000 20.52 51.02 
7500 14.95 38.94 
10000 9.95 33.25 
12500 5.55 25.27 
15000 2.53 19.09 
17500 1.95 5.37 
 
The results of this work reveal that the size of the nesting shell affects the inertial 
cavitation profile of the microbubble. Hypothetically, a microbubble nested within the 
aqueous core of an infinitely large shell can oscillate freely and will not be hindered by 
an interaction with the polymer shell. It can be assumed that as nesting shell diameter 
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decreases with respect to bubble diameter, the degree to which the bubble inertia departs 
from its free value becomes more prominent. As expected, the inertial cavitation profile 
for 20.52 μm nested microbubble sample shows similar behavior to that of an un-nested 
microbubble because of the large distance between the microbubble wall and polymer 
shell wall. As the shell size decreases, the microbubble inertial cavitation threshold 
increases and a higher pressure is required to cavitate the sample. Repulsion forces 
between the stiff polymer shell wall and the microbubble wall dampen the microbubble 
oscillation [131-133] which prevents the microbubble from ever reaching its critical 
radius upon which it would cavitate.  
 
A smaller nesting shell, with a decreased distance between the shell wall and the 
microbubble wall as compared to the larger nesting shells would magnify the effect of the 
wall to wall repulsion [43, 44]. For the smallest shell size of 1.95 μm, the microsphere 
diameter is close to that of the average microbubble (1 μm). Even at the highest pressure 
for this nesting shell diameter, only 34.18% of microbubbles have cavitated. The ability 
to tune the cavitation profile could be valuable in a clinical setting because it allows the 
clinician the capacity to achieve maximum acoustic response of the UCA with the least 
amount of input energy, and therefore lessening negative thermal effects from inertial 
cavitation within the body. However, nesting shell size is not the only factor that 
influences the cavitation threshold.  
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4.4.2 Varying Microbubble Concentration in Aqueous Core 
 
Given the fact that the interaction between the microbubble wall and nesting shell greatly 
affects the cavitation profile, it would also be conceivable that the microbubble wall to 
wall interactions within the nesting shell influence cavitation behavior. The interaction 
between two microbubbles would suppress oscillations as shown experimentally with two 
UCA microbubbles trapped near a wall in the work by Garbin et al [134]; therefore a 
larger number of microbubbles within the shell would lead to an increased inertial 
cavitation threshold. The amount of microbubbles used within the nested microbubble 
formulation has the ability to influence the inertial cavitation profile of the sample.  
 
It has been concluded from contrast brightness studies using a clinical ultrasound 
machine that more than one microbubble exists in each shell on average [112]. To gain a 
better understanding of the cavitation phenomenon that occurs within the shell when 
multiple bubbles are present, the concentration of microbubbles used during formulation 
was varied between 3 x 108 and 6 x 108 microbubbles/mL. This was done for two 
representative samples, both the largest shell with an average diameter of 20.52 ± 1.97 
μm and a smaller shell with an average diameter of 2.53 ± 0.55 μm. The smallest shell 
size was not used since the mean diameter of the shell is 1.95 ± 0.29 μm, and the mean 
diameter of a single microbubble is approximately 1 μm, so it is assumed that increasing 
the amount of microbubbles in the recipe leads to a smaller percentage of empty 
microspheres as opposed to a greater amount of microbubbles per microsphere. For the 
20.52 μm sample, 3 x 108 microbubbles per mL resulted in a cavitation profile very 
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                                                                                                                                      A 
comparison of varying amounts of microbubbles used during nested microbubble 
formulation with an average shell size of 20.52 μm. The labels for each sample are the 
concentration of microbubbles used during formulation. Because the nesting efficiency is 
unknown, this amount does not necessarily represent the exact amount of microbubbles 
nested within the sample of polymer shells. It is assumed that this size shell is able to nest 
the entire size population of microbubbles. As the amount of microbubbles in the 
formulation is increased, cavitation significantly decreases.    
similar to that of an un-nested bubble. Increasing the microbubble concentration increases 
the inertial cavitation threshold, as shown in Figures 4.16 and 4.17. 
 
 
54Figure 4.16:   Inertial cavitation profile for 20.52 µm shell with varying microbubble concentration.  
 
 
 
 
 
 
 
The percent destruction at 1 MPa for samples with a nesting shell diameter of 20.52 μm is 
100%, 51.02%, and 8.37% for 3 x 108, 4 x 108, and 6 x 108 microbubbles per mL of 
aqueous solution, respectively. The percent difference between the cavitation threshold 
for a sample with 3 x 108 and 6 x 108 microbubbles/mL is 169.11%.  
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                                                                                                                                                   A 
comparison of varying amounts of microbubbles used during nested microbubble formulation with 
an average shell diameter of 2.53 μm. The labels for each sample are the concentration of 
microbubbles used during formulation. Because the nesting efficiency is not known, this amount 
does not necessarily represent the exact amount of microbubbles nested within the sample of 
polymer shells. As the amount of microbubbles in the formulation is increased, cavitation slightly 
decreases.    
 
55Figure 4.17:   Inertial cavitation profile for 2.53 µm shell with varying microbubble concentration.
  
 
 
 
 
 
The inertial cavitation threshold at 1 MPa for this sample is 48.52%, 19.09%, and 11.62% 
for 3 x 108, 4 x 108, and 6 x 108 microbubbles per mL of aqueous solution, respectively. 
The percent difference between the cavitation threshold for a sample with 3 x 108 and 6 x 
108 microbubbles/mL is 122.71%. T-tests confirm that the mean percent destruction 
values at 1 MPa for the three concentrations are different for both the 20.52 μm shell and 
the 2.53 μm shell. The destruction profile for each sample follows the sigmoidal curve of 
the un-nested microbubbles, although the onset of cavitation occurs more gradually. 
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At 1 MPa, the microbubble destruction for the 20.52 μm shell varies between 10% and 
100%, while destruction for the 2.53 μm shell varies between 10% and 50% when the 
concentration is increased from 3 x 108 to 6 x 108 microbubbles/mL.  The formulation for 
the 20.52 μm shell results in a concentration of 4.53 x 106 microspheres/mL and 7.89 x 
107 microspheres/mL for the 2.53 μm shell. Thus increasing the concentration of 
microbubbles used during formulation results in a higher number of microbubbles per 
shell for the 20.52 μm shell than for the 2.53 μm shell if the assumption is made that 
nesting efficiency is equal for both samples. Also, the 20.52 μm shell has the physical 
capacity to nest more microbubbles within its shell than the 2.53 μm shell which only 
allows for one to two 1 μm microbubbles per shell. In conclusion, increasing the 
microbubble concentration with a smaller nesting shell affects the amount of microbubble 
destruction; however it does not have as large of an effect on the number of microbubbles 
per shell as it would on the 20.52 μm shell. Therefore increasing concentration of 
microbubbles used during formulation for the 20.52 μm shell has a greater effect on the 
cavitation profile than what is observed for the 2.53 μm shell.    
   
4.4.3 Influence of Nesting Shell on Inertial Cavitation 
 
It is believed that the inertial cavitation behavior of the nested microbubbles can be 
explained by examining the influence of the nesting shell on the resonance frequency of 
the microbubble. It is generally accepted that resonance frequency is altered when a 
restriction in oscillation occurs due to a nearby rigid body [131, 132, 135].  To find 
whether nesting causes an increase or decrease in resonance frequency, the cavitation 
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                                                                              Cavitation profile comparing un-nested 
microbubbles (red) to nested microbubbles (blue) with a 2.53 μm shell. The microbubbles used in 
both samples were encapsulated with a lipid monolayer comprised of 95% DSPC and 5% DSPE-
PEG3000. This comparison was made for a transmitting frequency of 2.25 MHz (square data points) 
and 1 MHz (circle data points). Although the trend is not as significant when sonicating at 1 MHz, it 
can be seen that nesting decreases cavitation for both samples. Results are shown with a 95% 
confidence interval. 
profiled of nested microbubbles and un-nested microbubbles both of identical 
microbubble monolayer composition was measured for two transmitting frequencies, 
2.25 MHz and 1 MHz within a 2.53 μm shell.  
 
 
56Figure 4.18:   Inertial cavitation profile at 1 and 2.25 MHz.  
 
 
 
 
 
 
Figure 4.18 shows that for both frequencies, nesting causes a decrease in inertial 
cavitation. As resonance frequency approaches the transmitting frequency, microbubble 
oscillations will increase leading to higher cavitation at any given pressure. For bubbles 
with a resonance frequency less than the primary driving frequency, an increase in the 
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resonance frequency associated with an increase in the stiffness of the shell makes the 
bubbles more susceptible to cavitation at the driving frequency [49]. The large size 
distribution in the microbubble sample presents difficulty when determining the 
resonance frequency of our sample. Current techniques are being employed to measure 
resonance frequency for a non-uniform size distribution, but for this study we continue 
our analysis through a logical process of elimination for four cases to determine if nesting 
causes an increase or decrease in resonance frequency as outlined below.   
 
We have cavitation results for identical microbubble compositions, both nested and un-
nested at a driving frequency of 1 MHz and 2.25 MHz. Note that concentration has no 
effect because only one bubble is being analyzed at a time in our cavitation detection 
system. If the resonance frequency of the sample were below 1 MHz then we would see 
more cavitation at 1 MHz than at 2.25 MHz which is not the case here so the resonance 
frequency must be either between 1 and 2.25 MHz or above 2.25 MHz. To determine 
whether nesting causes an increase or decrease in resonance frequency, we will examine 
four cases: 1a) resonance frequency is between 1 and 2.25 MHz and nesting causes a 
decrease in resonance frequency, 1b) resonance frequency is between 1 and 2.25 MHz 
and nesting causes an increase in resonance frequency, 2a) resonance frequency is above 
2.25 MHz and nesting causes a decrease in resonance frequency, or 2b) resonance 
frequency is above 2.25 MHz and nesting causes an increase in resonance frequency. If 
1a were true, nesting would cause the resonance frequency to approach the driving 
frequency of 1 MHz and become further from the driving frequency of 2.25 MHz. 
Therefore, we would observe an increase in cavitation for the nested sample at 1 MHz 
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and a decrease for the 2.25 MHz sample. This case can be eliminated since Figure 6 show 
that nesting causes a decrease in cavitation at both driving frequencies. 1b can also be 
dismissed using the same logic as we would observe an increase in cavitation at 2.25 
MHz for the nested sample and a decrease in cavitation at 1 MHz if this were true. 2a 
would result in the resonance frequency approaching the driving frequency of both 2.25 
and 1 MHz and an increase in cavitation, which is the opposite of what is observed in 
Figure 6. 2b is the only option that is justified by experimental results. Therefore we can 
conclude that the resonance frequency of the sample is above 2.25 MHz and nesting 
causes an increase in resonance frequency. Examination of the resonance frequency term 
can be accomplished through a modification of the Rayleigh-Plesset equation.  
 
4.5 Simulating Inertial Cavitation Threshold 
 
It is possible that further improvements in contrast agents could be achieved to accurately 
predict the cavitation profile with respect to microbubble material properties. The ability 
to predict if and when inertial cavitation will occur is attractive for a large number of 
clinical procedures ranging from delivery of therapeutic-loaded ELIP into tissue during 
stable cavitation and ablation of cancerous tissue during inertial cavitation [136, 137]. 
Theoretical models, such as the modified Rayleigh-Plesset equation, have been developed 
to describe the oscillations of un-nested microbubbles. This model makes the assumption 
that microbubbles are surrounded by an infinite fluid, which does not hold for our UCA 
formulation and a precise understanding of microbubble behavior within a nesting shell is 
necessary to accurately predict the likelihood of inertial cavitation events. One of the 
challenges in this field is developing a theoretical model describing a microbubble (or 
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multiple microbubbles) that exist within an impermeable spherical shell. Recent 
theoretical work simplifies the in vivo case of a microbubble oscillating in the center of a 
rigid tube which has led to predictions that a decrease in magnitude of microbubble 
oscillation and a change in resonance frequency will occur due to the restriction from a 
tube with a diameter of the same order of magnitude as the microbubble [135, 138, 139]. 
This manuscript attempts to explain the influence of the spherical nesting shell on 
microbubble resonance frequency using the Rayleigh-Plesset model with a modified 
damping term.  
 
Modification of Rayleigh-Plesset-Noltingk-Neppiras-Poritsky 
Now that we have determined that a rigid spherical shell causes an increase in resonance 
frequency which we can attribute to either a decrease in effective mass or an increase in 
shell stiffness, although we anticipate the change in effective mass is a relatively small 
influence compared to stiffness [49]. Experimental results agree qualitatively with the 
theory that stiffness effects are the primary cause for a change in resonance frequency as 
the passive diffusion modeling shows that equilibrium microbubble radius and nesting 
shell have an inverse relationship [112], which would mean that as nesting shell size is 
decreased, microbubble equilibrium radius prior to experimentation is increased. An 
increase in effective microbubble mass would lead to a decrease in resonance frequency 
and therefore more cavitation within the smaller nesting shells and this is not what we 
observe. Therefore examination of the resonance frequency can be represented by a 
change in stiffness of the system. The resonance frequency term is uncovered through a 
modification of the Rayleigh-Plesset equation.  
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Predictive models for a microbubble existing within the microvasculature or other 
microvessels have been presented [40, 131-133, 140] based on Rayleigh-Plesset 
equations accounting for the presence of a wall. However, up until this point, there have 
been no developments of a theoretical model describing a microbubble (or multiple 
microbubbles) that exist within an impermeable, spherical shell which we have shown to 
effectively increase inertial cavitation threshold. To describe the dynamic behavior of a 
coated, un-nested microbubble in a sound field, Equation 4.5 is derived from an energy 
balance in the form of a Rayleigh-Plesset-Noltingk-Neppiras-Poritsky (RPNNP)-type 
equation showing how the microbubble radius, R, changes in response to applied 
ultrasound pressure, P, as a function of time, t [141]. ?̇? and ?̈? are radial velocity and 
acceleration, respectively, R0 is the initial microbubble radius, ρ and μ are density and 
viscosity of the surrounding water, respectively, k is the polytropic factor, σ is interfacial 
tension, P0 is ambient pressure, and κs and Es are the surface dilatational viscosity and the 
elastic modulus of the microbubble monolayer, respectively. 
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                                  (Equation 4.5) 
 
When oscillations are relatively small nonlinear effects are rare and the linearization of 
Equation 4.5 enables an analytical expression for the resonance frequency to be obtained, 
from which the dependence upon the coating parameters can be clearly seen. Equation 
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4.6 is the linearized form of Equation 4.5 for the forced, damped oscillation of an un-
nested microbubble. 𝑟,̈ ?̇? and 𝑟 denote radius, radial velocity and acceleration, 
respectively for the linear oscillation. 
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     (Equation 4.6)  
 
The frequency at which the maximum amplitude occurs is significantly affected by the 
coating properties and bubble mass. The natural frequency can be expressed as stiffness 
of the system divided by effective mass. The stiffness is influenced by interfacial tension 
and elastic modulus of the microbubble coating. Both of these effects represent important 
considerations in interpreting acoustic emissions from bubbles and optimizing bubble 
oscillation behavior. 
 
Equation 4.5 was solved in MATLAB using ode113 to find microbubble radius as a 
function of time in the presence of ultrasound, where the shell properties are built into the 
model. Figure 4.19 displays the microbubble response in non-dimensional radius. The 
equation is numerically solved using the following parameters: P0 = 101300 Pa, R0 = 1 
μm, σ = 51 mN/m, κs = 7*10-9 N s /m, γ = 1.07, c = 1540 m/s, ρ = 998 kg/m3, and μ = 
0.001 Pa s. P(t) has the form of a 4 cycle sine burst with a driving frequency of 2.25 MHz 
where P(t)=1*106sin(2π*2.25t) Pa. The colloidal model proves to be stable in both the 
shape and the magnitude of the oscillations.  The results are displayed with an increasing 
Damping Square of natural frequency 
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                                                                                                        Normalized radius 
versus time of a 1 μm bubble for a driving pressure, P(t), consisting of a 4 cycle sine burst 
with a driving frequency of 2.25 MHz. P(t)=1*106sin(2π*2.25t) Pa.  The results are 
displayed with an increasing elasticity modulus ranging from 2.51x107 to 3.09x107 1/s. 
resonance frequency which was calculated by a representative change in elasticity 
modulus ranging from 20 mN/m to 100 mN/m (51 mN/m is a typical for phospholipid 
microbubbles [16]) and show that it is reasonable to claim that as resonance frequency is 
increased the microbubble oscillations are dampened due to an increase in shell stiffness. 
 
 
57Figure 4.19:   Normalized radius vs time of a microbubble exposed to ultrasound.
 
 
 
Using these radius values and an inertial cavitation threshold at R/R0=2, an inertial 
cavitation plot for varying KAs can be seen. As expected, as KA increases, inertial 
cavitation decreases because the microbubble oscillations are smaller and a larger 
population of microbubbles do not reach the inertial cavitation threshold. 
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                                                                                                                                Theoretical inertial 
cavitation profile for a 1 μm bubble for a driving pressure, P(t), consisting of a 4 cycle sine burst 
with a driving frequency of 2.25 MHz. P(t)=1*106sin(2π*2.25t) Pa.  The results are displayed for 
increasing KA value ranging from 20 to 200. 
 
58Figure 4.20:   Theoretical inertial cavitation threshold of polymeric nested microbubbles. 
 
 
 
4.6 Conclusion 
 
The aim of this study was to determine the effect of a spherical polymer nesting shell of 
varying diameter on the cavitation behavior of an SF6 microbubble with a 95% DSPC/ 
5% DSPE-PEG3000 monolayer. A home built cavitation detection system consisting of 
two 2.25 MHz transducers to detect the presence of an oscillating microbubble was used 
to determine the extent of inertial cavitation for each sample of nested microbubbles 
tested.   It was found that nesting an SF6 microbubble with a phospholipid coating within 
a spherical PLA shell increases the inertial cavitation threshold and also causes a change 
in the shape of the cavitation profile. At 1 MPa, the percent destruction of un-nested 
microbubbles is 97.96 %, while that of nested microbubbles is 51.02, 38.94, 33.25, 25.27, 
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19.09, and 5.37 % respectively for decreasing shell diameters of 20.571 to 1.948 μm. It is 
proposed that the change in behavior is due to a change in stiffness as manifested in a 
change in resonance frequency of the system but the details remain unknown.  It is clear 
that the shell impacts the cavitation behavior of the microbubbles which raises the 
question of how the water passes through the polymer shell and the inertial effect this has 
on the physics of the system. This study expands on the advantages of nested 
microbubbles as improved UCAs and further enhances our current understanding of the 
physics behind the fourth generation of UCAs. 
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CHAPTER 5: CONTRAST TO TISSUE RATIO 
 
5.1 Introduction 
 
Ultrasound contrast agents are micron size gas bubbles coated with a solid phospholipid 
monolayer. These microbubbles generally measure approximately 1-5 micrometers in 
diameter and can be used to enhance ultrasound imaging. However, when the contrast 
agents are injected into the blood stream during ultrasound therapy they disappear within 
seconds. The disappearance is due to the many external forces they experience, including 
Laplace pressure, blood pressure, and the driving frequency of ultrasound [142].  
 
In Chapter 4, the need for a safer alternative to commercially available contrast agents 
was discussed. Not only should the improved contrast agent result in less damaging 
localized effects, but also provide increased longevity. In the medical field, an enhanced 
ultrasound image may be required for up to 60 minutes [143]. One example of this is the 
induction of coagulation necrosis using radio frequency (RF) therapy for tumor ablation 
where contrast is required between 5 to 60 minutes [143, 144]. This technique involves 
an electrode probe inserted into the tumor where the probe generates thermal energy via 
an electric current within the tumor, therefore causing necrosis [145]. The use of contrast 
agents allows for real time imaging guidance of the probe and the potential to perform the 
procedure on an outpatient basis. The echogenecity of agents currently available has 
improved detection of parenchymal organ blood flow compared with the echogenecity 
achieved with routine color Doppler and power Doppler ultrasound [82]. For RF therapy 
to be considered successful, treatment of all identified metastases must be complete with 
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a peripheral margin of at least 5 mm to 1 cm of apparently normal hepatic tissue to 
prevent local recurrence [146]. If adequate margins are not obtained, peripheral tumor 
regrowth will occur with unfavorable geometry for retreatment [144, 146]. With the 
administration of contrast material, enhancement can depict viable tumor which 
previously appeared as hyperechoic on nonenhanced images [147]. However, the short 
life of commercially available contrast agents makes this process difficult due to a need 
for frequent doses of fresh contrast agent to attain sufficient images of the lesion. To 
improve exceed the lifetime of available contrast agents, the microbubbles will be nested 
within a polymer shell. The enhancement in contrast that the UCA provides is generally 
expressed by the contrast to tissue ratio (CTR). To improve the CTR, a technique is 
required that identifies the contrast blood echo and suppresses or attenuates the echo from 
non-contrast structures.  
 
5.2 CTR Ratio Detection 
 
The contrast agent sample is prepared and then imaged with a clinical Toshiba ultrasound 
imaging system. Throughout the imaging experiment, screenshots are taken at various 
time intervals and analyzed with a MATLAB imaging program. This program assigns a 
brightness value to the contrast agent and compares it to the surrounding tissue, which is 
described as the CTR or contrast ratio. The CTR of a contrast agent can be compared 
between samples.  
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Tissue Mimicking Phantom Preparation 
A tissue phantom whose acoustic properties match that of human tissue is used to 
conduct the experiment in vitro. The phantom is comprised of a 10 wt % PVA solution as 
described by Surry [148]. A 1 L solution of 10 wt % PVA is heated at 90 °C for 8 hours 
to allow the polymer to fully dissolve within the solution. Any water that is lost during 
the heating process is replaced to maintain an accurate weight percent. This solution is 
poured into the phantom mold (a 1.5 L steel box with a cylindrical cavity for the sample 
chamber) and is left at room temperature for 24 hours to allow any trapped gas to rise out 
of the solution. The mold is then subjected to three freeze thaw cycles such that the 
phantom is allowed to freeze completely to -20°C and then completely thawed to 20°C. 
These freeze thaw cycles are chosen so polymers of the PVA align into a tight crystal 
structure. The large cryogels developed by the preparation technique usually exhibit 
variations in properties due to the low thermal conductivity of the polymeric solution 
[149]. This leads to variations in freezing-thawing rates across the gels which results in 
nonhomogeneities that possess some scattering intensity. The speed of sound and density 
increase with freeze thaw cycles, where after three cycles the acoustic properties closely 
match that of human flesh [150]. The speed of sound in the phantom is 1535 m/s and the 
attenuation coefficients were in the range of 0.075-0.28 dB (cm MHz)-1. The phantom is 
stored in deionized water at 5°C to avoid dehydration of the cryogel. This phantom 
allows for the contrast agent brightness intensity to be compared with the tissue 
mimicking phantom using a clinical ultrasound to measure the contrast ratio. 
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The nonlinearity parameter of tissue substitutes is rarely reported because nonlinear 
effects are typically small and therefore difficult to determine using conventional 
techniques [52]. We were not able to find this value in literature for our recipe, nor did 
we have the means to measure it ourselves. 
 
Contrast Ratio Detection 
The contrast ratio was measured using captured brightness (B) mode images from a 
Toshiba Nemion XG SSA-580A (Toshiba Medical Systems Co., Tochigi-ken, Japan) 
clinical ultrasound machine to evaluate the lifetime of nested microbubbles. The FDA 
stipulates that the MI (mechanical index) of the transducer must be less than 1.9 [53]. To 
ensure that this experiment is clinically relevant, the MI of the transducer was set to 0.2. 
We chose this MI for practical reasons as the machine we had access to for these studies 
is used for linear imaging (we just recently gained access to a machine capable of 
nonlinear imaging) and because we were looking only at microbubble dissolution in 
response to ultrasound. In this study, we are only interested in the effects of dissolution 
alone, and not yet the nonlinear behavior of the nested formulation.  
 
A linear array transducer (PLM1204AT) with a center frequency of 12 MHz and a 
transmit frequency range of 8-14 MHz was used in conjunction with the ultrasound 
machine to capture images of the contrast agent as a function of time. The peak negative 
pressure (PNP) was calculated to be approximately 700 kPa using the MI equation, 
MI=PNP/√(Fc) where Fc is the center frequency of the ultrasound wave [13]. The number 
of wave cycles per pulse element is unknown as this is proprietary information. Samples 
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of either freely floating microbubbles or nested microbubbles were placed in a 40 mL 
cylindrical sample chamber within a PVA cryogel phantom. The linear transducer was 
placed horizontally against the tissue phantom so that a cross section of the 1.5 cm 
diameter sample chamber to be analyzed was within the dynamic focal plane of the 
transducer. Air and other gases impede sound waves so a coupling gel (a type of 
conductive medium in the gel phase) is used to prevent the formation of air bubbles 
between the transducer and the phantom wall. In this way, sound waves travel with 
minimal interruption [151]. The phantom was aligned on a stir plate for the duration of 
the experiment so that the contents within the sample chamber were continuously stirred 
at 400 rpm. Figure 5.1 shows the set up used for this experiment, while Figure 5.2 
displays a screenshot of the sample obtained during imaging with a field of view between 
0 and 6 cm.  
 
This method involves capturing a screenshot of the contrast agent sample as compared to 
the tissue phantom. An example of a typical image taken with the clinical ultrasound 
machine is shown in Figure 5.2. The tissue region is denoted by a white rectangle to the 
left of the image, while the contrast agent sample region is denoted by a black rectangle 
at the same depth within the circular contrast agent chamber. These regions remain in the 
same location for the entire experiment and are chosen as to avoid any dark areas that 
result from interference in the acoustic wave between the transducer and the region being 
monitored.   
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                                                                           The experimental set up for the contrast 
ratio experiment is shown. The contrast agent is placed in a 40 mL sample chamber 
within a PVA cryogel phantom. The linear transducer is placed horizontally against the 
tissue phantom so that a cross section of the sample chamber is to be analyzed. Coupling 
gel is used to exclude any small traces of air between the transducer and the phantom 
wall. The phantom is aligned on a stir plate for the duration of the experiment so that the 
contents within the sample chamber are continuously stirred. 
 
59Figure 5.1:   Experimental set up for contrast ratio detection.
 
 
 
 
 
 
Note that the set up in this figure shows that the ultrasound is coming from the right of 
the sample chamber, but in Figure 5.2 the ultrasound wave is coming from the top of the 
image and displaying a cross section of the image. To visualize this is just a matter of 
inverting the screenshot in Figure 5.2 90° clockwise. 
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                                                                         A screen shot from the clinical ultrasound 
machine displaying necessary parameters, including MI, frame rate, and imaging depth. 
The region chosen for brightness analysis is between 3.25 and 4.75 cm from the transducer. 
The contrast agent sample (a) region is denoted by a black rectangle within the circular 
contrast agent chamber, while the tissue region (b) is denoted by a white rectangle on the 
left side of the image. Both regions are at the same depth and these regions are chosen as to 
avoid any dark areas that result from interference in the acoustic waves between the 
transducer and the region being monitored. 
 
 
 
60Figure 5.2:   Screen shot from clinical ultrasound machine.
 
 
 
 
 
 
 
 
The sample is imaged continuously at a frame rate of 32 fps over a 40 minute time period 
of continuous ultrasound exposure. A MATLAB program applying a digitized analysis of 
the pixel resolution is used to determine the brightness of the contrast agent and tissue. 
Each pixel within the image was assigned a grayscale value between 0 (black) and 255 
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(white). The brightness of the pixels was averaged to account for any non-homogeneities 
within the sample region. The contrast ratio can be calculated from these brightness 
values, which is defined as the ratio of the scattered intensity from the contrast agent to 
the scattered intensity from the tissue mimic. The contrast ratio is defined below in 
Equation 5.1 (units are in decibels, dB). IC and IT define an arbitrary “intensity” of the 
brightness of the contrast agent and the phantom regions, respectively, as determined by 
MATLAB.  
 
𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 𝑟𝑎𝑡𝑖𝑜 = 20 log (
𝐼𝐶
𝐼𝑇
)               (Equation 5.1) 
 
The value for the contrast ratio is indicative of the level of discrimination between the 
contrast agent and the tissue.  Additionally a comparison was made between the 
brightness of this contrast agent and an equivalent sample of un-nested microbubbles. 
 
5.3 CTR of Polymeric Nested Microbubbles 
 
A means for increasing the longevity of microbubbles in vitro is to nest the microbubbles 
within the aqueous core of a vesicle-like structure with a shell that is largely impervious 
to gas. When microbubbles are nested within the aqueous interior of a poly-lactic acid 
(PLA) shell, the destruction of microbubbles at 1 MPa decreases from 70% to 20% [152]. 
PLA allows for greater stability of the contrast agent within the body and is already 
approved by the FDA for several in vivo applications, such as medical implants [53]. The 
microbubbles are protected from the ultrasound through the reflection of incident sound 
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waves at the polymer/water interface [153]. An anticipated added benefit of the nesting 
shell is the ability to attenuate gas dissolution from the microbubble; specifically the un-
nested microbubble dissolves completely while the nested microbubble appears to stop 
dissolving after 3 min [2].  This increased longevity is likely a result of the polymer shell 
inhibiting gas transport. That is, any gas that diffuses through the microbubble monolayer 
does not encounter a bulk aqueous phase but rather the aqueous interior of the 
microcapsule. The gas that escapes the microbubble dissolves until the aqueous interior is 
saturated, thereby prohibiting further diffusion of gas from the microbubble [16]. Nested 
microbubbles are thus attractive candidates as UCAs because, as compared to un-nested 
microbubbles, they have potential to be safer, through an increase in inertial cavitation 
threshold, and longer lasting, due to the minimization of ultrasound induced gas diffusion 
during imaging [2]. 
 
To realize the nesting shell’s full advantage for ultrasound imaging, the parameters 
determining the formulation’s contrast ratio, a measure of the intensity of UCA 
brightness as compared to a reference value, need to be studied. There are many 
complicating factors and this section focuses on the effect of the microcapsule diameter, 
ranging from 1.95 to 20.52 μm, and the concentration of microbubbles nested within the 
shell, ranging from 0 to 1.5 x 109 microbubbles/mL. A modified version of the model for 
gas transport from phospholipid-coated microbubbles into the surrounding medium by 
Sarkar et al. [63] is used in Section 5.4 to explain the behavior of the nested microbubbles 
prior to ultrasound exposure, which clarifies the trends that emerge during ultrasound 
exposure. 
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                                                                                                                         The CTR of 
95 % DSPC/ 5 % PEG-3000 microbubbles both nested and un-nested are calculated and 
plotted. The CTR decreases at a similar rate for the first two minutes, at which point the 
CTR of the nested microbubbles approaches steady state while the CTR of the un-nested 
microbubbles continues to decrease until it reaches the brightness of water after 15 
minutes. A negative CTR denotes that the sample is no longer a functioning UCA.  
5.3.1 Comparing Nested and Un-nested Microbubbles 
 
A complete study of the CTR of un-nested microbubbles can be found in Bartolomeo et 
al. [2]. To provide a complete picture of this study, the comparison between nested and 
un-nested microbubbles will be briefly discussed prior to the nested microbubble studies. 
A sample of 95 % DSPC/ 5 % PEG-3000 microbubbles are placed in the sample chamber 
and monitored for 30 minutes. An identical sample of microbubbles is nested within a 
PLA shell according to Section 2.2. The CTR of microbubbles and nested microbubbles 
are calculated and plotted in Figure 5.3.   
 
 
61Figure 5.3:   CTR of un-nested microbubbles compared to polymeric nested microbubbles.
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Figure 5.3 is slightly misleading in that the brightness of one microbubble does not equal the 
brightness of one nested microbubble, and the concentration of nested microbubbles required to 
match the CTR of the un-nested microbubbles is higher. Therefore, the characterization of the 
polymeric nested microbubbles is vital if they are to be compared to commercially 
available contrast agent. The first step in the characterization was to determine the 
number of nested microbubbles needed to provide the brightness of the un-nested 
microbubbles. This was accomplished by determining the CTR values of varying 
concentrations of both commercially available DefinityTM microbubbles, un-nested 
DSPC/ PEG-3000 microbubbles formulated in lab, and polymeric nested microbubbles.  
40 mL samples of varying concentrations were imaged in a tissue mimicking phantom 
using the clinical ultrasound unit described in the previous section. The brightness 
intensity of the nested microbubbles is less than the un-nested microbubbles (both 
DefinityTM microbubbles and those formulated in the lab) at the same particle/mL 
concentration as bubble/mL concentration. This is expected because of the uncertainty of 
microbubbles contained in each nested microbubble.  
 
Since the polymer shell contains microbubbles consisting of DSPC and 5 mole% DSPE-
PEG3000 synthesized from raw materials, it is beneficial to compare the CTR values of 
microbubbles within the nested microbubbles to the DefinityTM microbubbles. Figures 5.4 
and 5.5 show the CTR measurements of varying concentrations of DefinityTM 
microbubbles, DSPC/PEG-3000 microbubbles and nested microbubbles. Figure 5.6 
compares the CTR of the un-nested to the nested microbubbles [2].  
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                                                                              Contrast to tissue ratio comparison for 
varying concentrations of DefinityTM microbubbles versus 5% PEG-3000 microbubbles. 
Results shown are for DefinityTM microbubbles (triangle) and DSPC microbubbles 
containing 5 mole% DSPE-PEG3000 (circle).  The trends for both types of microbubbles 
are the same, where the brightness ratio increases with an increase in concentration until 
the brightness levels at high concentrations of around 1 million microbubbles/mL. Figure 
taken from Bartolomeo et al. [2]. 
                                                                                          As the concentration of 
polymeric nested microbubbles is increased, the CTR increases exponentially. 
 
62Figure 5.4:   CTR vs concentration of un-nested microbubbles.
 
 
 
 
 
 
 
63Figure 5.5:   CTR vs concentration of 2.52 µm nested microbubbles [2]. 
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                                                                                                          Contrast to tissue ratio 
of varying concentrations of free DefinityTM microbubbles and nested microbubbles. 
Results are shown for microbubbles and nested microbubbles. The DefinityTM 
microbubbles and nested microbubbles follow the same brightness trend. The DefinityTM 
microbubbles exhibit greater brightness than the nested microbubbles at comparable 
concentrations up until about 50 million particles/mL when the nested microbubble 
brightness levels off at a greater brightness than the Definity microbubbles. The 
conclusion drawn from this graph is that it takes 115 nested microbubbles to equal the 
brightness of 1 DefinityTM microbubble. Figure taken from Bartolomeo et al. [2]. 
 
.  
                                                                              Contrast to tissue ratio comparison for 
varying concentrations of DefinityTM microbubbles versus 5% PEG-3000 microbubbles. 
Results shown are for DefinityTM microbubbles (triangle) and DSPC microbubbles 
containing 5 mole% DSPE-PEG3000 (circle).  The trends for both types of microbubbles 
are the same, where the  
 
64Figure 5.6:   Calibration of concentrations of nested and un-nested microbubbles. 
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nested microbubbles are lower than DefinityTM microbubbles. Above these 
concentrations, there is no further increase in CTR, but the CTR values of the nested 
microbubbles level off at higher CTR values than the DefinityTM microbubbles. The 
equivalence was found to be that it takes 115 nested microbubbles to match the 
brightness of 1 DefinityTM microbubble. 
 
5.3.2 Encapsulation efficiency 
 
Based on microscopic images, it is known that each particle contains more than one 
microbubble on average. As of yet, there are no analytical techniques to deduce the 
number and size distribution of microbubbles in each nesting shell. Theoretical 
calculations are done in an attempt to determine the number of microbubbles within one 
microcapsule. In an excel spreadsheet a table of microcapsule diameters between 2 and 
25 μm was created. The aqueous volume (mL) within each microcapsule was calculated 
based on its diameter. A theoretical concentration of microbubbles within the capsule was 
found for each size capsule with a varying number of microbubbles between 1 and 10 by 
dividing the number of microbubbles by the volume of water in the capsule to get a 
concentration in terms of bubbles/mL. From this list of theoretical concentrations, a 
comparison was made to the concentration inside a vial of microbubbles, which is 1x109 
MB/mL. If the microbubble solution is not diluted during the formation of capsules, this 
concentration will remain constant. The combination of microcapsule size and number of 
microbubbles that resulted in a concentration as close to 1x109 MB/mL as possible are 
deemed the theoretical number of microbubbles within each shell size shown in Table 
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                                                                                       A theoretical concentration of 
microbubbles within the capsule was found for each size capsule with a varying number 
of microbubbles between 1 and 10 by dividing the number of microbubbles by the volume 
of water in the capsule to get a concentration in terms of bubbles/mL. From this list of 
theoretical concentrations, a comparison was made to the concentration inside a vial of 
microbubbles, which is 1x109 MB/mL. 
.  
5.1. Note that this does not take into account nesting efficiency or a given number of 
empty shells. It also does not take into account the volume of the microbubble, although 
we know the size distribution of microbubbles is heterogeneous. The results from this 
calculation are also shown in graphical form in Figure 5.7. 
 
7Table 5.1:   Theoretical number of microbubbles per capsule based on shell size. 
Microcapsule 
Diameter 
2 -12 
μm 
13-15 
μm 
16-17 
μm 
18-19 
μm 
20-21 
μm 
22 
μm 
23 
μm 
24 
μm 
25 
μm 
# of 
MB/Capsule 
1 2 3 4 5 6 7 8 9 
 
 
 
65Figure 5.7:   Theoretical number of microbubbles in polymeric shell. 
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                                                                                                 The number of overall 
microbubbles in the sample was calculated based on the number of microcapsules in a 
given solution. 
 
.  
From Table 5.1, the number of overall microbubbles in the sample was calculated based 
on the number of microcapsules in a given solution. For example, if you have 1 million 
15 μm particles with 2 microbubbles in each capsule, there is a total of 2 million 
microbubbles in the solution. This was done for each scenario to create a graph of total 
number of microbubbles versus number of microcapsules for each size microcapsule. 
 
 
66Figure 5.8:   Total number of microbubbles in nested microbubble sample. 
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                                                                                          The local concentration of a 
microbubble is calculated for each size microcapsule. If the microbubbles are not diluted, 
their concentration remains constant at 1x109 MB/mL. 
.  
                                                                                 The volume of liquid was compared to 
the volume of gas in each nested microbubble for each shell size.  
.  
 
67Figure 5.9:   Local concentration of microbubbles inside microcapsule. 
 
 
 
The liquid to gas volume ratio was also calculated based on the number of bubbles in each shell. 
 
 
68Figure 5.10:   Liquid to gas volume ratio for nested microbubbles.
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                                                                                             The contrast ratio value of the 
contrast agent versus ultrasound exposure time is shown with a 95% confidence interval. 
The contrast ratio value of the un-nested microbubbles falls below 0 after 4 minutes of 
ultrasound exposure which results in a non-functioning contrast agent. Brightness 
intensity continues to decrease until it reaches the brightness intensity of water. 
5.3.3 Variation of Polymer Shell Size 
 
The contrast ratio of nested microbubbles was evaluated using captured B mode images. 
The results from this study were used to compare the behavior of the nested microbubbles 
prepared with varying nesting shell diameters both to one another and to a control sample 
comprised of freely floating (un-nested) microbubbles. When continuously exposed to 
ultrasound over a 40 minute period a clear trend ensues between microcapsule size, the 
rate of diminishing brightness, and the steady state contrast ratio value as shown in 
Figure 5.11. This study was performed for six different nesting shell diameters ranging 
from 1.95 to 20.52 μm. 
 
 
69Figure 5.11:   CTR of nested microbubbles for varying polymer shell size. 
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                                                                                                                   Initial contrast 
ratio value as a function of the microbubble volume nested within the polymer shell 
formulated with a shell diameter of 9.95 μm is shown with a 95% confidence interval. 
5.3.4 Variation of Microbubble Concentration in Aqueous Core 
 
Formulation of a typical batch of nested microbubbles requires 0.4 mL of microbubble 
solution with a concentration of 1 x 109 microbubbles/mL for each study done up to this 
point. To determine whether this process could allow for the nesting of a larger quantity 
of microbubbles within each shell, the concentration of the microbubble suspension used 
during formulation was increased until a maximum contrast ratio value was reached. The 
concentration of microbubbles was also decreased to verify that the contrast ratio value 
would eventually reach that of the empty shell. This confirms that, on average, there is 
more than one microbubble within each shell during experimentation. The concentration 
of microbubbles was increased from 0 (empty shell) until a maximum contrast ratio value 
was reached. This was done for multiple polymer shell diameters but only the result for a 
shell diameter of 9.95 μm is shown. Other shell diameters show similar trends. The initial 
contrast ratio values for increasing microbubble concentration display a contrast ratio that 
increases until the maximum microbubble capacity is reached, as shown in Figure 5.12. 
 
 
70Figure 5.12:   CTR of 9.95 µm nested microbubbles varying microbubble concentration.
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                                                                                                                              A sample 
of nested microbubbles was made with varying homogenizer speed (5000, 10000 and 
15000 rpm). The amount of microbubble solution used during formulation for a typical 
sample is 0.4 mL of microbubbles per beaker, while the “HD” represents a half dilution 
of microbubbles; each beaker of particles was made with 0.2 mL of microbubbles. When 
the amount of microbubbles decreases, the CTR also decreases for each sample. 
 
A logarithmic relationship exists between the contrast ratio and the MB concentration. 
The contrast ratio increases with microbubble concentration until a maximum value is 
reached. A similar trend exists for all other shell diameters. 
 
To study the effect of the microbubble concentration on CTR for each shell size, a 
comparison of microbubble dilution for each shell size is shown in Figures 5.13 through 
5.19. Figure 5.13 compares a normal concentration of microbubbles (0.4 mL of 
microbubbles per beaker of sample) to a nested microbubble made with 0.2 mL of 
microbubble solution during formulation, presumably leading to a half dilution of 
microbubbles existing in the polymer core. 
 
 
71Figure 5.13:   Comparing effect of microbubble concentration on CTR of nested microbubbles.   
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For three different size polymer shell formulations, 5000, 7500, and 10000 rpm, the 
concentration of microbubbles used was varied between 0 mL (empty shell with a 
completely aqueous core) to 1.5 mL microbubbles, which is 3.75 times the typical 
volume of mL of microbubble solution (at a concentration of 1x109 MB/mL) . For each 
size shell, two graphs are shown. The first graph is the CTR vs time plot for the duration 
of the in vitro study. The second graph is the initial and steady state (SS) CTR versus 
microbubble concentration so that the maximum microbubble concentration can be 
identified, at which point increasing microbubble concentration does not coincide with an 
increase in CTR. Figures 5.14 through 5.16 show these results. 
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                                                                                                                        The 
concentration of microbubbles nested within a 20.52 µm shell (formulated at 5000 rpm) 
was varied between 0 mL (empty shell with a completely aqueous core) to 1.5 mL 
microbubbles, which is 3.75 times the typical volume of mL of microbubble solution (at 
a concentration of 1x109 MB/mL). a) CTR vs time plot for the duration of the in vitro 
study and b) initial and steady state (SS) CTR versus microbubble concentration so that 
the maximum microbubble concentration can be identified, which is 8x108 MB/mL. 
 
72Figure 5.14:   CTR values vs microbubble concentration for 20.52 µm nested microbubbles. 
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                                                                                                                        The 
concentration of microbubbles nested within a 14.95 µm shell (formulated at 7500 rpm) 
was varied between 0 mL (empty shell with a completely aqueous core) to 1.5 mL 
microbubbles, which is 3.75 times the typical volume of mL of microbubble solution (at 
a concentration of 1x109 MB/mL). a) CTR vs time plot for the duration of the in vitro 
study and b) initial and steady state (SS) CTR versus microbubble concentration so that 
the maximum microbubble concentration can be identified, which is 1x109 MB/mL. 
 
73Figure 5.15:   CTR values vs microbubble concentration for 14.95 µm nested microbubble. 
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                                                                                                                        The 
concentration of microbubbles nested within a 9.95 µm shell (formulated at 10000 rpm) 
was varied between 0 mL (empty shell with a completely aqueous core) to 1.5 mL 
microbubbles, which is 3.75 times the typical volume of mL of microbubble solution (at 
a concentration of 1x109 MB/mL). a) CTR vs time plot for the duration of the in vitro 
study and b) initial and steady state (SS) CTR versus microbubble concentration so that 
the maximum microbubble concentration can be identified, which is 6x108 MB/mL. 
 
 
74Figure 5.16:   CTR values vs microbubble concentration for 10000 rpm nested microbubble. 
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                                                                                                  The temperature is held for 
either 30 sec or 20 min. 
5.3.5 Variation of Experimental Temperature 
 
Temperature affects gas diffusion [154]; therefore it is logical to perform a temperature 
study to determine whether temperature influences the rate of change in CTR or the 
steady state CTR value. Two cases are shown: one when the sample is brought to the 
desired temperature and held for 30 sec, whereas in the second, the temperature is held 
for 20 min. The rate of ultrasound induced dissolution is increased during the studies 
performed at 100°C. The time that temperature is held seems to have no noticeable effect 
on the CTR profile. Figure 5.17 shows the CTR profile for a sample at 100°C; Figure 
5.18 shows the behavior at 0°C, and Figure 5.19 compares the study done at room 
temperature to those done at high and low temperatures. 
 
75Figure 5.17:   Brightness study at 100°C for polymeric nested microbubbles. 
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                                                                                            The temperature is held for 
either 30 sec or 20 min. 
                                                                                                                    The temperature 
is held for either 30 sec or 20 min. 
 
76Figure 5.18:   Brightness study at 0°C for polymeric nested microbubbles. 
 
 
77Figure 5.19:   Comparison of brightness of nested microbubbles at varying temperature.
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5.3.6 Variation of Polymer  
 
The mass density, elastic modulus and viscosity of polymers are related to changes in 
ultrasonic parameters [155]. In an acoustic sense, a material is fully characterized by two 
parameters: the ultrasonic velocity and the ultrasonic attenuation [156]. The first is the 
velocity of propagation of elastic waves and is calculated on the basis of the measured 
time of flight that is the time taken by the sound to travel through the sample. Sound 
velocity through a material depends on its density and viscoelastic properties. Attenuation 
is a measure of dissipative energy loss (converted to heat) as the wave travels through the 
polymer. These energy losses are due to the absorption and scattering of ultrasonic 
waves. The scattering contribution is considerable when the medium is non-
homogeneous and contains particles comparable in size to the ultrasonic wavelength, 
such as in filled polymers or in semicrystalline polymers [157]. The absorption is related 
to molecular rearrangements in the polymer structure, such as glass transition, melting, 
crystallization, and to chemical reactions. 
 
To improve the contrast agent, different densities of the PLA polymer were explored as 
alternatives to the typical 10 mg/mL PLA concentration used during formulation.  
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                                                                                                               The concentration 
of PLA was varied between 1.25 and 10 mg/mL to see how the CTR profile changed 
with polymer density.  
 
78Figure 5.20:   CTR profile for nested microbubbles with varying PLA concentrations.  
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                                                                                                 The brightness of polymeric 
nested microbubbles formulated with the new PLA sample was compared to that 
formulated with an older PLA sample. 
microbubbles) formulated with the “old” PLA to that of the “new” PLA. The two 
samples presumably had different densities, and therefore would reflect ultrasonic waves 
differently. This also lends insight into the sensitivity of CTR on the type of polymer 
used during polymeric nested microbubble formulation. The results are reported as 
brightness and CTR versus time.  
 
 
79Figure 5.21:   Brightness study for 2.53 µm empty polymeric microcapsules.
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                                                                                         The CTR of polymeric nested 
microbubbles formulated with the new PLA sample was compared to that formulated 
with an older PLA sample. 
                                                                                          The CTR of polymeric nested 
microbubbles formulated with the new PLA sample was compared to that formulated 
with an older PLA sample. 
 
80Figure 5.22:   CTR profile for 2.53 µm empty polymeric microcapsules. 
 
 
 
81Figure 5.23:   CTR profile for 14.95 µm empty polymeric microcapsules.
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                                                                                                       The contrast ratio values 
for the first 12 minutes of ultrasound exposure of the nested microbubbles and empty 
shells (at same concentration as nested microbubbles) are shown shell diameters of 20.52 
μm and b) 2.53 μm shell diameter.  
5.3.7 CTR of Empty Microcapsule 
 
The influence of the nesting shell requires further examination; therefore it is necessary 
to isolate the “empty” polymer microcapsule (no microbubbles in the system) so that a 
study can be done to differentiate the effects of the polymer shell from that of the 
microbubble. It is known that the microbubble allows for enhanced contrast of the 
ultrasound image [54], and it is also hypothesized that the scattering of the ultrasound 
wave due to the solid polymer shell contributes to an increased brightness for the six 
nested microbubble formulations. To confirm, the brightness of the polymeric nested 
microbubbles is compared to that of an empty polymer shell of the same diameter (no 
microbubbles nested within). These studies are shown below in Figure 5.24 for shell 
diameters of 20.52 and 2.53 μm. The contrast ratio values for the first 12 minutes are 
shown so that the rate of decreasing contrast ratio before steady state is reached can be 
more closely examined. 
 
 
82Figure 5.24:   Contrast ratio values for empty and nested polymer microcapsule. 
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                                                                                                             CTR of empty 
microcapsules for shell diameters of 1.95 to 14.95 µm.  
These results display a higher contrast ratio value for the nested microbubbles than for 
the empty shell proving that the shell alone provides some level of contrast during 
ultrasound exposure, but the microbubbles nested within the shell provide an additional 
level of contrast. The slight decrease in contrast ratio for empty shells, a trend that is 
more apparent in the 2.53 μm shell than in the 20.5 μm shell, is not yet explained. We can 
hypothesize that this is due to either one or a combination of the following: existence of 
air bubbles nested within the empty particle shell formed during homogenization and/or 
ultrasound-induced configurational change of the polymer. This is detailed in the Section 
5.3.8 where trends in the data are evaluated. A comparison of the CTR profile for each 
sample of empty microcapsule shell made with varying homogenizer speed is shown in 
Figure 5.25. The rate of initial decrease in CTR becomes more pronounced as average 
shell size decreases. 
 
 
83Figure 5.25:   CTR profile for empty polymer shells at varying homogenizing speeds.  
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                                                                                                                 CTR of empty 
microcapsules for shell diameters of 1.95 to 14.95 µm with varying dilutions. 
The relationship between empty microcapsule shell dilution and CTR values are 
determined for each average shell size in Figure 5.26. Initial CTR and steady state CTR 
values are shown as a function of polymer shell size and dilution in Figure 5.27. 
 
 
84Figure 5.26:   CTR profiles of empty polymer microcapsules at varying concentrations.
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                                                                                                              Comparison of initial 
CTR and CTR at steady state for empty microcapsules as a function of dilution from the 
typical formulation recipe, where concentrations for each shell size are given in Table 2.1 
 
85Figure 5.27:   Initial and steady state CTR versus empty microcapsule concentration.  
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                                                                                          To expose the behavior of the 
microbubble within the nesting shell, an attempt is made to separate the effect of the 
polymer shell on the CTR profile from the actual oscillating microbubble. The brightness 
of the empty shell is subtracted from the brightness of the nested microbubbles for each 
homogenizing speed.  
 
86Figure 5.28:   Apparent brightness of microbubble within nesting shell.
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absence of a delay in CTR which is transparent in the nested microbubble and empty 
shell CTR data. This could suggest that the shell is responsible for the delay in brightness 
decrease during the initial exposure to ultrasound shown in Figure 5.11. 
 
5.3.8 Explanation of Trends in Data 
 
As evidenced in each CTR profile, in particular the smaller nesting shells, there is a 
decrease in the CTR before reaching steady state. External microbubbles that were not 
encapsulated during formulation could potentially cause this decrease, as there is no 
nesting shell to inhibit their dissolution and/or destruction. To verify that this data truly 
represents the lipid coated microbubbles that we are studying, and not external 
microbubbles (either un-nested SF6 microbubbles or air bubbles that were formed during 
experimental set up), techniques were used to assure there were no external microbubbles 
in the nested microbubble sample.  
 
Centrifugation to Remove External Microbubbles 
The external solution of PVA that contains un-nested microbubbles which were not 
enclosed within the polymer shell during the double emulsion process is replaced with 
PBS through centrifugation. The solution was centrifuged at 10000 rpm for 10 min, after 
which a pellet formed at the bottom of the centrifuge tube. The supernatant was poured 
off and PBS was replaced as the solvent for the nested microbubbles. This was repeated 
at least one time and then the sample was tested with the in vitro set up to determine the 
effect of rinsing. Specifically, the initial drop in CTR is expected to reduce if external 
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                                                                                                          The effect of rinsing 
the polymeric nested microbubbles is examined. For the different homogenizing speeds, 
the difference in brightness between rinsing the sample once versus rinsing the sample 
three times is shown. The brightness decrease is logarithmic when rinsing several times, 
while a slight delay in brightness decrease is witnessed when the sample is only rinsed 
once.  
microbubbles were no longer present in the solution outside of the nesting shell. The 
result of any change in brightness is shown in Figure 5.29. 
 
 
87Figure 5.29:   Effect of rinsing on CTR profile for polymeric nested microbubbles. 
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                                                                                   The concentration of polymeric 
nested microbubbles within the sample chamber was doubled. The result is a decrease in 
brightness which suggests that either clumping occurs with a large volume of polymer 
spheres or an error occurred during formulation or experimentation.  
 
Increasing the nested microbubble concentration should theoretically increase the 
brightness of the sample. In the following Figure 5.30, the concentration of polymeric 
nested microbubbles within the sample chamber was doubled. The result is a decrease in 
brightness which suggests that either clumping occurs with a large volume of polymer 
spheres or an error occurred during formulation or experimentation.  
 
 
88Figure 5.30:   Effect of doubling nested microbubble concentration. 
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pressure was too high and actually destroyed both external bubbles and microbubbles 
within the shell during the filtration process. 
 
Cavitation Detection Technique to Determine Presence of Microbubbles in Solution 
The inertial cavitation detection system discussed in Chapter 4 reports two parameters, 
one being the number of microbubbles detected and the other being the number of 
microbubbles destroyed after ultrasound exposure. It is known that the system can detect 
microbubbles within the shell, but when the supernatant is drawn off the sample after 
centrifugation, insight into the existence of microbubbles in the external solution is 
gained. After centrifugation, the supernatant liquid was pulled off and tested using this 
system to determine whether external microbubbles existed after each rinse. It was found 
that a very limited number of un-nested microbubbles survived the centrifugation 
process. This eliminates the possibility of skewed data due to un-nested lipid 
microbubbles in the solvent, but does not exclude the possibility that air bubbles were 
formed during experimentation.  
 
Ultrasound Induced Configurational Change 
Another trend that requires further assessment is that for the smaller shell size of 2.53 
μm, empty polymer shells show a decline in contrast ratio as shown in Figure 5.26. This 
unexpected result could be due to either ultrasound-induced dissolution of air bubbles 
that formed in the sample chamber or air bubbles created within the “empty” polymer 
shell during homogenization in the formulation stage. Microscope images confirm a 
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small amount of air bubbles existing in empty smaller shells due to turbulence of the 
solution when homogenizing at these higher speeds (image not shown).  
 
A configurational change of the polymer shell during experimentation is confirmed using 
SEM shown in Figure 5.31 where a change in the shape of the polymer shell would result 
in different scattering properties. In order to visualize the morphology of the particle shell 
after ultrasound has been applied, SEM imaging is used to gain a better understanding of 
ultrasound-induced polymer deformation. A non-spherical shell could result in a greater 
loss in sound energy compared to a perfectly spherical shell [158] which may explain the 
brightness decrease of an empty microcapsule. 
 
By first considering the most general interpretation of Figure 5.31, it can be reasoned that 
the deformation develops from the imposed ultrasound pressure wave. With a 12 MHz 
transducer, the ultrasound peak to trough wavelength leads to pressure variation ranging 
from 4 to 32% over the size of capsules studied. The polymer shells shown in Figure 5.31 
are 5.55 μm in diameter on average which would result in only 8% change in pressure 
over the diameter of the capsule. This may seem insignificant but should not yet be 
excluded entirely from possible explanations of the observed phenomenon.  
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                                                                                         SEM images of 5.55 µm empty 
microparticles after a 40 minute imaging study. This is evidence that the theory of a 
configurational change during experimentation is plausible. The morphological 
examination of microspheres showing polymer deformation was performed using SEM 
(Zeiss Supra 50 VP, Germany). For the shape and surface analysis, the freeze dried 
microspheres were mounted onto aluminum stub using double-sided adhesive tape and 
then sputter coated with a thin layer of gold under argon atmosphere before examination. 
The coated specimen was then examined under the microscope at an acceleration voltage 
of 15 kV and photographed. 
 
 
89Figure 5.31:   SEM images of polymer shell after ultrasound exposure.
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The size range of our particles (2.5-20 μm) is too small to experience the full peak to 
peak pressure gradient along the wavelength. We are proposing this as one possible 
explanation to explain the results shown from microscopic images before and after 
ultrasound exposure. For a 12 MHz transducer, the peak to trough length of the 
ultrasound wave would be 62.5 μm (1/2 of 125 μm wavelength). However, we suppose 
that at ½ wavelength (peak to trough) a 62.5 μm particle would experience the full peak 
to trough pressure variation but particles in the range 2.5-20 μm will experience between 
4-32 % of the pressure variation range. 4% of the pressure gradient may seem 
insignificant but we believe it should not be completely ruled out. It is more likely that 
there is an additional complex mechanism accounting for the polymer deformation, but 
because of our experimental observations we would like to present the reader with one 
possible theory.  
 
5.4 Measurement of CTR in Vitro Using Flow System 
 
The in vitro system described in Section 5.2 uses a cylindrical chamber where the sample 
stirred using a stir bar at a constant speed. The next step towards an in vivo model is to 
use a flow system that more accurately represents how the contrast agent would function 
when injected into the bloodstream. A similar phantom is constructed, except a 
cylindrical cut out is made through the phantom. Tubing is inserted through the phantom 
and a centrifugal pump is used to circulate the contrast agent sample while ultrasound 
imaging is taken place. A video was made of the sample over a 15 minute period. 
Screenshots from the video will be shown below for various time intervals.  
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90Figure 5.32:   Baseline reading for in vitro flow system of nested microbubbles. 
 
 
91Figure 5.33:   Initial injection of nested microbubbles into in vitro flow system. 
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92Figure 5.34:   All nested microbubbles have been injected into the in vitro flow system. 
 
 
93Figure 5.35:   Contrast of nested microbubbles after 5 min of circulation in the in vitro flow system. 
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94Figure 5.36:   Contrast of nested microbubbles after 10 min of circulation in the in vitro flow system. 
 
 
95Figure 5.37:   Contrast of nested microbubbles after 15 min of circulation in the in vitro flow system. 
 
In Figure 5.38, a graphical representation of CTR for the flow system is shown over the 
15 min of ultrasound exposure in the flow system. This does not follow the same profile 
as the stationary system described in Section 5.2, nor do the nested microbubbles 
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                                                                                              The CTR for the in vitro flow 
system is calculated by comparing the brightness of the contrast agent to the brightness of 
the tissue region.  
maintain the same longevity. In the flow system, the nested microbubbles are distributed 
through the entire tubing, so not all nested microbubbles receive constant ultrasound 
exposure which would explain why the decrease in brightness is more gradual for the 
flow system than for that of the non-flow system. 
 
 
96Figure 5.38:   Graphical representation of CTR during flow system study.
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For an in vivo study, the diameter of the particles could not exceed 8 µm. It is suspected 
that during the filtration process, many of the particles were lost and the resulting 
concentration was too low to provide enough contrast. If another animal study is pursued, 
an alternative option to the filtration process described below study should be explored.  
 
For the filtration process to prepare the nested microbubble sample, a centrifugal pump 
was used in conjunction with an EMD Millipore disposable capsule filter. Specifically, a 
10 µm 47 mm Polygard-CN OptiScale filter was used first followed by a 5 µm 47 mm 
Polygard-CN OptiScale filter. These filters were chosen because OptiScale capsules 
streamline media screening and minimize potential bottlenecks that slow process scale-
up. Also, the flat filter placement within the device provides low hold-up volume so more 
experiments can be run with limited sample volumes. During formulation, the 
concentration of particles was increased 10 times the normal amount used in the in vitro 
studies in an attempt to maintain an equivalent final concentration. 
 
5.6 Dissolution of Microbubble in Presence of Ultrasound 
 
 
As shown in Figure 5.3, the steady state contrast ratio value for the nested microbubbles 
is always positive whereas the un-nested microbubbles continue to experience 
diminishing brightness until they have completely dissolved, providing no contrast and 
giving rise to negative contrast ratio values. When the microbubble is un-nested, gas 
transport continues unabated until all gas originally contained in the microbubble has 
dissolved into the bulk aqueous medium. On the other hand, when a microbubble is 
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                                                     The slope of the normalized contrast ratio during initial 
exposure to ultrasound until a steady state is reached, the time to reach steady state, and 
the final contrast ratio is shown for each nesting shell diameter. This demonstrates the 
clear trend that exists within the first few minutes of ultrasound exposure where a smaller 
particle size correlates to a steeper negative slope. 
 
nested within the polymer shell, the impermeable shell presents a barrier to gas transport. 
Prior to ultrasound exposure and directly after formulation, passive diffusion occurs to 
the extent allowed by the system. When the nested microbubbles are introduced to the 
testing apparatus, ultrasound-induced diffusion is the only observable phenomena. The 
water contained within the polymer shell becomes increasingly saturated with gas until 
the driving force for diffusion is insignificant and diffusion of the microbubble ceases.  
 
8Table 5.2:   Comparison of CTR phenomena.  
 
 
 
 
davg,shell 
(μm) 
mcontrast ratio 
(dB/sec) 
tSS 
(sec) 
final contrast ratio 
[dB] 
20.52 -8.10 x 10-5 150 20.51 
14.95 -1.59 x 10-4 210 14.95 
9.95 -1.12 x 10-3 420 9.95 
5.55 -1.51 x 10-3 420 5.55 
2.53 -2.50 x 10-3 420 2.35 
1.95 -4.81 x 10-3 420 0.25 
 
The rate of diminishing brightness increases as microcapsule size decreases as shown in 
Table 5.2. One might expect that with a larger shell size, and therefore a larger quantity 
of fluid surrounding the microbubble within the shell, the microbubble within the 
microcapsule would behave closer to that of an un-nested microbubble (an infinitely large 
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nesting capsule would be tantamount to no nesting capsule) resulting in a steeper 
decrease in the contrast ratio value during the first 500 seconds. However, just the 
opposite was observed. This can be explained by examining the size distribution of 
microbubbles that exist within the shell prior to ultrasound exposure. This requires a 
distinction between the two stages of dissolution- passive diffusion that occurs within the 
first few minutes after particle formulation and ultrasound-induced diffusion which is 
observed during our imaging studies. It is assumed that a larger nesting shell would 
contain the microbubbles on the larger end of the size distribution prior to ultrasound. 
However, we conclude that the larger nesting shell contains microbubbles with a smaller 
radius than that contained within the smaller nesting shells due to passive diffusion which 
occurs prior to ultrasound exposure. 
 
To demonstrate this, we use a modified version of the Sarkar et al. dissolution model [33] 
with the addition of a term accounting for the entrapment of gas within the aqueous space 
confined by the polymeric nesting shell. Note that this is not used to model the results 
obtained experimentally from ultrasound-induced diffusion, only to obtain an 
approximate size range of the microbubbles within each shell prior to experimentation to 
explain the results. 
 
5.7 Sarkar Model to Account for Diffusion within Nesting Shell 
 
We will briefly discuss the mathematics behind the original Sarkar et al. model, and then 
introduce the modified version. The original model was developed to show gas transport 
180 
 
from a freely floating microbubble into a bulk aqueous medium and thus involved a 
single value for the level of saturation and a time-invariant gas concentration far from the 
microbubble surface. The physical depiction of this phenomenon is shown in Figure 
5.39a for gas transport from within a coated microbubble into an aqueous medium. A 
brief description of the mathematical model is presented for clarification. We begin with 
the governing equation for gas concentration C in the surrounding medium and the 
boundary conditions (at the outer surface of the encapsulation and far away from the 
bubble). The model is assumed to be at steady state because the time scale of dissolution 
is much larger than the time scale of gas transport.  
 
1
𝑟2
𝜕
𝜕𝑟
(𝑟2
𝜕𝐶
𝜕𝑟
) = 0,         − 𝑘𝑔
𝜕𝐶
𝜕𝑟
|
𝑅
= ℎ𝑔[𝐶𝑊 − 𝐶(𝑅)],          𝐶(𝑟 → ∞) = 𝐶∞                     
 (Equation 5.2) 
 
where R is bubble radius, ℎ𝑔 is permeability of the gas through the encapsulation, 𝑘𝑔 is 
the diffusivity in the surrounding liquid, 𝐶𝑊 is the gas concentration at the inside wall of 
the encapsulation, and 𝐶∞ is the gas concentration far from the bubble. This linear model 
of permeability is appropriate for both Fickian diffusion as well as an energy barrier 
model that might be more appropriate for a monolayer [62]. Sarkar et al. then goes on to 
derive the following equation for the dissolution of an encapsulated microbubble (please 
see [33] for the full derivation) 
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𝑑𝑅
𝑑𝑡
=
−3𝐿𝑔𝑘𝑔
(
𝑘𝑔
ℎ𝑔
+ 𝑅)
[
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)
2
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 ,          𝑓𝑜𝑟 𝛾(𝑅) = 𝛾0 + 𝐸
𝑠 [
𝑅
𝑅0
2
− 1]
> 0, 
𝑑𝑅
𝑑𝑡
=
−𝐿𝑔𝑘𝑔
(
𝑘𝑔
ℎ𝑔
+𝑅)
(1 − 𝑓),          𝑓𝑜𝑟 𝛾(𝑅) = 0                                              (Equation 5.3) 
 
where R0 is the initial bubble radius, Lg is the Ostwald coefficient, patm is atmospheric 
pressure, f is the saturation of the medium, γ0 is the initial surface tension, and Es is the 
dilatational surface elasticity. However, the presence of a nesting shell causes the degree 
of saturation in the aqueous region between the microbubble monolayer coating and the 
polymeric nesting shell to increase with time. In the model by Sarkar et al. the saturation 
of the aqueous medium surrounding the microbubble, f, is constant. This saturation term 
is no longer a constant in the modified model to account for the increase in the degree of 
saturation that ensues as gas leaves the microbubble and enters the microcapsule aqueous 
core, which means the aqueous medium surrounding the microbubble is no longer an 
infinite sink. The physical depiction is shown in Figure 5.39b. 
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                                                                          a) The original model developed by Sarkar 
to show gas transport within an encapsulated microbubble into the surrounding medium. 
This model uses an estimated saturation of the bulk fluid, f. b) The modified version of 
the model incorporates an impermeable PLA shell which the microbubbles are nested 
within. The saturation value within the aqueous core of the shell increases as dissolution 
occurs.  
                                
97Figure 5.39:   Depiction of gas dissolution from microbubble.
 
 
 
 
 
For a polymeric nested microbubble formulation, the gas leaving the microbubble due to 
dissolution increases the saturation of the surrounding medium. The degree of saturation, 
f, is defined as the mass fraction of gas in the medium at a given time over the mass 
fraction of gas in the medium at saturation. The degree of saturation from passive 
dissolution was found by subtracting the mass of the microbubble at a given time, 𝑚(𝑖) 
where i is a time index, from the initial mass of the microbubble, 𝑚0. Dividing this by the 
mass of water in the shell, 𝑚𝐻2𝑂 , gives the mass fraction of gas in the medium due to 
dissolution, assuming the PLA shell is impermeable.  
 
𝑓 =
𝑚0−𝑚(𝑖)
𝑚𝐻2𝑂
⁄
𝑚𝑎𝑠𝑠 𝑓𝑟𝑎𝑐 𝑜𝑓 𝑆𝐹6 𝑎𝑡 𝑠𝑎𝑡𝑢𝑟𝑎𝑡𝑖𝑜𝑛
           (Equation 5.4) 
 
a b 
183 
 
To calculate the degree of saturation in terms of microbubble radius at any given time 
where i is a time index, the mass of sulfur hexafluoride (SF6) was rewritten in terms of 
the initial radius of the microbubble as 𝑅0, the radius of the nesting shell as 𝑅𝑠ℎ𝑒𝑙𝑙, the 
number of microbubbles nested within the shell as 𝑛, and the densities of the gas and 
water at room temperature as 𝜌𝑆𝐹6 and 𝜌𝐻2𝑂. The resulting equation is simplified to: 
 
              𝑓 =
[𝑅0−𝑟(𝑖)]
3𝜌𝑆𝐹6𝑛
[𝑅𝑠ℎ𝑒𝑙𝑙−𝑛𝑅0]3𝜌
𝐻2𝑂
⁄
𝑚𝑎𝑠𝑠 𝑓𝑟𝑎𝑐 𝑜𝑓 𝑆𝐹6 𝑎𝑡 𝑠𝑎𝑡𝑢𝑟𝑎𝑡𝑖𝑜𝑛
                 (Equation 5.5) 
 
The initial value and maximum value for saturation is defined by the user and varies 
between 0 (undersaturated medium) and 1 (saturated medium). The saturation term 
increases as gas is transferred from the microbubble core into the aqueous medium until 
the maximum saturation is reached. Equation 5.3 was non-dimensionalized as shown in 
[33] with the exception that the saturation term, f, is no longer a constant and is now a 
variable described by Equation 5.5. Equation 5.3 and Equation 5.5 were numerically 
solved with the initial conditions R/R0 (t=0) = 1 using MATLAB-R2007b (The 
MathWorks Inc., Natick, MA, USA). MATLAB subroutine ODE15s appropriate for stiff 
differential equations was used. Solution requires a user defined function that provides 
the right-hand side of Equation 5.2. Simulated results have been checked for their 
independence of the various option parameters (viz. absolute and relative tolerance 
values) of the solver.   
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                                                                                          The effect of shell radius on the 
normalized microbubble radius at equilibrium from passive diffusion only. Rshell=radius of 
nesting shell, R=microbubble radius, R0=initial radius of microbubble.  Es/γ0=1.5, R0=1.25 
μm, n=1, and the maximum saturation value, fmax, within the shell is 1.0. As the shell size 
increases from 2-11 μm, the equilibrium radius of the microbubble decreases. The larger 
shell allows more gas to leave the bubble because the aqueous volume is higher and can 
accommodate a larger amount of saturated gas. The equilibrium radius of the microbubble 
decreases as shell radius increases. 
The results from this passive diffusion model are shown in Figure 5.40 assuming a 
microbubble with an initial radius of 1.25 μm is nested within the shell. The model uses 
typical values for the surface elasticity (Es) and surface tension (γ0) of the monolayer 
encapsulating the bubble, resulting in Es/γ0~1.5 [33]. As shell diameter increases, the rate 
of gas dissolution also increases due to the larger volume of the aqueous core. This 
engenders an inverse relationship between shell diameter and equilibrium microbubble 
radius prior to ultrasound induced dissolution.   
 
 
98Figure 5.40:   Effect of shell radius on equilibrium microbubble radius. 
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A larger shell microcapsule results in greater ambient diffusion, and hence a smaller 
equilibrium radius of the microbubble due to a larger “sink” for gas dissolution during 
stage 1. Upon application of ultrasound, however, a second stage of ultrasound-induced 
gas diffusion ensues, which is observed in the experimental results. The amount of gas 
diffusion which can take place during stage 2 will depend on how much diffusion already 
took place during the passive diffusion stage. Thus, larger microcapsules, which allow 
more ambient diffusion, show less ultrasound-induced diffusion during experimentation 
and therefore exhibit greater resistance to a decrease in brightness. We believe the rate of 
decrease in contrast ratio observed in Figure 5.11 is easily explained by ultrasound-
induced diffusion of a microbubble that has already undergone passive diffusion as 
illustrated in Figure 5.41.  
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                                                                                          A to B depicts the passive 
diffusion of the microbubble which occurs within the first few minutes after formulation. 
B indicates the equilibrium radius of the microbubble found from the modified version of 
the Sarkar model. Due to the larger driving force for dissolution, the equilibrium radius 
within the larger nesting shell will be smaller than that of the microbubbles within the 
smaller nesting shell. B to C indicates ultrasound induced diffusion. The microbubbles 
nested within the smaller shell experience a larger decrease in radius. 
 
99Figure 5.41:   Passive and ultrasound induced diffusion of microbubble.
 
 
 
 
 
 
 
To confirm that the nested microbubbles in the sample chamber only experience a 
decrease in brightness when ultrasound is applied (demonstrating that the experimental 
results are for ultrasound induced dissolution and not passive diffusion), the sample is 
monitored with both constant ultrasound exposure no ultrasound exposure over the same 
time period. 
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                                                                                                                          The 
brightness of nested microbubbles is compared for two samples. In the sample labeled 
“15k C”, ultrasound is applied to the sample for the duration of the experiment. In the 
sample labeled “15k_NoUS C”, the transducer is only turned on to take an initial and 
final brightness reading.  
 
100Figure 5.42:   Brightness of nested microbubbles with constant and no ultrasound exposure.  
 
 
 
 
Microbubbles undergo passive diffusion in the first few minutes during formulation, 
beginning once the microbubble is removed from its sealed vial. Once the sample is 
placed in the experimental sample chamber, ultrasound induces further dissolution. This 
agrees with the data shown in Figure 5.42 where the sample with constant ultrasound 
exposure has a lower final brightness than the same sample where ultrasound was only 
applied at time=0 and at end of the experiment so that a brightness reading could be 
recorded.  
 
In Figures 5.43 and 5.44, un-nested microbubbles are taken directly from their air tight 
vial and placed in the sample chamber. Brightness is recorded for constant ultrasound 
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                                                                                                                                 Tissue 
brightness is shown to emphasize the fact that the contrast agent is no longer functioning 
once the brightness of the sample falls below the brightness of the tissue.  
exposure and no ultrasound exposure (except for the brief time that the transducer is used 
to take an initial and final brightness reading). Even without ultrasound, some decrease in 
brightness takes place which suggests that passive diffusion takes place in the first five 
minutes. A greater decrease in brightness is seen when ultrasound is applied indicating 
further ultrasound induced diffusion. 
 
 
101Figure 5.43:   1E7 microbubbles/mL un-nested sample with constant and no ultrasound exposure.  
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                                                                                                                                 Tissue 
brightness is shown to emphasize the fact that the contrast agent is no longer functioning 
once the brightness of the sample falls below the brightness of the tissue.  
 
102Figure 5.44:   3E7 microbubbles/mL un-nested sample with constant and no ultrasound exposure.
 
 
 
Another aspect of the data that requires further exploration is that for the smaller shell 
size of 2.53 μm empty nesting shells show a decline in contrast ratio as shown in Section 
5.3.7. This could be accounted for by a configurational change of the polymer shell 
during experimentation which is confirmed experimentally and shown in Figure 5.45. 
The left panel is a microscopic image of an empty nesting shell sample before and the 
two images on the right are taken after experimentation.  
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                                                                                 Left panel shows a batch of empty 2.53 
µm microparticles before ultrasound exposure. Note the spherical shape and lack of any 
deformities. The middle and right panel shows the same batch of microparticles after 
experimentation during a 40 minute imaging study, both with an optical microscope and 
using SEM (Zeiss Supra 50 VP, Germany).  
 
103Figure 5.45:   Polymer shell before and after ultrasound exposure.
 
 
 
 
5.7.1 Modelling Sensitivity Analysis 
 
The Sarkar model shows a very clear relationship in Figure 5.40 between microbubble 
equilibrium radius and nesting shell size. Other aspects, such as initial saturation of the 
aqueous core, number of microbubbles nested within the core, and the initial 
microbubbles radius, also affect the radius versus time profile for the microbubble. These 
parameters are explored in this section. One question the reader may have is how quickly 
does the gas in the shell becomes saturated during passive diffusion and ultrasound 
induced diffusion since the solubility in water of SF6 is fairly low- 0.007 vol/vol.  To 
demonstrate the minimal amount of gas diffusing into the shell, we can plot the mass of 
gas remaining in the bubble versus time for the first 100 seconds. An Es/γ0 value of 1.5 
and hf value of 8.7x10
-6 was used to match those found in literature for a DSPC/ PEG 
lipid monolayer. 
 
5 μm 5 μm 
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                                                                                                                       The mass of 
gas remaining in the bubble versus time for the first 100 seconds. An Es/γ0 value of 1.5 
and hf value of 8.7x10-6 was used to match those found in literature for a DSPC/ PEG 
lipid monolayer. 
 
 
 
104Figure 5.46:   Theoretical mass of gas remaining in microbubble for each nesting shell size.  
 
 
 
The saturation value, f, is increasing as gas diffuses through the bubble monolayer into 
the aqueous core of the nested microbubble. Typical diffusion is logarithmic; one may 
think the saturation of the aqueous medium increases quickly then levels off as the core 
becomes saturated (a logarithmic relationship) and therefore the microbubble radius 
would decrease quickly at first then reach an equilibrium radius. However, for an 
encapsulated microbubble there is more to the story (see Sarkar modeling for gas 
dissolution [63]). The rate of diffusion has a sigmoidal shape in some cases where the 
change in radius is slow at first then speeds up then slows down again. As the 
microbubble shrinks it gives rise to a compressive stress that counterbalances the surface 
tension and then it reaches its equilibrium value. For surface tension driven dissolution, 
we can obtain a nonzero equilibrium radius. For an SF6 microbubble where the medium 
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is saturated with air, the air diffuses into the bubble initially due to the concentration 
gradient which causes the radius to increase. Air partial pressure rises sharply and reaches 
an equilibrium with outside pressure within a few seconds. The initial bubble behavior is 
controlled by air diffusion therefore the bubble grows due to sharp air intake. Afterwards 
the SF6 diffusion controls the bubble behavior and the bubble radius is reduced. Elastic 
stress in the encapsulation resulting from the drop in radius below the stress free value R0 
counterbalances surface tension leading to a final equilibrium radius which is 61% of the 
initial radius. It takes about 3000 seconds to reach this state. At this point the bubble is an 
air bubble with SF6 dispelled from the bubble.  
 
Freely Floating Microbubble 
For a 1.25 µm SF6 bubble using Es/γ0=1.5 and a saturation value of f=1, the bubble radius 
decreases until it reaches a final equilibrium value, but the initial change in radius is not 
as rapid as it would be if a logarithmic relationship existed. Let’s first look at the free 
bubble with only the material properties of air replacing the material properties of SF6 
while all other parameters remain the same as is used in the nested microbubble 
modeling. The maximum saturation is varied from 0.8 (undersaturated) to 1.5 
(oversaturated) to demonstrate the effect on the microbubble radius, and also accentuate 
the effect of an intake of air for surface driven diffusion. 
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                                                                                               The maximum saturation is 
varied from 0.8 (undersaturated) to 1.5 (oversaturated) to demonstrate the effect on the 
microbubble radius, and also accentuate the effect of an intake of air for surface driven 
diffusion. 
 
                                                                                                         Diffusion of freely 
floating microbubble in a saturated medium (f=1). 
 
 
105Figure 5.47:  Diffusion profile for a freely floating un-nested microbubble.
 
       
  
Let us continue with the situation for a freely floating microbubble where f=1.0 
(complete saturation). The relationship appears logarithmic at first glance, but the 
behavior is made clear by looking closer at the first 100 seconds. 
 
 
 
106Figure 5.48:   Dissolution in a saturated medium for a freely floating microbubble. 
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                                                                             The rate of diffusion calculated by the 
change in bubble radius per time interval for freely floating microbubbles in an aqueous 
medium with varying levels of saturation ranging from 0.8 to 1.5. 
 
The change in radius appears to be less than that of a logarithmic diffusion process. We 
can plot the rate of diffusion as the change in radius over the change in time for both 
1000 seconds for all three types of saturation (undersaturated, saturated, and 
oversaturated). 
 
 
107Figure 5.49:   Rate of diffusion for freely floating microbubble. 
 
 
 
We now begin to notice the sigmoidal shape of the diffusion rate for the free bubble in a 
solution that is saturated (f=1), as well as non-logarithmic behavior of the undersaturated 
and oversaturated case as well. We can confirm this inflection point for the case where 
f=1 by plotting the second derivative of radius versus time. Due to the limitations of 
MATLAB, there are outliers in the data but the a very slight acceleration change from 
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                                                                                  The rate of acceleration of bubble wall 
calculated by the change in bubble velocity per time interval for freely floating 
microbubbles in a saturated aqueous medium. 
negative to positive to negative is found when evaluating the data for the plot shown in 
Figure 5.50 (numerical values not shown). 
 
108Figure 5.50:   Rate of acceleration for freely floating microbubble.
 
 
 
Saturation of Aqueous Medium  
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saturation term. This is the same case as the free microbubble except now the saturation 
value varies according to the amount of gas that diffuses out of the microbubble until the 
interior core is saturated. Figure 5.40 showed the normalized microbubble radius for a 
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microbubble mass was calculated and presented in this figure.  
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                                                                               The saturation value is not logarithmic 
due to the initial influx of air and subsequent diffusion of the heavy gas from the 
microbubble core.  
The saturation value is examined in Figure 5.51 for each of the cases presented in Figure 
5.40 and 5.46. The saturation value is not logarithmic due to the initial influx of air, and 
the data makes sense once we realize the microbubbles are not following a typical 
logarithmic diffusion behavior. 
 
 
109Figure 5.51:   Saturation of aqueous core in nested environment.
 
 
 
Figure 5.52 focuses on the first 8 seconds of the radius versus time graph shown in Figure 
5.40. 
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                                                                                                                   Looking at the 
first 8 seconds of microbubble radius for each shell diameter in a saturated aqueous 
medium. 
 
110Figure 5.52:   Initial behavior of normalized microbubble radius in nested environment.
 
 
 
When nested within a 2 µm shell, the microbubble behaves closest to what is expected 
for a dissolution process without considering air intake and surface tension effects. The 
saturation value, f, for the 2 µm shell sample also displays behavior closest to what one 
may expect- a sharp increase in saturation as the gas diffuses out and then a leveling off 
as the concentration gradient decreases. As the shell diameter grows, lending to a greater 
volume of air saturating the aqueous core and therefore a larger initial intake of air, the 
radius and saturation values further deviate from logarithmic behavior. This behavior is 
made clear when examining the first 8 seconds of the saturation versus time plot in 
Figure 5.53. 
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                                                                                               The un-nested microbubble is 
able to take in as much air from the “infinite sink” of dissolved air in the aqueous 
medium in order to reach its equilibrium radius, which is around 60% of its initial radius. 
In the case of the nested microbubble, the microbubble can only take in as much air as is 
in the aqueous core of the nested shell. 
 
111Figure 5.53:   Initial behavior of saturation value, f, in nested environment. 
 
 
 
 
Note that the freely floating, un-nested bubble is almost entirely an air bubble after 100 
seconds. The un-nested microbubble is able to take in as much air from the “infinite sink” 
of dissolved air in the aqueous medium in order to reach its equilibrium radius, which is 
around 60% of its initial radius. In the case of the nested microbubble, the microbubble 
can only take in as much air as is in the aqueous core of the nested shell. Also the nesting 
shell prevents the microbubble from growing to a certain extent because of the repulsion 
force between the shell of the polymer and the microbubble. Because of this, the 
microbubble at equilibrium is most likely not comprised solely of air, rather some mix of 
air and SF6 because 1) SF6 leaves the microbubble only until it saturates the core so the 
bubble retains some amount of SF6 and 2) the bubble can only take in as much air as is 
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available in the aqueous core and it can only replace the volume of gas that has diffused 
out. This is why, even if one expects the free microbubble to have a smaller equilibrium 
radius than a microbubble nested within a polymer shell, this is not what is actually 
shown through experimentation and this diffusion model. 
 
Now that the behavior of a freely floating microbubble and that of a nested microbubble 
has been thoroughly discussed, an in depth study on the effect of varying parameters will 
be discussed next. 
 
Initial Saturation of Aqueous Core 
The initial saturation of the aqueous core can either be 0 (no gas existing in the aqueous 
core), between 0 and 1 (undersaturated), 1 (saturated), or above 1 (oversaturated). An 
undersaturated medium allows for more diffusion than the other cases, so for this study 
the initial saturation, x, is varied between 0 and 0.1. Figure 5.54 shows the resulting 
radius versus time plot and Figure 5.55 displays the saturation versus time plot. 
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                                                                                                                                          The 
initial saturation of SF6 in the aqueous core of the polymeric nested microcapsule is 
varied between 0 and 0.1. Once x is greater than 0.1, no difference in the radius versus 
time plot is seen.  
                                                                                                                                          
Saturation versus time plot when the initial saturation of SF6 in the aqueous core of the 
polymeric nested microcapsule is varied between 0 and 0.1. Once x is greater than 0.1, no 
difference in the radius versus time plot is seen.  
 
112Figure 5.54:   Radius vs time for varying initial saturation of the aqueous core of a nested microbubble.  
 
 
 
 
113Figure 5.55:   Saturation vs time for varying initial saturation of the aqueous core of a nested microbubble. 
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                                                                            The maximum saturation value of SF6 in 
the aqueous core of the polymeric nested microcapsule is varied between 0.75 and 1.5.  
When the initial saturation rises above 0.1, the radius vs time plot collapses onto the same 
line. This trend is similar to what is seen in Fig 9 of the Sarkar et al. paper describing this 
model [63]. 
 
Maximum Saturation Value of Aqueous Core 
Now we look at the effect of changing the maximum saturation values, fmax, at which 
point gas diffusion from the microbubble ceases. The initial behavior does not depend on 
maximum saturation, but the point at which SF6 saturates the aqueous core determines the 
equilibrium radius of the microbubble and the time it takes to reach this point. A lower 
maximum saturation value results in a larger equilibrium radius for the microbubble.  
 
 
114Figure 5.56:   Radius vs time for varying maximum saturation. 
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                                                                                                                        The number of 
microbubbles nested within in the aqueous core of the polymeric shell is varied between 1 
and 3. The initial change in radius for a single bubble does not vary based on the number 
of microbubbles, but the diffusion process turns off earlier if more bubbles exist in the 
core. 
Number of Microbubbles Existing within Shell 
Increasing the number of microbubbles in the shell, n, has a similar effect on the 
microbubble radius to increasing maximum saturation. The initial behavior of the 
microbubble remains unchanged, but as the number of microbubbles within the core 
increase, gas more quickly saturates the core and the equilibrium radius of the 
microbubble increases. Note that this does not take into effect any bubble-bubble 
repulsion effects, only the dissolution process. A larger number of microbubbles existing 
in the core slows the rate of saturation so for n=3, the slope of the saturation value with 
respect to time is less than that of n=1 or n=2 as demonstrated in Figure 5.57. 
 
 
115Figure 5.57:   Saturation vs time for varying number of microbubbles in the aqueous core.
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5.8 Conclusion 
 
This study demonstrates that the nested microbubbles provide contrast at least nine times 
longer than that of un-nested microbubbles. The contrast ratio of the un-nested 
formulation drops below 0 after 4 minutes, while the nested microbubbles provide 
contrast for the duration of the 40 minute experiment. A contrast ratio below 0 indicates 
that the contrast agent has reached the brightness intensity below that of the reference 
material. After 40 minutes, no evidence of decreasing brightness from the nested 
microcapsules existed, indicating that contrast would last significantly longer than what 
was observed during the duration of the experiment but limited access to the clinical 
instrument used for these studies precluded longer acquisition times. The brightness of 
the ultrasound image depends on a combination of variables, including the size of the 
polymer shell of the microcapsule and the number of microbubbles nested within the 
shell. Specifically, this study shows that either an increase in microcapsule shell size or 
an increase in number of microbubbles nested within the microcapsule shell results in a 
larger steady state contrast ratio value. The larger shell scatters and reflects the signal, 
leading to an increased brightness. A higher concentration of microbubbles used during 
formulation also results in increased brightness.  
 
Nested microbubbles provide contrast equivalent to un-nested formulations, but allow for 
a sustained positive contrast ratio value for up to 40 minutes. At 40 minutes, there was no 
indication of decreasing contrast ratio from the nested formulations, but the 
experimentation time was limited to the availability of the clinical ultrasound machine. 
The results are consistent with a two stage dissolution process, ambient diffusion which 
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occurs immediately after formulation and ultrasound induced dissolution which occurs 
under ultrasound exposure. A modified version of the Sarkar model for gas diffusion 
from phospholipid-shelled microbubbles with the addition of a time dependent saturation 
term is used to model the first stage of ambient diffusion. The six nesting formulations 
with average outer capsule diameters of 1.95, 2.53, 5.55, 9.95, 14.95, and 20.51 μm 
reached final contrast to tissue ratio (contrast ratio) values of 0.25, 2.35, 3.68, 4.51, 5.93, 
and 8.00 dB respectively at the end of the 40 minute trial. The number and size of nested 
microbubbles affects the level of gas saturation that can be achieved for a given capsule 
size. Moreover, the heterogeneity of sizes within a given formulation will also influence 
the diffusion profiles during diffusion stages 1 and 2. The extent to which these effects 
manifest in the contrast ratio brightness studies described herein, which will require 
detailed knowledge of the bubble population inside the various formulations, is the 
subject of a separate study. 
 
The results acquired from this study provide us with a better comprehension of the nested 
microbubble behavior. For clinical trials, we require an average particle diameter less 
than 8 microns; however in this scientific study it is advantageous that we exploit a large 
size range (1-20 micron diameter spheres) to gain an extensive mastery of the dissolution 
process. The first step to interpreting the relationship between microbubble concentration, 
shell size, homogenizer speed during formulation, etc, is to attain an overall cognizance 
of the many different formulations of nested microbubbles to derive the most effective 
nested microbubble parameters for in vivo use. By working with a size range that extends 
past the limit for in vivo testing, we are able to investigate the effect of modifying the 
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physics of the contrast agent recipe to identify the most effective combination of 
microbubble concentration and nesting shell size for ultrasound imaging. Once the 
scientific theories surrounding the observed trends is elucidated, a precise model of the 
ultrasonic dissolution of nested microbubbles can be generated which will potentially 
allow a new generation of safe and long lasting contrast agents.  Studies that intertwine 
clinical ultrasonic imaging and the chemistry/physics of ultrasound contrast agents are 
pivotal to this goal.   
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CHAPTER 6: ULTRASOUND TRIGGERED DRUG DELIVERY 
 
6.1 Introduction 
 
Ultrasound has a growing role in the delivery of therapeutic agents. Its interaction with 
gas bodies such as microbubbles has the ability to permeabilize cell membranes and 
disrupt the vesicles that carry drugs. We are presenting a means for ultrasound triggered 
drug delivery by nesting a solution of microbubbles within the aqueous core of a 
liposome which protects both gas microbubbles and aqueous contents. This vehicle has 
the dual ability to enhance applications in imaging along with a targeted drug delivery 
vehicle with an external trigger. When exposed to ultrasound, the microbubble oscillates 
which induces microstreaming of the surrounding fluid and disrupts the membrane. In 
this case, poration of the membrane facilitates release of the drug from the liposome to a 
nearby structure, which we refer to as reverse sonoporation. In reverse sonoporation, the 
direction of transport and perhaps also the mechanism of poration is different than 
traditional sonoporation [159]. Using focused ultrasound, only the desired region within 
the focal zone of the transducer will receive enough energy to release the drug, reducing 
systemic side effects.   
 
This study evaluates a potential drug delivery vehicle which involves microbubble 
cavitation-induced leakage of a fluorescent dye encapsulated in the liposome shell. We 
discuss the vehicle design where SF6 microbubbles coated by a DSPC PEG-3000 
monolayer are nested within a liposome shell (70% Egg-PC/ 20% cholesterol/ 10% 
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triolein) with an average diameter of 4.74 μm using a double emulsion method. A 1 MHz 
focused transducer was driven with a home built pulser. Peak negative pressures ranged 
from 0.54 MPa to 3.74 MPa to induce either stable cavitation or inertial so that leakage 
under both conditions could be evaluated. Calcein leakage is monitored as a function of 
ultrasound pressure (50 kPa to 2 MPa), ultrasound exposure (0-10000 waveforms), 
average liposome shell diameter (1 and 18 μm), and concentration of microbubbles used 
during formulation (2x108 to 8x108 MB/mL). Leakage of the core is accomplished with 
both high and low frequency transducers, although high frequency studies (1-15 MHz) 
are of greater interest due to their potential in a clinical setting. Low frequency 
experiments with an ultrasound probe operating at 20 kHz proved that leakage was 
accomplished with and without microbubbles incorporated into the liposome core. In 
vitro experiments at high frequency are carried out with a 7.5 cm focused, 1 MHz 
transducer submerged in a glass beaker containing the sample insonated by a high voltage 
pulser generating a signal consisting of 4 cycle pulses with a pulse repetition frequency of 
5 Hz. Fluorescent measurements are taken at 200 second intervals ranging from 0 and up 
to 2000 seconds (depending when steady state is reached). 
 
The amount of calcein remaining within the liposome core is calculated by 
𝐹𝑠𝑜𝑛−𝐹0
𝐹𝑓−𝐹0
 where 
Fson is the fluorescence of the insonated sample, F0 is the initial fluorescence before any 
ultrasound exposure, and Ff is the fluorescent measurement after complete rupture of the 
liposome. Calcein was encapsulated within the liposome at a concentration of 0.1 mM 
and cobalt chloride was injected into the aqueous solution after liposome formulation to 
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quench any calcein not encapsulated within the liposome initially and also any that is 
released from the liposome membrane during sonication.  
 
6.2 Ultrasound Therapy Set Up 
 
For the following studies, calcein was used as a drug mimic to detect when leakage of the 
liposome or polymer microcapsule core occurred. Both low (20 kHz) and high (1-5 MHz) 
frequency ultrasound treatment were used to induce leakage for polymeric and liposomal 
nested microbubbles. The experimental set up will be described in this section, and the 
results for both polymeric and liposomal nested microbubbles will be described in 
Sections 6.3 and 6.4 respectively. 
  
6.2.1 Calcein Calibration 
 
In this study, we used calcein as hydrophilic marker which has been used as a model for 
drug/liposome interactions and determining the encapsulation efficiency. Calcein is a 
water soluble, fluorescent and self-quenching probe that is widely used in studies of cell 
viability and mitochondrial function by microscopy fluorescence imaging [160]. Calcein 
release phenomena have been utilized as an effective index to characterize the membrane 
properties of (model) biomembranes and to evaluate their stability in a variety of 
conditions [160]. 
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Drug release can be detected fluorometrically using a self-quenching assay. Self-
quenching can occur as a result of molecular interactions between the fluorophores that 
renders them non-fluorescent or due to the inner filter effect where absorption at the 
excitation or emission wavelengths occurs along the optical path. Encapsulation of 
molecules at a concentration sufficiently high to render the fluorophores non-fluorescent, 
i.e. molecular interaction quenching, can result in little or no detected fluorescence 
emissions from the sample. The self-quenching principle of calcein was used during 
studies done with polymeric nested microbubbles. 
 
In the case of the liposomal nested microbubble, it proved extremely difficult to separate 
the external calcein from the liposome solution. Centrifugation and rinsing were not a 
feasible option because the density of the liposomes is extremely low compared to the 
polymeric nested microbubble sample and packing material for column chromatography 
did not accommodate the micron sized liposomal nested microbubbles. An externally 
added quencher for the liposomal nested microbubble solution is needed. Chemical 
quenching is another technique used to detect drug release from liposomes. In some 
cases, a quenching agent can be added to the sample, which binds to the unencapsulated 
drug and quenches its fluorescence, while encapsulated molecules continue to fluoresce. 
At a neutral pH calcein is maximally fluorescent, but the presence of certain metal ions, 
such as Co+, results in fluorescence quenching. Thus cobalt chloride has been used to 
detect calcein release. The fluorescence emission spectrum of calcein is shown in Figure 
6.1. 
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                                                                                                     Fluorescence intensity of 
calcein as a function of concentration. Calcein fluorescence self-quenched due to the inner 
filter effect at concentrations above 20 mg/ml. For this figure only, the slit widths were 
changed to 2 nm (excitation and emission) for calcein in order to avoid saturating the 
detector at peak fluorescence concentrations. Calcein fluorescence was analyzed using a 
4-mm-path length cuvette in a Photon Technology International, Inc. (Birmingham, NJ) 
A-710 steady-state fluorescence spectrometer with 2-nm slit widths, 0.5-s integration time, 
and 1-nm step size. The emission spectrum was obtained using λex = 475 nm and 1-nm 
intervals between 490 and 540 nm. 
 
 
116Figure 6.1:   Fluorescence emission spectrum of calcein calibration curve [16]. 
 
 
 
 
 
 
 
 
6.2.2 Low Frequency Treatment 
 
Low frequency ultrasound treatment was performed using either a Misonix XL2020 
probe tip sonicator (Misonix Inc., Farmingdale, NY) operating at 24 kHz using a 418 tip 
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sonicator was calibrated using the tuning protocol and set to 10% output power 
(electrical) at a setting of 3. Peak-to-peak pressure amplitudes and spatial-peak, temporal-
peak intensity (Isptp) were measured using a Reson TC4038 hydrophone (Reson Inc., US, 
Goleta, CA) with a sensitivity of −228.2 dB re 1 V/μPa at 20 kHz. To avoid possible 
damage of the probe caused by inertial cavitation, the pressure amplitude was measured 
at several distances between 10 and 50 mm. The measurement data was plotted against 
distance and extrapolated to estimate the pressure amplitude at 1 cm, which is the 
distance at which the release assays were performed. The amplitude was calculated to be 
approximately 1027 ± 134 kPa, which corresponds to a spatial-peak, temporal-peak 
intensity of approximately 35.5 W/cm2.  
 
The suspension was exposed to low frequency (24 kHz), continuous wave ultrasound for 
the total exposure time of 45 minutes. Samples were placed in an ice water bath to 
maintain their temperature at 21 ± 3° C to avoid temperature-induced permeability.  
 
The centrifuged and rinsed, in some cases pretreated, particles were diluted in 100mL of 
PBS in a 150mL beaker. This volume was chosen to be enough to take 1 mL aliquots 
throughout the experiment while ensuring that the sonicator probe remains submerged in 
the sample. The samples were sonicated with the 24 kHz XL2020 Sonicator (Misonix 
Inc., Farmingdale, NY). Different ultrasound parameters were analyzed. Both continuous 
and pulsed applications were applied. The pulsed application was a pulse of 20s on and 
10s off, thus a duty cycle of 60%. Also different net exposure times were applied to 
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different samples. Each 1mL sample was diluted in 2mL of PBS and analyzed in the 
fluorescence spectrometer (PTI, Birmingham, NJ).  
 
6.2.3 High Frequency Treatment 
 
Ultrasound was delivered through an apparatus previously described [16, 127, 161]. 
Briefly, a 1 MHz 7.5 cm focused ultrasound transducer (Olympus NDT, Waltham, MA, 
USA) is driven by a home built high voltage pulser. The transducer generates a peak 
negative pressure (PNP) ranging from 0.54 to 3.74 MPa, which was measured using a 
calibrated PVDF membrane hydrophone. The pulser signal consists of 1000 damped 
sinusoidal waveforms with a 5 Hz prf which is repeated for the desired total number of 
waveforms. These variables were controlled by a MATLAB script. The face of the 
transducer is submerged within the 50 mL graduated cylinder at a height of 10 cm from 
the bottom, which guarantees that the focal point is within the sample region. The 
graduated cylinder contains the sample of nested microbubbles diluted with 40 mL of DI 
water. A 3 cm butyl rubber sheet was placed at the bottom of the glass cylinder to 
eliminate the presence of a standing wave. The sample chamber was placed on a stir plate 
at 300 rpm so that particles receive uniform ultrasound exposure. The setup is shown in 
Figure 6.2.  
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                                                                           Diagram of high frequency ultrasound 
experimental set up. Fluorescence intensity of calcein as a function of concentration. 
Calcein fluorescence self-quenched due to the inner filter effect at concentrations above 
20 mg/ml. For this figure only, the slit widths were changed to 2 nm (excitation and 
emission) for calcein in order to avoid saturating the detector at peak fluorescence 
concentrations. Calcein fluorescence was analyzed using a 4-mm-path length cuvette in 
a Photon Technology International, Inc. (Birmingham, NJ) A-710 steady-state 
fluorescence spectrometer with 2-nm slit widths, 0.5-s integration time, and 1-nm step 
size. The emission spectrum was obtained using λex = 475 nm and 1-nm intervals 
between 490 and 540 nm. 
 
eFocal region 
dDiagram of high frequency ultrasound experimental set up. The 1 MHz focused 
transducer is placed at the top of the graduated cylinder where the face of the transducer 
is 10 cm from the rubber sheet at the bottom of the cylinder. This permits the focal region 
at a distance of 7.5 cm from the center of the transducer to be located within the sample 
chamber. The transducer is driven by a voltage pulser controlled by a Matlab script. 
 
 a 
ab 
dLeakage from nested microbubbles after 1 hour of UV light exposure a) fluorescence 
 
117Figure 6.2:   High frequency ultrasound experimental set up.
 
 
 
 
 
 
 
 
 
Fluorescence Leakage Detection 
Calcein release was detected using a cobalt quenching assay. At the beginning of each 
experiment 50 μL of 40 mM CoCl2 was added to the nested microbubble solution in order 
to quench unencapsulated calcein. Before both high and low frequency studies, solutions 
were placed in the sample chamber and fluorescent measurements were taken over a 30 
min period to confirm that there was no cause for liposome leakage due to the 
Focal region 
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experimental setup, and therefore any fluorescent leakage detected was a result of 
ultrasound exposure. Samples were exposed to either low frequency ultrasound (24 kHz) 
continuously for 45 minutes or high frequency ultrasound (1 MHz) for a total exposure 
time of 40 minutes. Negative controls were performed with either no ultrasound exposure 
(measuring fluorescence of the solution exposed to atmospheric conditions over time) or 
“empty” microcapsules that were made with the same contents except the microbubble 
solution was replaced with PBS. A 500 μL aliquot of the sample was removed at each 
time point during the experiment and diluted with 2.5 mL of PBS at which point the 
fluorescence intensity of each sample was measured. To verify that the entire contents of 
the liposome was not released at steady state for the liposomal nested microbubble, the 
sample was treated with 1% Triton X-100 detergent to release all encapsulated calcein 
(positive control) and the fluorescence intensity was measured again. The positive control 
for the polymeric nested microbubble solution was taken after the polymer shells were re-
dissolved in DCM to release all contents.  
 
A spectrophotometric technique was used to quantify leakage.  Calcein emission of an 
initial sample before ultrasound exposure and samples from each time point were 
analyzed using a 4-mm-path length cuvette in a Photon Technology International, Inc. 
(Birmingham, NJ) A-710 steady-state fluorescence spectrometer with 2-nm slit widths, 
0.5-s integration time, and 1-nm step size. The emission spectra were obtained using λex = 
475 nm and 1-nm intervals between 490 and 540 nm. The amount of calcein remaining 
within the liposome core is calculated by 
𝐹𝑠𝑜𝑛−𝐹0
𝐹𝑓−𝐹0
 where Fson is the fluorescence of the 
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insonated sample, F0 is the initial fluorescence before any ultrasound exposure, and Ff is 
the fluorescent measurement after complete rupture of the liposome with Triton X-100.  
 
6.3 Leakage from Polymeric Nested Microbubble 
 
The objective was to achieve controlled drug release from polymer microspheres 
triggered with low-frequency ultrasound. The inertial cavitation and contrast imaging 
behavior of these polymeric nested microbubbles are well understood, making them the 
ideal candidate for a drug delivery vehicle if leakage from the core can be accomplished. 
Two main approaches were carried out. The first approach was polymer degradation of 
the microparticles encapsulating the fluorescent dye before applying ultrasound. The 
second approach was testing other polymers for the microcapsules, such as Poly (L-lactic 
Acid) (PLA) and Poly (methyl methacrylate) (PMMA). The fluorescence dye, calcein, 
was used as a replacement for a hydrophilic drug. PLA degradation was induced by UV-
light exposure and deep freezing; however, no leakage was observed. By re-dissolving 
PLA-microparticles in DCM and PBS it was possible to prove the polymer shells were in 
fact encapsulating calcein. Also, the influence of ultrasound and high temperatures on 
calcein fluorescence was studied. Degradation of calcein fluorescence intensity due to 
high temperatures was observed. 
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6.3.1 Leakage at Low Frequency: UV Light Degradation 
 
Low frequency (high intensity) ultrasound was used to sonicate a sample of PLA 
microcapsules over a period of 40 minutes to induce calcein leakage, but no leakage was 
detected at any point throughout the experiment. A microscope was used to visually 
confirm that no fluorescence could be seen within the bulk fluid. 
 
In an attempt to degrade the polymer so that it would rupture easily when subjected to 
shear stress caused my microbubble oscillations, the microcapsules were exposed to 
ultraviolet (UV) light before applying ultrasound. UV facilitated degradation of PLA has 
been studied and confirmed in numerous papers [162-164]. Samples were exposed for 
varying lengths of time to UV light and then subjected to low frequency ultrasound 
(LFUS). Four different beakers with PLA microcapsules co-encapsulating microbubbles 
and calcein were prepared with the double emulsion method as with 0.1mL of 
microbubbles and 0.1 mL of 70 mM calcein.  
 
A 4 W Spectroline UV-4b lamp (Spectronics Corporation, Westbury, NY) with a 
spectrum of 365 nm was secured ten centimeters from the surface of the microcapsule 
solution. The solution remained stirring at 400 rpm for the duration of the experiment so 
that the UV exposure was evenly distributed within the microcapsule solution. Different 
UV exposure times were applied ranging from 1 hour, 6 hours 45 minutes to an unknown 
amount of hours, which will be referred to as x hours. In the case of x hours, the sample 
was meant to be exposed to UV-light for 24 hours but the lamp went out over night at an 
unknown time, thus the exposure time is definitely over 6 hours and 45 minutes. This 
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exposure time will be referred to as x hours. The last sample was the control, which was 
set on the stir plate for 24 hours without exposure to UV-light. After each sample was 
centrifuged and rinsed twice it was then diluted in 100mL of PBS in a 150mL beaker. 
 
The solutions were then sonicated using a 24 kHz XL2020 Sonicator (Misonix Inc., 
Farmingdale, NY) at 20% amplitude with a duty cycle of 60% to prevent overheating for 
a total of 30 minutes. An aliquot of the sample was taken every 30 seconds up until the 
second minute, then every minute up until 5 minutes, and then every 5 minutes until the 
thirtieth minute. For the control sample every sample was taken as described above with 
exception to the last two samples. Each aliquot was analyzed using a fluorescence 
spectrometer (PTI, Birmingham, NJ). The excitation wavelength of calcein is 495 nm 
while the emission wavelength is 515 nm, resulting in an observed peak in the graphs 
below at 515 nm if calcein is detected.  
 
The results of the fluorescence spectrometer (PTI, Birmingham, NJ) are displayed in 
Figures 6.3-6.6. It can be concluded from these figures that the UV-light made no 
difference in regard to fluorescence of the solution nor to release of calcein from the 
PLA-microcapsules. In fact, the opposite of the hypothesized trend was observed. It was 
expected to see high fluorescence intensity after a certain amount of US exposure 
indicating that the PLA microcapsules have cracked open and released their calcein 
which transitions from self-quenched to unquenched and thus fluoresces. However, a 
decrease of the fluorescence intensity gradually proportional to time was observed.  
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For each figure, the first graph will show the raw data of fluorescence intensity versus 
wavelength so that the decrease in intensity is observed. The second graph is the 
calculated percent calcein remaining in the microcapsule using the equation 
𝐹𝑠𝑜𝑛−𝐹0
𝐹𝑓−𝐹0
, 
which is normalized by the fluorescence intensity observed if all nested calcein was 
released. The raw data is shown to explain the false trend of an increase in calcein 
remaining over time.  
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                                                                                                           Control for polymeric 
nested microbubbles with no UV light exposure a) fluorescence spectrometer analysis of 
PLA microparticles in PBS, after LFUS exposure, without any UV light exposure and b) 
percent calcein remaining in microcapsule. Samples were sonicated at 20% amplitude, 
60% duty cycle for a net exposure time of 30 minutes. 
 
 
 
118Figure 6.3:   Control for polymeric nested microbubble leakage at low frequency.
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                                                                                                                             Leakage 
from nested microbubbles after 1 hour of UV light exposure a)) fluorescence 
spectrometer analysis of PLA microparticles in PBS, after LFUS exposure, without any 
UV light exposure and b) percent calcein remaining in microcapsule. Samples were 
sonicated at 20% amplitude, 60% duty cycle for a net exposure time of 30 minutes. 
 
 
 
 
119Figure 6.4:   Leakage from polymeric nested microbubbles after 1 hour of UV light exposure.
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Leakage from nested microbubbles after 6 hours 45 min of UV light exposure a) 
fluorescence spectrometer analysis of PLA microparticles in PBS, after LFUS exposure, 
without any UV light exposure and b) percent calcein remaining in microcapsule. 
Samples were sonicated at 20% amplitude, 60% duty cycle for a net exposure time of 30 
minutes. 
 
 
 
 
120Figure 6.5:   Leakage from polymeric nested microbubbles after 6 hours 45 min of UV light exposure. 
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                                                                                                                                Leakage 
from nested microbubbles after X hours of UV light exposure a) fluorescence 
spectrometer analysis of PLA microparticles in PBS after X hours of UV light exposure 
and LFUS exposure and b) percent calcein remaining in microcapsule. Samples were 
sonicated at 20% amplitude, 60% duty cycle for a net exposure time of 30 minutes. 
 
 
 
121Figure 6.6:   Leakage from polymeric nested microbubbles after X hours of UV light exposure.
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                                                                                                                  Control for 
polymeric nested microbubbles with no UV light exposure a) fluorescence spectrometer 
analysis of PLA microparticles in PBS, after LFUS exposure, without any UV light 
exposure and b) percent calcein remaining in microcapsule. Samples were sonicated at 
5% amplitude, 60% duty cycle for a net exposure time of 30 minutes. 
 
It is concluded that no release of calcein was seen in any of the samples; therefore any 
change in intensity between samples is not significant enough to conclude the presence of 
calcein leakage (which would display an intensity value close to 1,500,000 units). The 
decrease in fluorescence intensity seen in Figures 6.3 through 6.6 is unexpected and 
further explored. If the calcein was released, the fluorescence intensity would increase. 
From these experiments, a relationship between calcein and ultrasound/ temperature is 
identified. After studying these interactions it was concluded that the heat produced by 
LFUS degrades the calcein resulting in a decrease in florescence. To avoid this problem, 
the next set of experiments was carried out at 5 % amplitude. The temperature of the 
solution was monitored during the US application to ensure it does not exceed 30.2⁰C to 
avoid temperature degradation of calcein.  
 
 
122Figure 6.7:   Control for polymeric nested microbubble leakage at low frequency at 30.2 °C. 
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Leakage from nested microbubbles after X hours of UV light exposure fluorescence 
spectrometer analysis of PLA microparticles in PBS after X hours of UV light exposure 
and LFUS. Samples were sonicated at 5% amplitude, 60% duty cycle for a net exposure 
time of 30 minutes. Temperature was maintained so that it did not exceed 30.2 °C, 
 
 
 
123Figure 6.8:   Leakage from polymeric nested microbubbles after X hours of UV light exposure at 30.2 °C.  
 
 
 
 
No leakage occurs in these studies, although the fluorescence intensity no longer decreases over 
time since temperature is kept below 30.2⁰C. The results of this set of experiments did not 
show positive leakage results. Possible reasons could be insufficient power of the UV 
lamp or exposure time.  
 
6.3.2 Leakage at Low Frequency: PMMA Shell 
 
The second approach in an attempt to induce leakage was to replace the PLA shell with a 
more brittle polymer more susceptible to rupture from the energy caused by microbubble 
cavitation. Poly (methyl methacrylate) (PMMA) was used to replace PLA since this 
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                                                                                                                   Calcein leakage 
from PMMA microcapsules where microcapsule solution was analyzed for its 
fluorescence intensity (arbitrary units) after LFUS at 20% amplitude, 60% duty cycle 
using fluorescence spectrometry. The legend denotes ultrasound exposure time for each 
sample. This test confirms there was no calcein leakage. 
 
polymer has a higher glass transition temperature of 105⁰C compared to PLA which has a 
relatively low glass-transition temperature between 60⁰C and 65⁰C. A higher glass 
transition temperature could presumably prevent the transition from a hard and relatively 
brittle state into a molten or rubber-like state that occurs when heat is added to the system 
during sonication. PMMA microcapsules were formulated in the same manner as the 
PLA microcapsules, except that the polymer PLA was replaced with PMMA during 
synthesis. Ultrasound exposure parameters were identical to that of the leakage 
experiment done on PLA microcapsules, at 20% amplitude with a 60% duty cycle for a 
net exposure time to ultrasound of 30 minutes. There was no leakage seen for these 
microcapsules, although the decrease in fluorescence from heat damage to cacein at the 
higher amplitude is witnessed. 
 
 
124Figure 6.9:   Leakage from 10 mg/mL PMMA nested microbubbles at 20% amplitude. 
 
0.00E+00
2.00E+04
4.00E+04
6.00E+04
8.00E+04
1.00E+05
1.20E+05
1.40E+05
1.60E+05
1.80E+05
2.00E+05
490 500 510 520 530 540
In
te
n
si
ty
Wavelength [nm]
0 sec
30 sec
1 min
1.5 min
2 min
3 min
4 min
5 min
10 min
15 min
20 min
30 min
40 min
45 min
 
 
                                                                                                                 Fluorescence 
spectrometer analysis of PMMA-microspheres (prepared with 10mg/mL of PMMA 
dissolved in DCM) after sonication with LFUS at 5% amplitude, a duty cycle of 60% and 
a net exposure time of 30 minute. 
In Figure 6.9, evidence of calcein degradation is seen. For the next set of experiments, the 
PMMA nested microbubbles are sonicated at 5% amplitude to avoid this. Two samples of 
PMMA nested microbubbles were analyzed- one prepared with a 10 mg/mL stock 
solution of PMMA, and the other prepared with a 50 mg/mL stock solution. The 
microspheres were prepared with the double emulsion method and then sonicated with 
the 24 kHz XL2020 sonicator after centrifuging and rinsing 4 times. The ultrasound 
parameters for this experiment are 5% amplitude, 60% duty cycle and a net exposure 
time to US of 30 minutes. 1 mL samples were taken after definite time intervals, similar 
to the LFUS experiments with PLA nested microbubbles.  
 
 
125Figure 6.10:  Leakage from 10 mg/mL PMMA nested microbubbles at 5% amplitude. 
 
 
0
500
1000
1500
2000
2500
3000
3500
4000
4500
490 510 530
In
te
n
si
ty
Wavelength [nm]
0sec of US
20sec of US
40sec of US
1min of US
1min20sec of US
2min of US
2min 40sec of US
3min20sec of US
6min40sec of US
10min of US
13min20sec of US
20min of US
26min40sec of US
30min of US
227 
 
                                                                                                                 Fluorescence 
spectrometer analysis of PMMA-microspheres (prepared with 50mg/mL of PMMA 
dissolved in DCM) after sonication with LFUS at 5% amplitude, a duty cycle of 60% and 
a net exposure time of 30 minute. 
 
126Figure 6.11:   Leakage from 50 mg/mL PMMA nested microbubbles at 5% amplitude. 
 
 
 
 
In Figure 6.12 fluorescent images of the PMMA particles before and after sonication are 
displayed to show that the calcein remains nested within the polymer shell. Neither 
sample showed any evidence of calcein leakage. 
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                                                                                                               Fluorescence 
images of PMMA-microspheres co-encapsulating calcein. Image A was taken before 
sonication, while Image B was taken after 45 minutes of experiment (30 minutes of net 
exposure time to LFUS). Images taken with Optical Carl Zeiss Aioskop 2+ Microscope 
(Carl Zeiss AM, Oberkochen, Germany) 
 
 
127Figure 6.12:   PMMA nested microbubbles before and after low frequency sonication. 
  
 
 
 
 
6.3.3 Leakage at Low Frequency: Polymer Shell Cryofracturing 
 
The last approach to achieve leakage from the PLA nested microbubble was to use 
cryofracturing to degrade the polymer in order to achieve calcein leakage after sonication 
by freezing the particles with liquid nitrogen. The nested microbubbles were centrifuged, 
rinsed, and pipetted from the centrifuge tube into a 20 mL scintillation vial. Liquid 
nitrogen was poured into the vial. Liquid nitrogen has a boiling temperature of -196°C, 
while PLA has a glass transition temperature of 60-65⁰C, thus the particles were in the 
crystal phase after treatment with liquid nitrogen.  
 
The first sample was sonicated in continuous mode at 20% amplitude for ten minutes. A 
3mL sample was taken at 0, 5 and 10 min. A gradual degradation of calcein fluorescence 
is seen, but no leakage was observed. Considering the localized high temperature that 
229 
 
                                                                                           Fluorescence spectrometer 
analysis of deep frozen microparticles after 10 minutes of continuous LFUS application at 
20% amplitude. 
LFUS produces, the particle solution reached 0 C after 1 minute of US exposure and 
continued to rise. These experiments did not lead to calcein leakage. It is possible that the 
heat which LFUS produces reversed the frozen state of the PLA shell.   
 
 
 
128Figure 6.13:   Cryo-frozen PLA nested microbubbles at 20 % amplitude.  
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                                                                                           Fluorescence spectrometer 
analysis of deep frozen microparticles after 10 minutes of continuous LFUS application at 
5% amplitude. 
 
129Figure 6.14:  Cryo-frozen PLA nested microbubbles at 5 % amplitude.  
 
 
 
6.3.4 Eliminating Sources of Error in Low Frequency Leakage Study 
 
Re-dissolving PLA Microcapsules in DCM  
None of the attempts to leak calcein from the polymeric nested microbubble were 
successful. To eliminate any sources of error that could have prevent leakage from 
occurring, first a study was conducted to prove that the PLA microcapsules were in fact 
encapsulating calcein. The particles were re-dissolved in a solution of 10 mL of DCM 
and 10mL of PBS. This allows for a positive leakage result if the calcein is nested within 
the polymer shell because the DCM dissolves the PLA shell while the nested hydrophilic 
calcein is released from the shell and un-quenched in aqueous PBS. 
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                                                                                         The particles were re-dissolved in 
a solution of 10 mL of DCM and 10mL of PBS. This allows for a positive leakage result 
if the calcein is nested within the polymer shell because the DCM dissolves the PLA shell 
while the nested hydrophilic calcein is released from the shell and un-quenched in 
aqueous PBS. 
 
The sample was stirred with a magnetic bar for 24 hours. Samples were taken 
periodically after 30 minutes for 4 hours and 30 minutes one final reading after 24 hours. 
From Figure 6.15 leakage was observed after 1 hour. After 2 hours and 30 minutes the 
fluorescence intensity decreased remarkably. This may be due to an interaction between 
DCM and calcein that causes a decrease in fluorescence. Figure 6.16 is a fluorescent 
image of the PLA microcapsules before and after desolvation in DCM. This image shows 
the fluorescing calcein contained within the capsule before desolvation, and no sign of 
polymer spheres after desolvation presumably due to the absence of particles.  
 
 
130Figure 6.15:   Re-dissolved PLA nested microbubbles in DCM and PBS. 
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                                                                                                                          Fluorescence 
images of PLA-microspheres co-encapsulating calcein. Image A was taken right after 
dissolving the microparticles in DCM, while Image B was taken after 24 hours of stirring 
the particles in 10 mL of DCM and 10 mL of PBS. Images taken with Optical Carl Zeiss 
Aioskop 2+ Microscope (Carl Zeiss AM, Oberkochen, Germany) 
 
 
131Figure 6.16:   Fluorescent image of re-dissolved PLA nested microbubbles in DCM and PBS. 
 
 
 
 
 
Heat degradation of calcein 
70 mM Calcein was diluted until its fluorescence intensity reached that of the intensity 
measured for the nested microbubble samples. The concentration of calcein for this 
intensity was approximately 0.12 µM, a relatively low concentration of calcein in PBS. 
To determine the influence of sonication on calcein, 100mL of 0.12 µM calcein in PBS 
was sonicated with a 24 kHz XL2020 sonicator for a net exposure time of 30 min with a 
60% duty cycle and 20% amplitude in Figure 6.17. The temperature of solution was 
recorded throughout the experiment, which reached 50.3⁰C at the conclusion of the 
experiment. To differentiate between the influence of temperature on calcein and the 
effect of sonication, another 100 mL sample of 0.12 µM calcein in PBS was heated up 
slowly on a hotplate to 50.3⁰C. 3mL aliquots were taken from this sample for each 
temperature matching that of the temperature during sonication in Figure 6.18.   
233 
 
                                                             0.12 µM calcein dissolved in PBS and exposed to 
LFUS at 20% amplitude with a 60% duty cycle for a net exposure time of 30 minutes and 
then analyzed with the fluorescence spectrometer. 
                                                                                                 0.12 µM calcein dissolved in 
PBS heated up to 50.8⁰C and then analyzed with the fluorescence spectrometer. 
 
 
132Figure 6.17:   Temperature study of sonicated calcein.
 
 
 
 
133Figure 6.18:   Temperature effect on fluorescence intensity of calcein in PBS.  
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The results shown in Figures 6.17 and 6.18 rule out the possibility that the decrease of 
fluorescence intensity was due to some previously unknown interaction between the 
polymeric nested microbubbles and ultrasound. The supposition which was proved with 
these experiments is that the undesired heat LFUS produces degrades calcein causing a 
decrease in the fluorescence intensity. The temperature was monitored for every 
measurement which reached 50.3⁰C during the experiment. In a separate study, 100 mL 
solution of diluted 70mM calcein in PBS (approximately 0.12 µM calcein in PBS) was 
slowly heated up to 50.3⁰C. Both Figures 6.17 and 6.18 show a gradual decrease of 
fluorescence intensity as temperature increases.  
 
6.3.5 Leakage at High Frequency 
 
If no leakage occurred during high intensity, low frequency ultrasound exposure, one 
would expect an inability to attain leakage at low intensity, high frequency ultrasound as 
well. To confirm, a 1 MHz 7.5 cm focused ultrasound transducer (Olympus NDT, 
Waltham, MA, USA) is used to generate a peak negative pressure (PNP) ranging from 
0.54 to 3.74 MPa. Two experiments are carried out- one at low pressure (0.54 MPa) and 
one at high pressure (3.74 MPa). No leakage is observed in either of these tests from a 
polymeric nested microbubble with a PLA shell. We conclude that, at least for the time 
being, the polymeric nested microbubble is not an effective candidate for drug delivery. 
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                                                                                                                               Polymeric 
nested microbubbles exposed to 1 MHz ultrasound at both low and high pressure 
amplitudes, 0.54 and 3.74 MPa.  
 
134Figure 6.19:   Leakage of polymeric nested microbubbles exposed to high frequency ultrasound.
 
 
 
To eliminate any probability that the calcein concentration was too low to detect leakage, 
the same experiment is carried out at high pressure (3.74 MPa) at three different 
concentration of quenched calcein. No statistically significant decrease in fluorescence 
was detected at any concentration.  
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 2 4 6 8 10 12
%
 L
e
ak
ag
e
Ultrasound exposure time (min)
Xamp=45
Amp=3
236 
 
                                                                                                                                
Polymeric nested microbubbles exposed to 1 MHz ultrasound where the concentration of 
calcein used during formulation is varied to eliminate the probability that the calcein 
concentration was too low.  
 
135Figure 6.20:   High frequency leakage of polymeric nested microbubbles at varying calcein concentrations. 
 
 
 
6.4 Liposomal Nested Microbubbles 
 
If leakage can not be accomplished with a polymer shell, a more flexible membrane is 
used to replace the polymer. In this case we assess liposomal nested microbubbles for 
their ability to leak an aqueous solution from the core upon ultrasound exposure. 
Liposomal nested microbubble formation is described in Chapter 2 but will be briefly 
discussed for this experiment. A double emulsion technique is used to encapsulate 
microbubbles plus calcein, a self-quenching fluorophore, within the liposome shell. 
Liposomal nested microbubbles were prepared with an Egg-PC/ cholesterol/ triolein lipid 
mixture to form the unilamellar vesicle using the water/oil/water (W1/O/W2) emulsion 
technique [109, 110]. A solution of 0.5 mL of the previously described microbubbles and 
0.5 mL of 0.1 mM calcein solution (internal aqueous phase W1) was added to 1 mL of a 
lipid solution containing 733.5 μL of chloroform, 185 μL of 25 mg/mL Egg-PC in 
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chloroform, 50.5 μL of 50 mg/mL cholesterol in chloroform, and 31.0 μL of 100 mg/mL 
triolein in chloroform (intermediate organic phase O). The solution of 
microbubbles/calcein and lipid mixture was homogenized with the Polytron PT3100 
(Kinematica Inc, Lucerne, Switzerland) for 1 minute. The speed of the homogenizer was 
varied between 5000 rpm and 15000 rpm to control the size of the unilamellar vesicle. 
After 1 minute, the solution was added to 8 mL of 2% PVA in water (outer aqueous 
phase W2) and further homogenized for 2 minutes at the same speed as in the previous 
step. After homogenization of solution, the contents were added to 8 mL of the W2 phase 
and placed on a magnetic stir plate at 300 rpm for 24 hours so that the chloroform 
evaporates from the solution, leaving aqueous phase W1 nested within the lipid bilayer. 
External calcein was quenched with 50 μL of 40 mM CoCl2.  
 
The average diameter of the liposome was varied systematically by adjusting the 
homogenizing speed. The size distribution was obtained from a Coulter Multisizer II 
(Beckmann-Coulter, Brea, CA) for a 50 μL sample of nested microbubbles diluted by a 
factor of 100. These results are shown below in Table 6.1.  
 
9Table 6.1:   Size distribution of liposomal nested microbubbles. 
Homogenizer 
Speed (RPM) 
Liposome Diameter (μm)  
(Mean ± SD) 
Concentration of 
nested MB  
(Particles/mL) 
5000 6.04 ± 1.38 5.42x107 
7500 5.78 ± 1.07 7.87x107 
10000 5.26 ± 1.01 9.04x107 
12500 5.01 ± 0.83 9.32x107 
15000 4.74 ± 0.76 9.60x107 
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The following results are for liposomes with an average diameter of 4.74 μm unless 
otherwise stated. The percent of calcein remaining within the liposomes for amplitudes 5-
45 are between 30 and 60% at steady state. The leakage behavior (rate of calcein leakage) 
seems to be initially controlled by inertial cavitation of the microbubbles. The rate of 
leakage is slower at low amplitudes where less cavitation events are detected, and faster 
at higher amplitudes where most of the microbubbles are inertially cavitated. The amount 
of calcein leakage and ultrasound exposure required for steady state behavior does not 
seem to be correlated with ultrasound amplitude. Using an ANOVA test in conjunction 
with Tukey pairwise comparisons, it is confirmed that leakage after 1000 waveforms of 
ultrasound exposure for amplitudes 3-14 are not statistically different, demonstrating that 
leakage seems to be correlated with inertial cavitation events. After 6000 waveforms, a 
Tukey pairwise comparison test confirmed that there is no correlation between the 
amplitude and percent of calcein leakage. Another study proves that at both high and low 
amplitude, leakage only persists during ultrasound exposure. When fluorescent 
measurements were taken after ultrasound is turned off, leakage ceases proving that the 
pores forming in the membrane that allow for release of the liposome contents during 
ultrasound exposure are not permanent damage to the membrane. Another interesting 
phenomenon of the microbubble/liposome formulation is that increasing the microbubble 
concentration above 4x108 MB/mL does not increase calcein leakage, but decreasing 
concentration to 2x108 does in fact increase leakage. This is consistent with previous 
studies of nested microbubbles (although the microbubbles were nested within a polymer 
shell) that suggest less microbubbles within the shell allow for greater microbubble 
expansion which leads to more inertial cavitation events, and could be the explanation for 
239 
 
                                                                                                                       Fluorescence 
measurements for 20 kHz continuous ultrasound exposure over the duration of 45 
minutes. Leakage with and without microbubbles followed the same profile. The sample 
was kept in an ice bath to ensure that the temperature remained constant. This avoids the 
possibility that liposome poration is caused by a thermal trigger [3]. 
an increase in leakage at lower microbubble concentrations. It is also seen that liposome 
diameter affects leakage behavior, although no clear trend emerges between liposome 
diameter and steady state leakage/initial leakage behavior.  
 
6.4.1 Leakage at Low Frequency 
 
A low frequency study using a 24 kHz sonicator was used to induce leakage of the 
liposomes with and without microbubbles. At an ultrasound intensity of 2.2 W cm-2 it 
was found that complete rupture of the liposome occurred within three minutes. Low-
frequency ultrasound is known to induce inertial cavitation at relatively low intensities, 
even in the absence of microbubbles [165], and Figure 6.22 confirms this as identical 
leakage behavior was found for samples with and without microbubbles.  
 
 
136Figure 6.21:   Leakage from liposomal nested microbubbles exposed to 24 kHz ultrasound.
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The fact that low frequency (high intensity) ultrasound can rupture liposomes without 
microbubbles points to generation and activation of gas bodies in the medium, which can 
serve as cavitation nuclei [166]. While low frequency ultrasound is useful in some 
clinical applications, high frequency ultrasound is more desirable for a controlled 
delivery application. That is, one would prefer to avoid nucleation and cavitation in the 
bodily fluids. As cavitation seems necessary for release, the question then becomes 
whether one can reproduce the low frequency results of Figure 6.22 at high frequency.  
 
6.4.2 Leakage at High Frequency: Variation of Ultrasound Pressure 
 
What makes leakage possible at high frequency is the presence of microbubbles, which 
become essential for release. As shown in Figure 6.23, no leakage was observed for 
liposomes without microbubbles (as was the case for no ultrasound). The results of 
Figure 6.23 are for liposomes with an average diameter of 4.74 μm unless otherwise 
stated. The percent of calcein remaining within the liposomes for amplitudes 0.54 to 3.74 
MPa fall between 36.57% and 62.41% respectively at steady state.  
 
241 
 
                                                                                                                      Graph showing 
the results of fluorescence measurements for 1 MHz ultrasound transducer over an 
exposure time of 45 min. Note that the axis is “US exposure time” which is true for all 
samples except the “No US” sample. For this sample, no ultrasound was applied and the 
fluorescence is measured every 200 seconds, but only exposed to atmospheric conditions. 
 
137Figure 6.22:   Leakage from liposomal nested microbubbles exposed to 1 MHz ultrasound.  
    
 
 
 
 
The results confirm that unless both microbubbles and ultrasound are present, no leakage 
occurs; thus leakage results from microbubble acoustic activity. Variation in the 
fluorescence value for the samples without microbubbles and without ultrasound is due to 
non-homogeneity in the size distribution and concentration of liposomes that existed in 
the aliquot of sample used for fluorescence detection, as well as fluctuations caused by 
instrumental error. Applied pressure ranges from 0.54 MPa to 3.74 MPa and release from 
the liposome core is accomplished at each pressure when microbubbles are present. The 
leakage behavior at each pressure is similar in profile, but initial leakage rate is 
dependent on peak negative pressure. 
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                                                                                                       Liposomal nested 
microbubbles a) fluorescence image before ultrasound exposure where calcein is 
fluorescing within the liposome, but no leakage has occurred so the fluorescence remains 
contained and b) same sample as shown in a) but without fluorescence to show that 
microbubbles exist within the liposome. 
 
Fluorescent image of liposomal nested microbubbles a) after ultrasound exposure of 2 
MPa where calcein is no longer fluorescing within the liposome, but the surrounding 
solution now shows fluorescence (calcein has leaked from the solution but has not been 
quenched with CoCl2) and b) and image of the same phenomena but with a different 
sample.   
 
 
 
 
138Figure 6.23:   Microscopic image of liposomal nested microbubbles with calcein.
 
 
 
 
 
139Figure 6.24:   Microscopic image of liposomal nested microbubbles with calcein after ultrasound exposure. 
 
 
 
  
 
 
 
a) b) 
a) b) 
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                                                                                           Liposomal nested microbubbles 
a) after exposure to ultrasound PNP of 0.8 MPa where the microbubbles nested within 
liposomes survive but most of the un nested microbubbles outside of the shell are gone, 
b) after exposure to ultrasound PNP of 50 kPa where microbubbles exist inside and 
outside of liposome shell, c) after exposure to ultrasound PNP of 2 MPa where 
microbubbles within liposomes are destroyed and only remnants of lipids remain 
(background is other liposomes out of focus), and d) after exposure to ultrasound PNP of 
0.8 MPa where microbubbles exist inside of the liposome, while most outside of the shell 
have been destroyed. 
 
Figure 6.26 shows additional microscopic images of liposomal nested microbubbles 
before and after ultrasound exposure.  
 
 
140Figure 6.25:   Liposomal nested microbubbles after ultrasound exposure.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) b) 
c) d) 
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                                                                                                          A dequenching assay is 
used where calcein is nested within the liposome above its self-quenching concentration. 
The change in fluorescence is too small to detect, likely owing to the fact that separating 
excess calcein from the liposomes is difficult.  
Dequenching Assay 
In the liposomal nested microbubble study, cobalt chloride is used to quench calcein once 
the calcein leaves the liposomal core and makes contact with the external solution. In an 
attempt to recreate the leakage results with a dequenching assay as oppose to a quenching 
assay would increase the reliability of the study. In a dequenching assay, as was used for 
the polymeric nested microbubble study discussed in Section 6.3, calcein is nested within 
the liposome above its self-quenching concentration so that it does not fluoresce while in 
the liposome, and calcein leakage is exemplified by an increase in fluorescence intensity 
when the calcein is no longer quenched in the external solution. However, the study done 
with a calcein dequenching assay shows no change in fluorescence in Figure 6.27, most 
likely due to the fact that the change in fluorescence is too small to detect.  
 
 
141Figure 6.26:   Dequenching assay for leakage from liposomal nested microbubbles. 
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6.4.3 Leakage at High Frequency: Temporal Release Study 
 
For clarification of the interactions between microbubble oscillations and membrane 
disruption, it is necessary to differentiate between dilation/ temporary induced poration, 
where leakage of the liposome content occurs only while ultrasound is being applied, and 
persisting pore formation, where we would continue to see leakage of the fluorescent dye 
after ultrasound is removed. For this study, ultrasound was repeatedly applied for 400 sec 
at both low (PNP=0.54 MPa) and high (PNP=3.74 MPa) pressure and then removed for 
120 sec. During the 120 sec rest interval the ultrasound transducer is removed and the 
liposomes are allowed to stir in the sample chamber without ultrasound exposure. The 
application and subsequent removal was repeated four times for a total of 1600 sec of 
ultrasound exposure. Fluorescence was measured before and after each interval of 
ultrasound application. Figure 6.28 shows that at the lower applied pressure of PNP=0.54 
MPa, leakage ceases with removal of ultrasound and the fluorescence value does not 
change during the 120 seconds between intervals of ultrasound application. At the higher 
pressure amplitude of PNP=3.74 MPa, leakage continues to decrease following the 
removal of ultrasound, resulting in a drop in fluorescence between ultrasound 
applications.  
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                                                                                            Ultrasound is applied with a 1 
MHz focused transducer. The sample is subjected to 400 sec of ultrasound exposure.  At 
this point, ultrasound is turned off for 120 seconds to determine whether the percent of 
fluorescence remaining will continue to decrease or remain the same during this period 
which gives insight into the type of membrane disruption at each pressure. This process is 
repeated for a total of four periods of ultrasound application and subsequent removal. One 
sample is tested at low pressure (0.54 MPa) where stable cavitation is occurring, while the 
other sample is done at high pressure (3.74 MPa) where 35.62 % ± 6.32 % of the 
microbubble population experiences inertial cavitation. 
 
 
142Figure 6.27:   Temporal release study for liposomal nested microbubbles.
 
 
 
 
 
 
 
 
 
This study is also shown as a plot of fluorescence remaining in liposome as a function of 
ultrasound exposure time in Figure 6.29. 
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                                                                                             The percent fluorescence 
remaining in the liposome is shown as a function of ultrasound exposure time. After 800 
seconds, the ultrasound exposure is turned off for two of the samples. Leakage ceased 
immediately at low pressure, but continued after ultrasound was turned off at high 
pressure.  
 
143Figure 6.28:   Temporal release profile for liposomal nested microbubbles.
 
 
 
 
6.4.4 Leakage at High Frequency: Varying Microbubble Concentration 
 
Changing ultrasound pressure amplitude is not the only factor in this system that has an 
effect on the type of cavitation experienced by the microbubble. Theoretical work 
involving a microbubble oscillating in the center of a rigid tube has led to predictions that 
a decrease in magnitude of microbubble oscillation and a change in resonance frequency 
will occur due to the restriction from a tube with a diameter of the same order of 
magnitude as the microbubble [135, 138, 139]. Accordingly, it is reasonable to think that 
the interaction between two microbubbles would also suppress oscillations as shown 
experimentally with two UCA microbubbles trapped near a wall in the work by Garbin et 
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Samples are exposed to 1 MHz ultrasound where the only variation between samples is 
the concentration of microbubbles used during preparation. The sample is exposed to an 
ultrasound PNP of 1.54 MPa 
al [134]. Therefore a smaller number of microbubbles within the liposome would lead to 
greater oscillations and the potential for increased membrane disruption. 
 
Our typical recipe for microbubbles nested within the liposomes requires a microbubble 
concentration of 5x108 MB/mL. To determine if the amount of microbubbles used in the 
recipe influences the leakage behavior of the sample, the concentration of microbubbles 
used for each recipe was varied between 2x108 and 8x108 MB/mL and exposed to an 
ultrasound PNP of 1.54 MPa. It is assumed that a greater concentration of microbubbles 
used in the recipe results in an increased number of microbubbles nested within the 
liposome, although the encapsulation efficiency remains unknown. 
 
 
144Figure 6.29:   Leakage from liposomal nested microbubbles with varying microbubble concentration.  
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                                                                                                                          Samples are 
exposed to 1 MHz ultrasound where the only variation between samples is the diameter of 
nesting shell used during preparation. The sample is exposed to an ultrasound PNP of 
1.54 MPa 
Increasing the microbubble concentration from 4x108 to 8x108 MB/mL has no effect on 
leakage behavior, but below this at a concentration of 2x108 MB/mL, a 13.66% decrease 
in fluorescence is observed at the conclusion of the experiment. This is consistent with 
increased activity found in other nested microbubble formulations for a decrease in 
microbubble concentration [112].  
 
If microbubble repulsions affect the leakage profile as demonstrated in Figure 6.30, then 
we may also hypothesize that the repulsion between the liposome wall and microbubble 
wall will also affect the leakage profile. To investigate further, the average diameter of 
liposomes is varied between 4.74 and 6.04 μm by changing the homogenizer speed while 
keeping the microbubble concentration constant at 5x108 MB/mL and exposing the 
sample to an ultrasound PNP of 1.54 MPa. 
 
 
145Figure 6.30:   Leakage from liposomal nested microbubbles with varying liposome diameter. 
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                                                                                                       Combinations of 
microbubble concentration to calcein to PBS are examined. 
 
Upon inspection of Figure 6.30, we see that the liposomes with an average diameter of 
5.01 μm and 5.26 μm give maximal leakage out of the size distributions examined which 
suggests that there may be an optimal ratio of microbubble diameter to liposome 
diameter.   
 
The ratio of microbubbles to calcein to PBS also affects the leakage profile. Figures 6.31 
and 6.32 show results for different combinations of these concentrations. 
 
 
146Figure 6.31:   Leakage profile of liposomal nested microbubbles at low MB conc.
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                                                                               Combinations of microbubble 
concentration to calcein to PBS are examined. 
 
 
147Figure 6.32:   Leakage profile of liposomal nested microbubbles.
 
 
6.4.5 Influence of Transducer Focal Region on Leakage Profile 
 
It was observed during experimentation that if the transducer was placed less than 7.5 cm 
from the bottom of the beaker so that the focal region of the transducer is not within the 
sample chamber, the amount of leakage taking place greatly decreases. This is evidenced 
in Figure 6.34 which shows that most of the leakage from the liposomes takes place in 
the focal region of the transducer. In this study, the transducer was placed more than 7.5 
cm from the bottom of the tube for the first 1000 waveforms then moved so that the focal 
region of the transducer was no longer in the sample chamber. At this point, there is a 
cessation of leakage after 1000 waveforms. This confirms that leakage only occurs in the 
focal region. 
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                                                                                                                                          For 
the first 1000 waveforms the transducer is placed so that its focal region is within the 
sample. At this point the transducer is moved closer to the bottom of the sample chamber 
(less than 7.5 cm away) so that the focal region is no longer in the sample, where we see 
that leakage ceases. 
 
148Figure 6.33:   Influence of transducer focal region on leakage profile of liposomal nested microbubbles.  
 
 
 
 
 
A coulter counter was used to count the number of surviving particles at ultrasound 
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A coulter counter was used to count the number of surviving particles at ultrasound 
exposure time. It was confirmed there is no statistically significant change in liposome 
size before and after ultrasound intervals. 
 
 
149Figure 6.34:   Particle count for liposomal nested microbubbles as a function of ultrasound exposure time.  
 
 
 
It was confirmed there is no statistically significant change in liposome size before and 
after ultrasound (not shown). This suggests that the only aspect of the system that varies 
with ultrasound peak negative pressure is the behavior of the microbubble. 
 
6.4.6 Stability of Liposomes 
 
To test the stability of the solution, leakage studies were performed 3 hours and 24 hours 
after formulation. No difference was found between leakage for “wet” or “dry” liposomes 
(with and without chloroform) which suggests the liposomes are stable at any point up to 
24 hours after formulation. 
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                                                                    Liposomes that were tested 3 hours after 
formulation and 24 hours after formulation both gave similar leakage profiles, suggesting 
the sample is stable up to 24 hours after formulation. 
                                                                                                                                                          
 
150Figure 6.35:   Stability of liposomal nested microbubbles.
 
 
 
6.4.7 Statistical Analysis 
 
Data is presented as mean ± standard deviation. Statistical analysis was performed with a 
one-way ANOVA with significance taken to be P<0.05 using Minitab 17 Statistical 
Software to detect statistically significant differences between means. A Tukey’s multiple 
comparison test was used to determine which of the means are statistically different.  
Fluorescence measurements before and after ultrasound exposure were compared with 
negative controls.  
 
Using an ANOVA test in conjunction with Tukey pairwise comparisons, it is confirmed 
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cavitation events. After 6000 waveforms, a Tukey pairwise comparison test confirmed 
that there is no correlation between the amplitude and percent of calcein leakage. 
 
Minitab was used to run the statistical tests. An example of the results is shown below for 
a one way ANOVA test and Tukey test for the fluorescence remaining after 1000 
waveforms of ultrasound exposure for each pressure amplitude. This was done to 
determine whether the difference in values were statistically significant.  
 
One-way ANOVA: 
Method 
Null hypothesis: All means are equal 
Alternative hypothesis: At least one mean is different 
Significance level: α = 0.05 
Equal variances were assumed for the analysis. 
 
Factor Information 
Factor Levels Values 
Amplitude 8 3, 5, 8, 14, 24, 30, 37, 45 
 
 
Analysis of Variance 
Source DF Adj SS Adj MS F-value P-value 
Amplitude 7 0.220619 0.031517 38730.33 0.000 
Error 8 0.000007 0.000001   
Total 15 0.220626    
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Model Summary 
S R-sq R-sq (adj) R-sq (pred) 
0.0009021 100.00% 99.99% 99.99% 
 
 
Means 
Amplitude N Mean StDev 95% CI 
3 2 0.001515 0.000247 (0.000044, 0.002985) 
5 2 0.002652 0.000052 (0.001181, 0.004123) 
8 2 0.004693 0.000626 (0.003222, 0.006163) 
14 2 0.001661 0.000037 (0.000190, 0.003132) 
24 2 0.245195 0.000491 (0.243724, 0.246665) 
30 2 0.216027 0.000651 (0.214556, 0.217497) 
37 2 0.25701 0.00198 ( 0.25554,  0.25849) 
45 2 0.227399 0.001213 (0.225929, 0.228870) 
 
Pooled StDev = 0.000902085 
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Tukey Pairwise Comparisons:  
 
Grouping Information Using the Tukey Method and 95% Confidence 
 
 
Means that do not share a letter are significantly different. 
  
6.5 Temporary and Permanent Poration of Liposome Membrane 
 
This study shows conclusively that focused ultrasound can be used to trigger release of 
the internal aqueous contents of a liposome. However, ultrasound alone is not sufficient 
to trigger release at clinically relevant (high frequency ~1-10 MHz) conditions. Rather, 
content release is achieved via the presence of microbubbles nested inside of the 
liposome’s aqueous core; ultrasound induces microbubble oscillations which in turn 
facilitate release. A question naturally arises, namely, what is the mechanism of release?  
 
It is well documented that cavitating microbubbles cause membrane disruption as de Jong 
first disclosed with real-time, ultrafast transmission microscopy that the interaction 
Amplitude N Mean Grouping 
37 2 0.25701 A 
24 2 0.245195 B 
45 2 0.227399 C 
30 2 0.216027 D 
8 2 0.004693 E 
5 2 0.002652 E 
14 2 0.001661 E 
3 2 0.001515 E 
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between microbubbles and cell membrane was responsible for membrane poration [92, 
93, 166-172]. Focused ultrasound can cause size oscillations in injected or existing 
micro-bubbles at a targeted location within the body. Microbubble oscillations are 
categorized as either stable or inertial cavitation and the type of cavitation determines the 
extent of membrane disruption. Non-inertial cavitation, or stable cavitation, is present 
when using low intensity ultrasound. Such stable oscillations are able to gently push and 
pull the membrane, creating a liquid flow around the microbubbles [173]. When these 
oscillating microbubbles are in close vicinity of cell membranes, the membrane will 
experience shear stress. The level of shear stress is largely dependent on the ultrasound 
parameters and can, according to simulations, range between 100 Pa and 1000 Pa [174]. 
The mechanical effects of stable cavitation induce moderate and reversible changes at the 
cellular level, including opening cell walls and loosening tight junctions [167]. This 
increased permeability in the membrane allows a drug or drug mimic to enter the 
membrane, or in this case, be released from the interior of a liposome as long as the 
oscillating microbubbles are present [172]. This phenomenon is consistent with transient 
poration and/or dilation of the vesicle bilayer.  
 
The drug mimic, calcein, used in this study is a fluorescent dye with a reported molecular 
radius of 0.65 nm [175]. If calcein is diffusing through a pore in the membrane, the pore 
need not be permanent. The diffusion length of calcein is 28.02 μm for the negative 
amplitude of one ultrasound pulse which is orders of magnitude larger than the thickness 
of a lipid bilayer. Generally, pore sizes obtained with rather modest acoustic pressures 
were reported from several tens of nanometers to a few hundreds of nanometers [166]. 
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                                                              Cartoon illustration depicting a) dilation of the lipid 
bilayer and b) poration of the lipid bilayer that is either temporary lasting only while 
ultrasound is applied or permanent damage to the liposome bilayer believed to be caused by 
inertial cavitation of the microbubble. (Source: Jennifer Bing, Program Coordinator of 
Department of Chemical and Biological Engineering at Drexel University. 2014) 
The size of calcein presents no obvious complications for these studies, and diffusion 
through membrane pores can not be ruled out.  
 
If pressure amplitude is sufficiently high and above a certain threshold level, inertial 
cavitation is observed. When a collapsing microbubble is located close to a surface like a 
membrane, an asymmetrical collapse takes place, and results in the formation of a liquid 
jet towards the nearby surface [159]. It has been shown that these shock waves and 
microjets create very high forces which cause either permanent poration due to large 
lesions in the cell membrane or cell lysis in some cases due to the turbulence associated 
with bubble translation. Figure 6.37 a) illustrates dilation of the membrane while Figure 
6.37 b) illustrates poration, either temporary or permanent.  
 
 
151Figure 6.36:   Dilation and poration of a lipid bilayer.  
 
 
 
 
 
a) Dilation b) Poration  
(temporary or permanent) 
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Figure 6.23 shows the results of a set of studies done for liposomes with an average 
diameter of 4.74 μm where the percent of calcein remaining within the liposomes is 
observed for peak negative pressures between 0.54 and 3.74 MPa. The amount of release 
is not a linear function of ultrasound pressure; rather, the rate of calcein leakage seems to 
be controlled by the type of cavitation of the microbubble. It appears that two regimes 
exist with a threshold between 1.26 and 2.06 MPa. Observations of thresholds associated 
with cavitation-induced biologic effects and other ultrasonic phenomena are not unusual 
and are very well documented [35, 126, 159, 166, 176]. For the purpose of this study, it 
has been confirmed that at the lowest peak negative pressure (PNP=0.54 MPa) 0.52 % ± 
5.69 % of the sample is inertially cavitating and at the highest pressure (PNP=3.74 MPa) 
35.62 % ± 6.32 % of the sample is inertially cavitating. A detailed analysis of this 
cavitation detection method that was used can be found in Mleczko, et al [127]. 
 
A one-way ANOVA test was done in conjunction with Tukey pairwise comparisons to 
determine with 95% confidence whether the percent of fluorescence remaining in the 
liposome after 200 seconds of ultrasound exposure for peak negative pressures of 0.54 to 
1.26 MPa are statistically different. It was found that there is no statistical difference in 
this “low pressure” regime between samples at this time point, demonstrating that the 
leakage profile seems to be correlated with stable cavitation occurring in all low intensity 
experiments so long as the pressure amplitude is below the inertial cavitation threshold.  
There is also no statistical difference in the fluorescence measurements after 200 seconds 
from the “high pressure” regime with peak negative pressures between 2.06 and 3.74 
MPa. This study seems to agree with two separate mechanisms differentiating between 
261 
 
damage caused by stable cavitation versus inertial cavitation. The rate of decrease in 
fluorescence is slower (-3.148%) at 0.54 MPa for the first 1000 seconds of 
experimentation where less inertial cavitation events are detected and faster (-4.877%) at 
3.74 MPa where 35.62% of the microbubbles undergo inertial cavitation. Neither the 
amount of calcein released from the vesicle as well as ultrasound exposure time required 
to reach steady state do not seem to be correlated with ultrasound amplitude.  
 
We deduce that leakage is caused by dilation, poration and/or catastrophic rupture of the 
membrane, where the extent of membrane disruption, either temporary or permanent, is 
dependent on acoustic pressure and therefore the type of cavitation- stable or inertial- that 
the microbubble undergoes. If leakage is due to dilation/poration caused by stable 
cavitation then we expect the temporal release profile to display a decrease in 
fluorescence remaining within the liposome during ultrasonic exposure then remain 
constant when ultrasound is removed for the duration of the experiment. If leakage is 
caused by permanent poration/rupture of the liposome due to inertial cavitation then we 
expect a decrease in fluorescence remaining within the liposome even after ultrasound is 
removed from the sample chamber.  
 
To determine whether membrane disruption is permanent or temporary, ultrasound was 
turned on and off for intervals of 400 sec of ultrasound exposure followed by 120 sec of 
rest. Fluorescence was measured before after each interval of ultrasound application to 
determine if the transport of calcein from the interior of the liposome to the external 
solution would continue when ultrasound was removed. The study was done at 3.74 MPa 
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and 0.54 MPa to determine if results were pressure dependent. Figure 6.28 proves that at 
low amplitude (0.54 MPa), leakage only persists during ultrasound exposure. When 
fluorescent measurements were taken after ultrasound is removed, leakage ceased 
immediately proving that the pores forming and/or dilation of the membrane that allow 
for release of the liposome contents during ultrasound exposure are not permanent 
damage to the membrane. Fast resealing of cell membrane porations are reported to occur 
in the order of milliseconds to seconds [177-179] after switching off the ultrasound at 
relatively low pressures. The fact that cell membrane permeabilization is rapidly 
decaying indicates that pores exist as longs as the oscillating microbubbles are present 
[93, 169, 172, 180]. The pores forming in the membrane that allow for release of the 
liposome contents during ultrasound exposure are not permanent damage to the 
membrane. 
 
However, Yudina et al. demonstrated that the cellular uptake of cell-impermeable small 
compounds persisted up to 24 h with a half-life of 8 h [92] at higher amplitudes so we 
also measured fluorescence of the sample for the highest peak negative pressure used in 
this study (3.74 MPa). Studies at high amplitude (PNP=3.74 MPa) show that leakage 
continues to occur during each period where ultrasound was turned off. This could be 
evidence that the disruption to the membrane is more extreme at these high pressures so a 
fraction of the sample is either destroyed or permanently porated due to inertial 
cavitation. The damaged vesicles continue to release their contents even during the fourth 
period of ultrasound removal (after 1600 sec of ultrasound application). The data from 
the temporal release study agrees with the inertial cavitation study as evidenced by 
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fluorescence decrease both during ultrasound application and while ultrasound is turned 
off. 35.62% of the sample is inertially cavitating, which likely owes to the decrease in 
fluorescence during periods of “rest” (result of permanent damage) while the remaining 
fraction of the sample experiences temporary membrane disruption and allows for release 
when ultrasound is reapplied. 
 
6.6 Conclusion 
 
Polymeric nested microbubbles 
No leakage of hydrophilic fluorescent calcein was achieved with neither a PLA nor 
PMMA polymeric shell. After studying the influence of low-frequency ultrasound on 
calcein, a degradation effect of high temperatures above 30°C on calcein fluorescence 
was observed. For this reason the low-frequency ultrasound parameters were optimized in 
order to avoid these high temperatures by applying the US at lower amplitudes. The two 
approaches to achieve LFUS triggered leakage of polymer microspheres studied herein 
seem to be promising. In regard to UV light degradation longer exposure times should be 
considered and particularly a UV lamp with higher power, at least 20-fold the lamp used 
in this study. 
 
Liposomal nested microbubbles 
Microbubble concentration to liposome diameter ratio may play a role when determining 
the desired leakage rate and final percentage of calcein remaining in the liposome, but 
further studies are needed to confirm this. While stably cavitating microbubbles need to 
be within 1 microbubble diameter from the cell to affect the membrane [176], the effects 
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of inertially cavitating microbubbles reach over a larger distance. However, it was 
calculated that the maximal distance between microbubble and cell membrane should not 
exceed the microbubble diameter to have an effective impact on the cellular membrane 
[167].  
 
Figures 6.30 and 6.31 were used to determine whether the microbubble concentration and 
liposome diameter affect leakage behavior. The identical profiles for both 5.01 and 5.26 
μm suggest that there may an ideal range of liposome size- if not an optimum- that allows 
for the most leakage when exposed to ultrasound. This is consistent with previous studies 
of nested microbubbles (although the microbubbles were nested within a polymer shell) 
that suggest a smaller concentration of microbubbles within the shell allows for greater 
microbubble expansion, leading to an increase in inertial cavitation events. This could 
explain an increase in leakage at lower microbubble concentrations. We suspect there is a 
set of conditions that allow for maximum leakage and the highest leakage rate, which is 
dependent on the type of cavitation event (pressure dependent), liposome formulation, 
liposome diameter, and microbubble concentration. Microbubble size also presumably 
plays a role in the leakage behavior, but the microbubble samples used during 
experimentation had a Gaussian size distribution following formulation and were not 
further separated or filtered by size.  
 
A one-way ANOVA combined with a Tukey pairwise comparison confirm that for 
concentrations 4x108 to 8x108 MB/mL there is no statistically significant difference in the 
percent fluorescence remaining after 1000 waveforms, but as seen on the graph, 2x108 
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MB/mL gives a different leakage profile. This concentration of microbubbles resulted in 
the most leakage which suggests that the microbubbles inside of the liposome cause 
sonoporation, not the ones existing outside of the liposome. 
 
An important aspect of this research is the relationship between the cavitation event and 
membrane disruption. Two regimes exist during the initial membrane disruption caused 
by cavitating microbubbles. A faster release rate, as well as permanent membrane 
damage is seen for samples exposed to high pressure (2.06 to 3.74 MPa) 1 MHz 
ultrasound transducer. A slower release rate and dilation/temporary poration is 
characteristic of stable cavitation for low pressure studies (0.54 to 1.74 MPa). Further 
research will include a thorough study of the type of cavitation (inertial versus stable) at 
each peak negative pressure. It is believed that at low pressures, stable cavitation within 
these liposomes occurs up to 1.26 MPa which explains why the leakage behavior for 
samples at and below this pressure follow one profile, while leakage for pressures above 
this follow a different profile- one with a sharper initial decrease in fluorescence 
remaining within the liposome. It would be reasonable to assert that inertial cavitation is 
causing larger, more permanent membrane damage in accordance with research done by 
Lentacker et al. which results in a greater initial loss in fluorescence [166]. A detailed 
study evaluating the fraction of sample undergoing inertial cavitation for each peak 
negative pressure is imperative to understanding this novel drug delivery vehicle.  
 
Future work may also include using different size molecules for the fluorescence 
quenching assay to determine pore size at each pressure amplitude. Generally speaking, 
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pore sizes which have been reported as a consequence of inertial cavitation (hundreds of 
nanometers to micrometer range) are larger than pores reported during stable cavitation 
(few nm to hundreds of nanometers). Moreover, pore size has been shown to correlate 
with acoustic pressure; higher acoustic pressures result in larger microbubble oscillations 
and larger pores [181] and [182]. It is clear that the liposome shell, microbubble 
concentration, and ultrasound pressure amplitude all impact the leakage behavior of the 
nested microbubbles which gives insight into the inertial effect this has on the physics of 
the system. This study expands on the advantages of nested microbubbles as triggered 
drug delivery vehicles and provides insight as to their mechanism(s) of action. 
 
 
 
CHAPTER 7: ULTRASOUND INDUCED PHOSPHATIDYLSERINE EXPOSURE 
 
7.1 Introduction 
 
Endothelial microparticles (MP) are complex vesicular structures shed from activated or 
apoptotic endothelial cells [183]. They play a significant role in coagulation, 
inflammation, endothelial function, and angiogenesis, contributing to the progression of 
vascular diseases [184]. The flopping of phosphatidylserine (PS) to the outer leaflet of the 
plasma membrane is the key event that will ultimately lead to the shedding of 
procoagulant MP from activated or apoptotic cells [185]. Apoptotic bodies are larger than 
MP and are characterized by externalized PS and, unlike MP, a permeable membrane 
facilitating propidium iodide staining of the nuclear material they contain [184]. 
Apoptosis is a crucial pathway for a variety of biological events, including physiology of 
mammalian development and surveillance against tumors or other malfunctioning cells.  
 
When cells are activated, or enter apoptosis, lipid asymmetry can be disturbed by other 
lipid transporters (scramblase) that shuttle phospholipids between the two monolayers. 
This exposes phosphatidylserine (PS) at the cells’ outer surface. Since PS promotes blood 
coagulation, defective scramblase activity upon platelet stimulation causes a bleeding 
disorder (Scott syndrome). PS exposure also plays a pivotal role in the recognition and 
removal of apoptotic cells via a PS-recognizing receptor [186]. Furthermore, expression 
of PS at the cell surface can occur in a wide variety of disorders [187]. In this work, 
sonication treatment is used in conjunction with an ultrasound contrast agent to determine 
the effect on endothelial cells.  Surface exposure of phophatidylserine (PS) was detected 
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by adding annexin V-FITC to the cells. Propidium iodide was added to distinguish 
between early apoptotic cells with PS-exposure and necrotic or late apoptotic cells. 
 
This work was performed under Prof. Dr.-Ing. Georg Schmitz and Dr.-Ing. Stefanie 
Dencks at Ruhr-Universität Bochum in conjunction with a study abroad program through 
a collaboration between Drexel University and Ruhr-Universität Bochum. 
 
7.2 Materials  
 
Cell culture 
Human umbilical vein endothelial cells (HUVECs) were purchased from PromoCell 
(Heidelberg, Germany) in passage 1 and only used at low passage numbers. Cells were 
cultured in MCDB 131 medium supplemented with 20 % FCS (fetal calf serum), 2 mM 
glutamine (Gibco, Eggenstein, Germany), 50 μg/ml ECGS (endothelial growth 
supplement), 5 U/ml Heparin (Sigma, Taufkirchen, Germany), and maintained at 37°C in 
5 % CO2. All cell culture dishes were coated with 0.2 % gelatine.  
 
Reagents 
SonoVue (Bracco S.p.A., Milano, Italy) is an ultrasound contrast agent consisting of 
microbubbles which contain a sulphur hexafluoride (SF6) gas, stabilized by a membrane 
of an amphiphilic phospholipid monolayer. The microbubble diameter ranges from 1 to 
10 μm with a mean size of 2.5 μm (Greis 2004). SonoVue dispersion was compounded 
according to the manufacturer´s instructions, resulting in a final concentration of 16*106 
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microbubbles/100 μl. Lastly, the improvement of coagulation activity by the exposure of 
PS on endothelial cells was studied using the factor X activation assay. 
 
7.3 Experimental Setup 
 
Ultrasound exposure 
For ultrasound treatment, HUVECs were grown in gelatine-coated cell containers 
(μSlides 0.4 Luer ibiTreat, ibidi, Martinsried, Germany). 1,2*105 cells were seeded in a 
volume of 240 μl and cultured for 48 hours in a humidified atmosphere with 5 % CO2 at 
37°C. Immediately before sonication, medium was replaced by 300 μl fresh MCDB 131 
medium containing 30 μl SonoVue solution; the cell container was sealed hermetically. 
 
Ultrasound setup 
The set-up consisted of a focused ultrasound transducer (H-102; Sonic Concepts Inc., 
Bothell, WA, USA) with a center frequency of 1.1 MHz, an active diameter of 64.0 mm 
with a central opening of 20 mm, and a geometric focal length of 62.6 mm. The 
transducer is connected using its impedance matching network. All signals were 
generated with an arbitrary waveform generator (33250A; Agilent Technologies, Santa 
Clara, CA, USA) and a power amplifier (150A250; Amplifier Research, Souderton, PA, 
USA). The signal at one position comprised 30 bursts of 25 sine cycles (center frequency 
1.1 MHz) with a burst repetition rate of 100 Hz. The peak negative pressure ranged from 
190 kPa (20 mV) to 860 kPa (100 mV). 
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                                                                                                           a) Ibidi cell container 
placed upside down in water bath containing cells and floating microbubbles adjacent to 
the cells. b) Complete set up of ibidi cell container in water tank where ultrasound 
transducer is adjusted using a computerized positioning system to scan the ibidi cell 
container.  
The ibidi cell container (µ-slide I 0.4 Luer, ibidi, Martinsried, Germany) was positioned 
upside down in a water bath in the focus of the transducer, so that the floating 
microbubbles were adjacent to the cells. The cell compartment was scanned with a 
positioning system (Owis, Staufen, Germany) in steps of 1 mm. The complete set-up is 
shown in Figure 7.1. 
 
 
152Figure 7.1:  Set up for ultrasonic treatment experiment using ibidi cell container.  
 
 
 
 
The acoustic output measurements were accomplished with a calibrated 0.2 mm needle 
hydrophone (with corresponding DC coupler, preamplifier PA07084, and booster 
amplifier, Precision Acoustics Ltd, Dorchester, UK) according to the DIN EN 62127-1 
using the same devices (signal generator, power amplifier) as described above. The 
signals were recorded with a 12 bit PCI digitizer (DP308 Acqiris; Agilent Technologies, 
Santa Clara, CA, USA) at 100 MHz sampling frequency. At one position, 200 signals 
a)  
b)  
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                                                                              The sound field (peak negative pressure) 
measured for the three orthogonal planes, a) xy plane, b) xz plane and c) yz plane. The -6 
dB lateral focal width is 2.6 mm and the axial focal width is 19.2 mm. The sound field 
was scanned in steps of 0.4 mm in x- and y-direction (lateral) and in steps of 2 mm in z-
direction using a positioning system (XPS, Newport Corporation, Irvine, CA, USA). 
  
were averaged to reduce noise. The sound field was scanned in steps of 0.4 mm in x- and 
y-direction (lateral) and in steps of 2 mm in z-direction using a positioning system (XPS, 
Newport Corporation, Irvine, CA, USA). The data were interpolated by a factor of 5. In 
the Figure 7.2, the sound field (peak negative pressure) is shown for the three orthogonal 
planes. The -6 dB lateral focal width is 2.6 mm and the axial focal width is 19.2 mm. 
 
 
 
153Figure 7.2:   Measured sound field for three orthogonal planes.
 
 
 
c)  
a)  
b)  
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To estimate the spatial-peak temporal-average intensity Ispta, the relevant part of the 
sound field was scanned with a finer grid (0.2 mm in x-and y-direction, 1 mm in z-
direction). For one burst of 10 sine cycles, the spatial-peak temporal-average intensity 
Ispta was evaluated in the time interval in which the envelope of the pressure amounted at 
least 10 % of the maximum amplitude. Since the steady state was reached within these 10 
sine cycles the Ispta for one burst of 25 sine cycles could be calculated to be 𝐼𝑠𝑝𝑡𝑎 =
456 W/cm2 for a peak negative pressure of 1 MPa. 
 
7.4 Analysis of Phosphatidylserine Exposure after Ultrasonic Treatment 
 
Analysis of Ultrasound-induced Phosphatidylserine Exposure Using Flow cytometry 
After a post-incubation time of 2 hours, ultrasound-treated cells were detached from ibidi 
cell container by trypsinization (0.05% Trypsin, 0.02% ETDA, PAA), washed twice with 
phosphate-buffered saline (PBS, Gibco) and resuspended in 100 μl binding buffer 
according to Schellenberger (Schellenberger 2003). Surface exposure of 
phophatidylserine (PS) was detected by adding annexin V-FITC to the cells in a final 
concentration of 0.225 μg/1,5*105 cells (2.25 μg/ml). To distinguish between early 
apoptotic cells with PS-exposure and necrotic or late apoptotic cells, 1.5 μg propidium 
iodide per 1,5*105 cells (15 μg/ml) was added. The cells were subsequently incubated at 
room temperature in the dark for 10 minutes. After one further washing step, cells were 
directly measured using a FACS Calibur Flow Cytometer (Becton-Dickinson, San Jose, 
USA). For each measurement, 10,000 cells were counted and results were analysed with 
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CellQuest Pro Software (BD). Annexin V-FITC positive cells were considered as early 
apoptotic; Propidium iodide/FITC positive cells as late apoptotic or necrotic. 
 
Factor X Activation Assay 
To demonstrate the improvement of coagulation activity by the exposure of PS on 
endothelial cells, we performed factor X activation assay as described by Ruf et al. (Ruf 
et al., 1991). Briefly, 20 μl of the following reagents were added to each well of a 96-
well-microtiter plate: (a) 50 nM recombinant FVIIa (Novo-Nordisk, Bagsværd, 
Denmark) in TBS containing 0.1% bovine serum albumin (BSA); (b) 750 pM tTF-NGR 
protein in TBS-BSA; (c) 25 nM CaCl2 in TBS-BSA and, instead of phospholipids, (d) 
5000 ultrasound-treated HUVECs with a post-incubation time of 2 hours at 37°C and 5 % 
CO2, or 5000 untreated cells. After 10 minutes at room temperature, the substrate FX 
(Enzyme Research Laboratories, Swansea, UK) was added in a final concentration of 
1 μM. After additional 10 minutes, the reaction was stopped in 100 nM EDTA and 
Spectrozyme FXa (American Diagnostica, Greenwich, USA; final concentration 0.7 mM) 
was added. The rates of FXa generation were monitored by the development of color at 
405 nm with a microplate reader (Bio-Rad, München, Germany).  
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CHAPTER 8: PROJECT SUMMARY 
 
8.1 Summary 
 
This study first introduces the three structures that are discussed throughout the thesis, the 
lipid encapsulated SF6 microbubble (also referred to as un-nested or freely floating 
microbubble), a polymeric nested microbubble consisting of a polymer microsphere with 
an aqueous core containing the SF6 microbubbles, and a liposomal nested microbubble 
identical to the polymeric nested microbubble except that the polymer microsphere is 
replaced with a liposome. The polymeric nested microbubble is advantageous for contrast 
imaging because it offers increased longevity and decreased inertial cavitation events 
compared to un-nested microbubbles. As the diameter of the polymeric nested 
microbubble increases from 2-20 µm, the brightness and longevity of the contrast agent 
increase but the resistance to inertial cavitation decreases. An ideal polymeric nested 
microbubble in the mid-size range would be ideal for increasing longevity while 
simultaneously increasing resistance to inertial cavitation events. In order to achieve 
leakage of the nested microbubble contents, we switch over to the liposomal nested 
microbubble formulation. The flexible structure allows for poration of its membrane so 
that a drug contained within the core is released with an ultrasound trigger. The last study 
discussed in Chapter 7 studies the influence of microbubble cavitation on cell death, but 
unfortunately mechanical issues with the system did not allow for any meaningful results. 
The methods are discussed in hopes that this study can be continued. 
 
275 
 
The aim of the inertial cavitation study was to determine the effect of a spherical polymer 
nesting shell of varying diameter on the cavitation behavior of an SF6 microbubble with a 
95% DSPC/5% DSPE-PEG3000 monolayer. A home built cavitation detection system 
consisting of two 2.25 MHz transducers to detect the presence of an oscillating 
microbubble was used to determine the extent of inertial cavitation for each sample of 
nested microbubbles tested.   It was found that nesting an SF6 microbubble with a 
phospholipid coating within a spherical PLA shell increases the inertial cavitation 
threshold and also causes a change in the shape of the cavitation profile. At 1 MPa, the 
percent destruction of un-nested microbubbles is 97.96%, while that of nested 
microbubbles is 51.02, 38.94, 33.25, 25.27, 19.09, and 5.37 % respectively for decreasing 
shell diameters of 20.571 to 1.948 μm. It is proposed that the change in behavior is due to 
a change in stiffness as manifested in a change in resonance frequency of the system but 
the details remain unknown.  It is clear that the shell impacts the cavitation behavior of 
the microbubbles which begs the question of how the water passes through the polymer 
shell and the inertial effect this has on the physics of the system.  
 
Nested microbubbles also have the ability to improve contrast longevity while providing 
contrast equivalent to un-nested formulations. At 40 minutes, there was no indication of 
decreasing contrast ratio from the nested formulations, but the experimentation time was 
limited to the availability of the clinical ultrasound machine. The results are consistent 
with a two stage dissolution process, ambient diffusion which occurs immediately after 
formulation and ultrasound induced dissolution which occurs under ultrasound exposure. 
A modified version of the Sarkar model for gas diffusion from phospholipid-shelled 
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microbubbles with the addition of a time dependent saturation term is used to model the 
first stage of ambient diffusion. The six nesting formulations with average outer capsule 
diameters of 1.95, 2.53, 5.55, 9.95, 14.95, and 20.51 μm reached final contrast to tissue 
ratio (contrast ratio) values of 0.25, 2.35, 3.68, 4.51, 5.93, and 8.00 dB respectively at the 
end of the 40 minute trial. The number and size of nested microbubbles affects the level 
of gas saturation that can be achieved for a given capsule size. Moreover, the 
heterogeneity of sizes within a given formulation will also influence the diffusion profiles 
during diffusion stages 1 and 2.  
 
Although leakage was not obtained with the polymeric nested microbubbles, when a 
nesting shell comprised of a liposome replaces the polymer shell, we find that the 
liposomal nested microbubbles are effective candidates for triggered drug delivery 
vehicles with an ultrasound trigger. The liposomal nested formulation has dual benefits: 
triggered release of contents of the aqueous core of the liposome and an increase in image 
brightness longevity.  Triggered release can be accomplished with both high and low 
frequency transducers, although high frequency is of greater interest due to its potential 
use in a clinical setting owing to avoidance of deleterious effects to tissue. Low 
frequency experiments with an ultrasound probe operating at 24 kHz proved that leakage 
was accomplished with and without microbubbles incorporated into the liposome core. 
 
8.2 Implications 
 
In recent years, advocacy groups such as the International Contrast Ultrasound Society 
have made major efforts toward proving the diagnostic potential and safety of ultrasound 
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contrast agents [22]. The routine clinical use of contrast agents as drug delivery vehicles 
is still in the beginning stages of clinical acceptance. The regulatory status of the novel 
use of ultrasound-directed therapies in conjunction with microbubble contrast agents will 
receive more attention as research proves its efficiency for a wide variety of applications 
in the medical field. Many treatments allowed with contrast agents, such as gene therapy, 
could transform the handling of inherited conditions. In 2006, two patients received retro 
viral vector treatment to restore gp91 phox function leading to the formation of the 
chemical compounds needed for white blood cells to kill bacteria [12]. Shortly after this 
study, cancer was treated for the first time using the gene therapy of adoptive cell 
therapy. In this study, autologous lymphocytes were reengineered using a retrovirus to 
target and attack advanced metastatic melanoma in 25 patients [79]. 
 
The current clinical applications of UCAs are exclusively approved for diagnostic 
imaging [188]. However, future applications include an exemplar shift towards 
therapeutic options. The microbubbles that currently serves as a ‘‘stealth’’ agent have the 
potential to become a unique vehicle for delivering site-specific, drugs and/or genes to 
the target organs. The transformation of UCAs from a diagnostic modality to a 
therapeutic option is created when in vivo microspheres are acoustically disrupted by an 
externally applied acoustic energy that results in a disruption of the bubbles and release 
of its payload at a target site. More recently, the uses of UCAs include site-specific 
delivery of drugs/genes. Thus, an entirely new field of non-viral, ultrasound mediated 
drug delivery is opening up [188]. Leading scientists throughout the world have 
successfully demonstrated non-viral transduction through sonoporation in a variety of 
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pre-clinical scenarios [24]. This demonstrates the scientific advancements in therapeutic 
options possible with contrast agents. 
 
A large effort is being dedicated to making major advancements in all aspects of the 
contrast agent technology. Expertise in the fields of cellular physiology, genetics, 
physical chemistry, and acoustic physics are all working on common goals that involve 
microbubble contrast agents. It is believable that the new partnerships made between 
these fields will be developed among industry, research labs, and pharmaceutical 
companies to accelerate the novel fields of microbubble based science. 
 
8.3 Future Outlook 
. 
The path forward will most likely involve the liposomal nested microbubble and their 
potential as a triggered drug delivery vehicle as discussed in Chapter 6. A detailed study 
for various nested formulations evaluating the fraction of microbubbles undergoing 
inertial cavitation for each peak negative pressure is imperative to understanding this 
novel drug delivery vehicle. The first step towards doing this would be to combine the 
inertial cavitation testing apparatus with the calcein leakage detection system so that 
when the ultrasound transducer frequency is varied, one can simultaneously measure 
calcein release and inertial cavitation events. A well-documented relationship between 
the cavitation events and subsequent leakage from the liposome would allow the 
development of a model for transport of the drug molecule as a function of ultrasound 
pressure. This proves to be a very complex model due to the complications involved with 
identifying pore radius as a function of ultrasound time and differentiating between 
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dilation and temporary poration as well as between permanent poration and rupture of the 
vesicle. 
 
Future work may include the use of molecular weight size markers in the fluorescence 
quenching assay to determine pore size at high and low pressure amplitudes (in order to 
differentiate between dilation, poration, and rupture). Generally speaking, pore sizes 
which have been reported as a consequence of inertial cavitation (hundreds of nanometer 
to micrometer range) are larger than pores reported during stable cavitation (nanometer to 
hundreds of nanometers). Determining the relative contribution of the two major routes to 
release- liposome destruction vs. diffusion through the lipid membrane- as a function of 
bilayer properties and ultrasound parameters is of utmost importance for the development 
of a theoretical model for US-induced pore nucleation and growth in lipid bilayers. 
. 
Another seeming phenomenon is the identification of a suspected “optimum” formulation 
for the liposomal nested microbubble which takes into account the microbubble to 
liposome diameter ratio. Identifying this, or at least creating a thorough set of 
experiments varying microbubble concentration and liposome diameter, would be 
pertinent to create a personalized drug delivery vehicle. If an opportunity arises, an in 
vivo study would be ideal for drug release monitoring. 
 
The resounding theme of this research, specifically with the nested formulations, is a 
need to extrapolate the number of microbubbles nested within a shell, the size distribution 
of the microbubbles within a shell, and the efficiency of the nesting process. These key 
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pieces of information of pertinent to modeling the nested microbubbles for their use in 
drug delivery and imaging. Theories are constructed around an estimate for each of these 
parameters, but it is not yet on a sound scientific footing. To mathematically describe the 
nested formulation, the wall to wall interactions between microbubbles and shell must be 
elucidated. 
 
To accurately measure the resonance frequency of a microbubble nested within both a 
polymer shell and a liposome, a reliable experimental apparatus should be explored and 
constructed. Identifying the change in resonance frequency brought on by the nesting 
shell is key to creating a model for the inertial cavitation of nested microbubbles. For 
inertial cavitation studies, the research from here on out involves varying surface tension 
and dilational viscosity using phospholipids (different chains lengths like DLPC, DMPC, 
DPPC, DSPC, DAPC). New contributions to existing model for inertial cavitation include 
capturing the influence of elasticity using area expansion modulus, KA, which varies in a 
known way with respect to PEG and using a modified equation to examine inertial 
cavitation phenomena to identify a critical microbubble wall velocity for cavitation. 
 
The nested formulation shows great promise in the field of ultrasound imaging as a safer, 
longer lasting alternative. Experiments have been done to prove the reliability of the 
polymeric nested microbubbles for this application, but as of yet, an ultrasound induced 
dissolution model has not been developed to understand the mechanism of their behavior. 
The influence of the number and size of microbubbles inside each microcapsule should 
be tested so that a modification of the mathematical model to account for added 
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resistance to cavitation imposed by capsule wall can be constructed. A means to measure 
gas dissolution or change in microbubble radius as a function of time in the presence of 
ultrasound is desired. Gaining access to a high speed camera would likely be necessary in 
order to do this.   
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APPENDIX A: List of Abbreviations 
 
CTR   Contrast to tissue ratio 
DAPC  Diarachidoyl phosphatidylcholine 
DLPC  Dilauroyl phosphatidylcholine 
DMPC Dimyristoyl phosphatidylcholine 
DPPC  Dipalmitoyl phosphatidylcholine 
DSPC  Distearoyl phosphatidylcholine 
ED50  Median effective drug dose 
FDA  Food and Drug Administration 
GUV  Giant uni-lamellar vesicles 
LD50  Median lethal drug dose 
LFUS   Low frequency ultrasound 
MB  Microbubbles 
MI  Mechanical index 
MW  Molecular weight 
PBS  Phosphate Buffer Solution 
PEG  Polyethylene glycol 
PLA  Poly (l-lactic acid) 
PNP  Peak negative pressure 
PVA  Polyvinyl alcohol 
RPNNP Rayleigh-Plesset-Noltingk-Neppiras-Poritsk 
SEM  Scanning electron microscope 
SF6  Sulfur hexafluoride 
tPA  Tissue plasminogen activator 
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UCA  Ultrasound contrast agent 
US  Ultrasound 
UV   Ultraviolet  
W/O/W Water in oil in water 
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APPENDIX B: List of Symbols 
 
𝑪∞   Gas concentration far from the bubble 
𝑪𝑾   Gas concentration at the inside wall of encapsulation monolayer 
?̈?   Bubble wall acceleration 
?̇?   Bubble wall velocity 
𝒉𝒈   Permeability of gas through the encapsulation monolayer 
𝒌𝒈   Diffusivity of gas in the surrounding liquid 
𝝆𝑯𝟐𝑶   Density of water 
𝝆𝑺𝑭𝟔    Density of gas 
𝝆𝑺𝑭𝟔    Density of gas 
𝝆𝒍   Density of liquid 
c  Speed of sound 
Dw   Gas diffusivity in water 
Es   Dilatational surface elasticity 
f   Saturation of the medium 
f   Degree of saturation in bulk medium 
L  Ostwald coefficient 
Lg   Ostwald coefficient 
patm   Atmospheric pressure  
Pσ Internal microbubble pressure 
R   Bubble radius 
R0  Initial microbubble radius 
Rshell   Resistance of shell to gas permeation,  
γ0   Initial surface tension 
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η  Ratio of particles greater than 5 μm to between 2.5 and 5 μm 
ηs  Shear viscosity 
κ   Polytropic factor 
λ  Relaxation time 
μ   Viscosity of the surrounding medium 
σ  Microbubble surface tension  
σshell   Surface tension of shell  
ω0  Microbubble resonance frequency 
𝑷(𝒕)   Driving pressure 
𝒏   Number of microbubbles nested within the shell  
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